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ABSTRACT 
Stigma can affect many aspects of life for those who are subject to stigmatization. 
As contact with stigmatized groups increases, less stigmatization occurs. Marijuana is 
one of the most commonly used illegal substances and is growing in popularity. 
Relatively few studies have examined the relations between stigma and specific 
substance use or particular characteristics of non-users that may influence stigma. 
Additionally, current anti-stigma interventions targeted at the general population have 
been largely unsuccessful in the reduction of stigma. The current study assesses a 25-
minute online psychoeducational module designed to increase knowledge and reduce the 
stigma of recreational marijuana users in a more efficient, practical, engaging, and cost-
effective way which can be easily applied to any anti-stigma intervention program. The 
module surveyed 201 college students from a public Midwestern university where 
participants were randomly assigned to one of two groups; a module group (N = 104) and 
a control group (N = 97). Specifically, the module was shown to increase knowledge 
regarding marijuana, however, there was little to no impact on stigma (i.e., preferred 
social distance, perceived dangerousness, negative emotions regarding marijuana use). 
Additionally, findings indicate strong associations between the level of familiarity, the 
level of contact, and stigma. Specifically, as the level of familiarity or level of contact 
increases, less stigmatization occurs. In addition, limited support was found for the 
moderating role of gender, past marijuana use, and age on the established association 
between the level of familiarity and level of contact on stigma levels. Furthermore, we 
explored the relationship between the level of familiarity, the level of contact, and the 
likelihood of future use. After establishing this strong relationship, we examined whether 
sex, any past marijuana use, and age would moderate this potential relationship. Results 
indicate that when familiarity is high, individuals will have a higher likelihood of future 
use if they already have a prior history of marijuana use. However, there were little to no 
differences in the likelihood of future use when familiarity was low, even with a prior 
history of marijuana use. No other characteristics seemed to impact this relationship. 
Findings have implications for anti-stigma interventions. 
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Marijuana is the most commonly used drug today across varied age and 
demographic groups with nearly 19.8 million Americans reporting marijuana use in the 
past month (Substance Abuse and Mental Health Services Administration [SAMHSA], 
2014). However, members of the wider public often view marijuana use as aberrant 
(Bottorff et al., 2013), despite rapid shifts in public opinion towards the legalization of 
marijuana in recent years (Pew Research, 2015). Currently, the majority of Americans 
(53%) support marijuana legalization. However, not everyone is supportive towards 
legalization efforts which can leave room for stigmatization towards those who currently 
use or want to legalize marijuana (Pew Research, 2015). These negative societal views 
which deem illicit drug use as unacceptable behavior can create more negative opinions 
about users which, in turn, can promote stigma (Ahern, Stuber, & Galea, 2007).  
Exposure to stigma poses a risk to the health and well-being of those who are 
subject to stigmatization (Feldman & Crandall, 2007), as well as significant economic 
impacts on a societal level and adverse effects on employment opportunities for the 
stigmatized (Sharac, McCrone, Clement, & Thornicroft, 2010). Mental illness stigma has 
been broadly researched and mainly focuses on the impact of stigma on severe mental 
disorders (Link, Struening, Neese-Todd, Asmussen, & Phelan, 2001; Rusch, 
Angermeyer, & Corrigan, 2005), with particular emphasis on schizophrenia, major 
depression, and substance use (Corrigan, Edwards, Green, Diwan, & Penn, 2001; 
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Griffiths et al., 2006; Holmes, Corrigan, Williams, Canar, & Kubiak, 1999; Link, Phelan, 
Bresnahan, Stueve, & Pescosolido, 1999; Stuart & Arboledo-Florez, 2001). Substance 
use, in particular, has been found to be associated with varying degrees of stigma, with 
illicit drug users among the most stigmatized groups (Ahern et al., 2007; Corrigan, 
Sachiko, & O’Shaughnessy, 2009). Research on substance use has broadly provided a 
wealth of information regarding the perceived causes and impact of stigma towards those 
with mental illness. However, there is still a noticeable gap in the literature examining 
stigma of specific substance use (Brown, 2011; Livingston, Milne, Fang, & Amari, 2011) 
and particular characteristics of non-users that may influence stigma (Palamar, Kiang, & 
Halkitis, 2012). Identification of characteristics that could influence the relation between 
stigma and specific substance use is an essential step toward implementing targeted anti-
stigma intervention programs. Research in this area is crucial given that relatively few 
anti-stigma interventions for substance use disorders have been shown to work in the 
reduction of stigma for the general public (Livingston et al., 2011). Reducing stigma 
through education has had limited success specific to substance use stigma (Livingston et 
al., 2011), however, providing factual information focusing on common misconceptions 
has had success in past mental health stigma research (Mayville & Penn, 1998; Penn & 
Martin, 1998). 
The current study focuses on pilot-testing a psychoeducational intervention 
module to increase knowledge and reduce stigmatized views towards recreational 
marijuana users.  First, the study assessed whether the psychoeducational module about 
marijuana reduces stigma by increasing knowledge and familiarity with marijuana and its 
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uses. Next, we examined the relations between the level of contact and the level of 
familiarity with recreational marijuana users and the accompanying stigma level (i.e., 
preferred social distance, perceived dangerousness, and negative affect). Finally, this 
study investigated certain characteristics (i.e., sex, age, and current marijuana use) that 
may account for differences in the relation between the level of contact or level of 
familiarity and stigma. 
Defining Stigma and Strategies for Change 
Stigma is a socially constructed concept defined as a process where an individual 
(or group of people) are perceived negatively to the point of being considered defective 
because of a disparaging attribute (Goffman, 1963; Link, Yang, Phelan, & Collins, 2004) 
which symbolizes deviance from societal values (Jones et al., 1984). Stigma ultimately 
dehumanizes the person targeted by this form of discrimination (Link et al., 2004), and 
mental-health-related stigma has been described as having worse consequences than the 
mental health condition itself (Thornicroft, Deb, & Henderson, 2016). Broadly, stigma 
depends on the context of a particular social situation (Janulis, Ferrari, & Fowler, 2013; 
Major & O’Brien, 2005). Specifically, individuals may be subject to stigmatization in 
certain situations but not in others. For example, a person may experience stigmatization 
because of their disorder when going to see a doctor for alcoholism, but may not 
experience stigma when they go to a bar with friends. Thus, previous research indicates 
that stigma can be context-specific, and is the product of a particular social situation 
(Janulis et al., 2013). While stigma is context-specific, several categories of stigma also 
exist; for instance, some of the more researched forms of stigma are self-stigma and 
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public stigma (Corrigan, Markowitz, Watson, Rowan, & Kubiak, 2003). Self-stigma 
refers to an individual’s internalized loss of self-esteem and self-efficacy that makes the 
stigmatized foster dislike toward themselves. In contrast, public stigma refers to members 
of society having negative attitudes towards individuals from stigmatized groups 
(Corrigan & Watson, 2002; Janulis et al., 2013).  
Currently, researchers are starting to apply information learned about prejudice 
and stereotypes to public stigma related to mental illness which aids in the understanding 
of how public stereotypes have been translated into discriminatory behavior (Corrigan & 
Watson, 2002). Three components of public stigma exist (i.e., stereotypes, prejudice, and 
discrimination) that build on one another. Stereotypes are mutually held notions about 
members of a particular social group. Prejudice goes beyond stereotypes by ultimately 
producing negative emotional reactions due to the support of negative stereotypes. 
Finally, discrimination takes this one step further by making individuals act on their 
prejudices, resulting in harm towards those from a particular group (Corrigan et al., 
2003). For example, people who perceive mental illness as dangerous or aggressive 
behavior are more willing to discriminate against this target group (Angermeyer & 
Matschinger, 1996; Corrigan, Green, Lundin, Kubiak, & Penn, 2001), indicating the 
major role perceived dangerousness plays in public stigma. Identifying the antecedents of 
public stigma is essential for the design of intervention programs that target the reduction 
of stigma.   
Several strategies have been suggested to change public stigma including protest, 
education, and contact (Corrigan & Penn, 1999). The efforts of groups who challenge 
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stigma by protesting incorrect and hostile depictions of mental illness send messages to 
the media and the public (Corrigan & Watson, 2002). The message the protesters send to 
the media is to stop reporting incorrect depictions while the message they send to the 
public is to stop believing the primarily negative opinions about mental illness (Corrigan 
& Penn, 1999). However, there is very little research assessing the impact of protest 
campaigns on discrimination and stigma, suggesting an avenue for future research efforts 
(Corrigan & Watson, 2002). Reducing stigma through education, on the other hand, 
attempts to promote more positive attitudes supported by facts (Corrigan & Watson, 
2002). Successful reduction of stigma and improved attitudes about person with these 
problems through education has received greater empirical support (Corrigan, River et 
al., 2001; Holmes et al., 1999; Keane, 1990; Link & Cullen, 1986; Morrison, Cocozza, & 
Vanderwyst, 1980; Penn et al., 1994) and seem to be effective for a wide range of 
participants (Corrigan & Watson, 2002). Additionally, increasing contact with people 
from a stigmatized group is related to a decrease in the level of stigma (Corrigan & 
Watson, 2002). Specifically, less stigmatization occurs when contact with stigmatized 
groups increases (Corrigan & Watson, 2002; Feldman & Crandall, 2007). While it is 
important to understand these various ways stigma can be changed in the mental health 
field as it aids in the development of successful, anti-stigma interventions, researchers 
must also understand the impact stigma can have on an individual’s life.  
Mental Illness, Stigma, and its Effects 
Past research has primarily focused on the impact of stigma on mental illness in 
general (Corrigan, Green et al., 2001; Griffiths et al., 2006; Link et al., 1999; Link et al., 
6 
 
2001; Rusch et al., 2005). Mental illness is a very serious issue and is highly prevalent in 
the adult population of the United States, estimated to affect about 26% of the population 
(Kessler, Chiu, Demler, & Walters, 2005). Although some cases are milder than others, 
about 14% of the estimated 26% are considered to be serious (Kessler et al., 2005), 
making mental illness a prominent issue in the United States. Mental illness can be 
harmful to those suffering from it in two ways. First, there are tangible and direct effects 
that occur because of the disorder itself, whether it be cognitive, emotional, or behavioral 
difficulties. These effects can be detrimental to the individual. Secondly, those suffering 
from mental illness may also experience stigma.  
Mental illness stigma has been examined on a national level using the Behavioral 
Risk Factor Surveillance System (BRFSS). The BRFSS is an established health survey 
issued by the Centers for Disease Control in all 50 states, the District of Columbia, Puerto 
Rico, the U.S. Virgin Islands, and Guam. The vast majority of adults (> 80%) surveyed in 
the US agreed that treatment is effective for individuals who have a mental illness, but 
fewer adults (35-67%) agreed that others are caring and sympathetic to persons living 
with mental illness (Kobau et al., 2012). Respondents who had already been receiving 
mental health services and who reported mental illness symptoms more often strongly 
disagreed that others are caring and sympathetic to individuals living with mental illness 
(Kobau et al., 2012). These findings show that the majority of people who experience 
mental illness symptoms do not believe others to be caring or sympathetic to their 
situation which is only one example of the many consequences of stigma.  
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Stigma has far-reaching psychological, social, and financial consequences at both 
the individual and societal level. When individuals are branded as belonging to a 
particular group (e.g., marijuana user), nonusers devalue their defining qualities and traits 
based on this tarnished identity (Brown, 2011; Hinshaw, 2007). Hence, those suffering 
from stigmatization receive automatic judgment and discrimination that might be based 
primarily on being part of a particular group. So, not only do these individuals have to 
suffer through the struggles that accompany being involved with a particular group or 
having a mental disorder, but they also receive unfair treatment as a consequence.  
The psychological and social consequences of stigma are extensive (Agnew & 
South, 2014; Baumeister, Twenge, & Nuss, 2002; Cukrowicz & Poindexter, 2014; 
DeWall & Bushman, 2011; Feldman & Crandall, 2007; Leary, 2010), and may result in 
unfair treatment of those who are subject to stigmatization (Feldman & Crandall, 2007). 
This stigmatization may impact many aspects of life and may be expressed through 
family discord, job discrimination, social rejection, interpersonal disruption, or a faulty 
social identity (Corrigan, Watson, & Miller, 2006; Feldman & Crandall, 2007). 
Specifically, individuals who are stigmatized experience interpersonal disruption where 
they have difficulty starting or maintaining interpersonal relationships (Agnew & South, 
2014). According to the interpersonal theory of suicide, trouble maintaining these 
interpersonal relationships puts them at an increased risk for suicidal ideation (Cukrowicz 
& Poindexter, 2014). Additionally, stigmatized individuals may experience either social 
rejection (i.e., others try to exclude them from a relationship or social group) or faulty 
social identity (i.e., inconsistency between virtual and actual social identity; Leary, 2010; 
8 
 
Goffman, 1963). This experience of rejection and faulty identity has detrimental effects 
on an individual’s psychological well-being (Corrigan, 2004; Link & Phelan, 2006). In 
addition, social rejection can influence both cognitions and emotions of the stigmatized 
individual (DeWall & Bushman, 2011). It also increases negative emotions such as hurt 
feelings (DeWall & Bushman, 2011), as well as anger, anxiety, depression, sadness, and 
jealousy (Leary, 2010). Stigma can even impact cognitive performance on challenging 
intellectual tasks (Baumeister et al., 2002). Furthermore, mental illness stigma is a major 
barrier to finding and receiving psychological treatment (Corrigan, 2004; Link et al., 
2001).  
Additionally, the financial consequences of stigma and mental disorders are 
considerable and can impact society financially in a variety of ways (Kessler et al., 2008). 
For instance, there are direct costs that are associated with mental disorders which 
include medication, hospitalization, and clinic visits, however, there are also indirect 
costs that occur such as lost earnings which are estimated to cost the nation nearly $193 
billion annually (Kessler et al., 2008). This may even be an underestimate of the 
potentially lost earnings because very few participants had chronic illnesses (e.g., autism, 
schizophrenia, etc.) and the study did not assess people in hospitals or prisons (Kessler et 
al., 2008). The negative, wide-ranging impacts resulting from stigma at both a societal 
and individual level makes anti-stigma intervention research particularly important. 
Although past research most often focused on stigma related to mental illness broadly, in 
more recent years, researchers focus more on stigma related to specific mental illnesses 
such as major depression, anxiety, schizophrenia, and substance use (Alonso et al., 2008; 
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Holmes et al., 1999; Latalova, Kamaradova, & Prasko, 2014; Stuart & Arboledo-Florez, 
2001). Substance use, in particular, is a vastly underexplored topic, especially when 
considering the broad range of substances available.  
Substance Use Stigma 
Relatively few studies have addressed the impact of stigma on specific 
psychological disorders. Fewer studies still have explored substance use disorders, 
although illegal drug use is often subject to stigma all over the world (Palamar et al., 
2012), and substance use disorders are among the most dangerous psychological 
disorders (Link et al., 1999). Substance use disorders are fairly common, affecting 
approximately 21.6 million Americans nationwide (SAMHSA, 2014). Furthermore, drug-
related emergency department visits seem to be on the rise. Over 125 million total visits 
were made to emergency departments in 2011 (SAMHSA, 2013). The Drug Abuse 
Warning Network estimates the number of drug-related emergency department visits to 
be over 5 million of the total visits; this represents a 29% increase from the 2009 number 
of emergency department visits (SAMHSA, 2013).  Of these 5 million emergency visits, 
about 2.5 million visits involved drug misuse or abuse, indicating a 19% increase since 
2009 alone (SAMHSA, 2013). The increase in visits takes a toll financially on society. 
Furthermore, there are a number of serious consequences to society due to substance use 
disorders (Rasinski, Woll, & Cooke, 2005), including the potential to generate extremely 
high costs for individuals with the disorder, their family, and society in general (Luoma, 
Kulesza, Hayes, Kohlenberg, & Larimer, 2014).  
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Other health conditions tend to be less stigmatized than substance use disorder 
(Corrigan et al., 2005; Rao et al., 2009; Ronzani, Higgins-Biddle, & Furtado, 2009; 
Room, 2005; Schomerus et al., 2011). Greater stigmatization of substance use disorders 
could be due to the unique stigma associated with the disorders where individuals view it 
as both a crime and a disease. Society has criminalized substance-using behaviors to deter 
others from using these drugs (Livingston et al., 2011). However, criminalizing substance 
use only exacerbates stigma by making people more prone to exclude individuals who 
use illegal substances. For instance, stigma is often used to deter (Janulis et al., 2013) and 
marginalize unhealthy behaviors (Livingston et al., 2011); however, this has an added 
consequence of devaluing and marginalizing certain social groups, which can be 
detrimental to those already using the drugs (Room, 2005). Substance use stigma lowers 
societal support for intervention programs (Capitanio & Herek, 1999) and discourages 
individuals from seeking treatment (Fortney et al., 2004; Kushner & Sher, 1991). 
Furthermore, stigma increases embarrassment and decreases expectations for substance 
users (Luoma et al., 2007; Semple, Grant, & Patterson, 2005) and their family members 
(Corrigan et al., 2006). These consequences hinder the stigmatized individual’s ability to 
receive adequate treatment for their disorder, potentially impacting their life even further. 
Research on the detrimental consequences of substance use stigma highlights the need for 
successful, specifically targeted anti-stigma intervention programs.   
Current Anti-Stigma Interventions in the Substance Stigma Field 
 Current stigma research has provided a better understanding of the magnitude of 
the problems associated with stigma and its harmful effects (Livingston & Boyd, 2010; 
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Logie & Gadalla, 2009; Mak, Poon, Pun, & Cheung, 2007), however, research has been 
relatively limited on anti-stigma intervention strategies (Dalky, 2011; Schachter et al., 
2008). Livingston and colleagues (2011) conducted a systematic review empirically 
evaluating thirteen wide-ranging studies (e.g., target groups, methods) to get a better 
understanding of which anti-stigma intervention approaches have been used thus far. The 
type of stigma varied across studies and included self-stigma (i.e., individual with 
substance use disorder attitudes), social stigma (i.e., general public’s attitudes), and 
structural stigma (i.e., medical student, police officer, and substance use counselor 
attitudes; Livingston et al., 2011).  
Many different types of intervention approaches were used across each type of 
stigma. For instance, the interventions used to reduce self-stigma included an Acceptance 
and Commitment Therapy (ACT) group (Luoma, Kohlenberg, Hayes, Bunting, & Rye, 
2008), a surgical procedure to remove needle track marks from injection drug users 
(Shuster & Lewin, 1968), and a skills training and vocational counseling program 
(National Institute on Drug Abuse [NIDA], 1978). Additionally, most structural stigma 
interventions comprised of a variety of techniques aimed at structured education, 
including direct contact with substance users (Bland et al., 2001; Meng, Rayburn, 
Ramirez-Cacho, & Rayburn, 2007; Ramirez-Cacho, Strickland, Beraun, Meng, & 
Rayburn, 2007; Silins, Conigrave, Rakvin, Dobbins, & Curry, 2007) and educational 
critical reflection techniques (Ballon & Skinner, 2008). The remaining structural stigma 
interventions used a Crisis Intervention Team program (Bahora, Hanafi, Chien, & 
Compton, 2008) and multi-cultural training (Hayes et al., 2004). Furthermore, social 
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stigma intervention approaches included educational factsheets (Luty, Umoh, Sessay, & 
Sarkhel, 2007), motivational interviewing (Luty, Umoh, & Nuamah, 2009), and positive 
recovery/remission story leaflets (Luty, Rao, Arokiadass, Easow, & Sarkhel, 2008).  
The results from the social stigma studies are of particular importance for the 
current study (Luty et al., 2007; Luty et al., 2009; Luty et al., 2008) which focuses on 
reducing stigma through education. Findings indicate only small effects when presenting 
individuals with factsheets and asking them to read through them or having individuals 
go through extensive education courses (Luty et al., 2009; Mayville & Penn, 1998; Penn 
& Martin, 1998). However, providing factual information focusing on common 
misconceptions about those suffering from mental illness have been reported to reduce 
stigma, regardless of the method of delivery (Mayville & Penn, 1998; Penn & Martin, 
1998). Currently, time commitment for successful interventions for mental illness stigma 
tend to last several days (Bahora et al., 2008) to weeks (Bland et al., 2001), and are not 
typically targeted at the general public, but rather persons providing services to 
stigmatized individuals such as police officers or healthcare professionals. While 
targeting these individuals for anti-stigma interventions is of vital importance, targeting 
the general public could potentially address stigma on a larger scale rather than an 
individual level.   
Unfortunately, Livingston and colleagues (2011) were unable to make any 
conclusive remarks about what kind of intervention strategies are effective for reducing 
self, social, and structural stigma, given the wide range of studies and approaches as well 
as the overall lack of research in this area. Their systematic review highlights several 
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inconsistencies in the anti-substance use stigma intervention literature (Livingston et al., 
2011). For instance, this review emphasizes the noticeable gap in the literature of anti-
stigma interventions aimed at child and youth populations, which may be a frontline 
preventative measure against stigma (Livingston et al., 2011; Schachter et al., 2008). 
Additionally, very few studies assessed stigma outcomes beyond the immediate post-
intervention period, therefore, it remains unclear whether these effects would carry over 
in the medium- to long-term (Livingston et al., 2011). Furthermore, there is a noticeable 
gap in the literature on shorter anti-stigma interventions, with the shortest spanning over 
several days (Livingston et al., 2011). These findings suggest a need for more research 
aimed at anti-stigma interventions in the substance use stigma field. One step towards this 
may be through the identification of characteristics and traits of individuals who are more 
likely to stigmatize others (Palamar et al., 2012). Researchers may be able to better target 
individuals who need anti-stigma programs the most by examining specific 
characteristics and traits of individuals who are likely to stigmatize.  
Predictors and Potential Moderators of Marijuana Use Stigma 
The most extensively researched predictors of stigma are the level of familiarity 
and contact which play a significant role in regards to stigma. Several studies have 
explored the level of familiarity and contact in predicting stigma in mental illness, and 
more specifically, substance use (Brown, 2011; Feldman & Crandall, 2007). As 
mentioned above, exposing individuals to people from a stigmatized group is related to a 
decrease in the level of stigma (Corrigan & Watson, 2002). Specifically, as contact with 
stigmatized groups increases, less stigmatization occurs (Corrigan & Watson, 2002; 
14 
 
Feldman & Crandall, 2007). This could be due to the fact that increasing familiarity or 
contact with people from the stigmatized group helps to address any common 
misconceptions an individual may have, which has been successful in the reduction of 
stigma (Mayville & Penn, 1998; Penn & Martin, 1998). These findings indicate an 
important link between the level of familiarity and contact with stigma, which should be 
targeted in the development of successful anti-stigma intervention programs.  
In addition to the level of familiarity and the level of contact predicting stigma, 
other individual characteristics have also been examined as predictors of stigma. For 
instance, Palamar et al. (2012) found some support for demographic characteristics as 
predictors of stigma towards the use of different types of illicit drugs in New York City. 
Specifically, findings indicate that lifetime drug use of marijuana is a significant 
predictor in the stigmatization of marijuana, powder cocaine, ecstasy, opioids, and 
amphetamine use (Palamar et al., 2012). Additionally, findings indicate that age is a 
significant predictor in the stigmatization of powder cocaine, ecstasy, opioids, and 
amphetamine use (Palamar et al., 2012). Furthermore, findings indicate additional 
support for exposure to users as a predictor of stigma (Palamar et al., 2012). These factors 
contribute to the overall understanding of stigma and what specific characteristics may 
influence how stigma relates to other factors. This can help target specific groups for 
anti-stigma interventions.   
Although Palamar and colleagues (2012)  did not find biological sex as a 
predictor of stigma, pilot study results conducted by the author and colleagues indicate 
that sex differences in stigma may exist towards substance users as well, although in a 
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different way (Strong, Guajardo, & Arsiwalla, 2015). Research in the substance use 
stigma field indicates sex differences exist in the attitudes towards substance use, such 
that females typically use illegal substances less than males and are more likely to 
disapprove of substance use (Maricic, Sucic, & Sakic, 2013). In the pilot study, 
researchers took this a step further and examined biological sex as a moderator variable 
between the levels of familiarity/contact with stigma (Strong et al., 2015). Findings 
indicate support for biological sex as a moderator; specifically, females have greater 
preferred social distance when the level of contact and level of familiarity are low, but 
when the level of contact and level of familiarity are high, there is virtually no difference 
between males and females (Strong et al., 2015). This study seeks to expand on the pilot 
study findings as there is currently a gap in the literature examining moderator variables 
that may impact the relationship between the level of familiarity or the level of contact 
and stigma.  
Introducing Marijuana and its Current Status in the United States 
The commonality of marijuana use and increased use within the United States 
makes it an important area of interest in the substance use stigma field. Marijuana is the 
most commonly used psychoactive substance in the United States (American 
Psychological Association [APA], 2013). The 2013 National Survey on Drug Use and 
Health (NSDUH) sponsored by the Substance Abuse and Mental Health Services 
Administration found that 19.8 million Americans had reported using marijuana in the 
past month as compared to only 14.5 million in 2007 (SAMHSA, 2014), indicating an 
upward trend in use.  
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Furthermore, an estimated 2.6 million individuals are legal medical marijuana 
patients (“Number of Legal Medical Marijuana Patients,” 2016). The term medical 
marijuana refers to using marijuana to treat symptoms of an illness or other condition 
(“Drug Facts: Marijuana,” 2016) whereas recreational marijuana is a term that refers to 
the use of marijuana for its psychoactive effects rather than for any medicinal benefits. 
Currently, it is unclear whether individuals who use marijuana for medical purposes 
differ from individuals who use marijuana recreationally (Roy-Byrne et al., 2015). 
However, preliminary evidence suggests that medical and recreational users show 
significant overlaps, with many individuals indicating they use marijuana both 
recreationally and medically (Furler, Einarson, Millson, Walmsley, & Bendayan, 2004). 
Additionally, a longitudinal study conducted in the state of Washington examining the 
similarities and differences between recreational and medical marijuana users suggests 
that there are very few distinct differences (Roy-Byrne et al., 2015). Hence, given that the 
differences between recreational and medicinal marijuana users remain ambiguous (Roy-
Byrne et al., 2015), it is imperative to distinguish between recreational and medicinal 
marijuana use in case future research reveals distinct characteristics between these 
groups.   
Marijuana derives from the Cannabis sativa or Cannabis indica hemp plant and is 
typically green, brown, or gray in color (“Drug Facts: Marijuana,” 2016). It is a blend of 
dried and shredded leaves, flowers, seeds, and stems of the plant (“Drug Facts: 
Marijuana,” 2016). There is a third species of marijuana, known as Cannabis ruderalis, 
however, is not commonly grown for industrial, recreational, or medicinal use as it only 
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has trace amounts of the chemical responsible for the mind-altering effects of the 
substance (Small & Cronquist, 1976). Marijuana has approximately 489 distinct 
compounds within 18 chemical classes which contain at least 100 different 
phytocannabinoid compounds that have been identified so far in the limited research that 
has been permitted on marijuana (Elsohly & Slade, 2005; Hill, Williams, Whalley, & 
Stephens, 2012). Of these 489 chemical compounds, delta-9-tetrahyrocannabinol (THC) 
is arguably the most well-known and is responsible for many of the psychotropic or 
mind-altering effects of this substance (Julien, 2013). In addition to THC, another 
common chemical found in marijuana is Cannabidiol (CBD; see Medical/Therapeutic 
Benefits of Marijuana section; Julien, 2013).  
There are a variety of ways marijuana can be consumed. The most common route 
of administration is through smoking marijuana by a variety of methods including pipes, 
hollowed-out cigars (blunts), water pipes (bongs or hookahs), and cigarettes (joints or 
reefers; APA, 2013). When users smoke marijuana, the psychoactive chemical THC 
enters the lungs and rapidly passes the bloodstream, carrying it to organs throughout the 
body, including the brain (Julien, 2013). The effects of marijuana begin almost 
immediately when smoked and can last for one to three hours (Julien, 2013). 
Additionally, marijuana can be vaporized, mixed in with foods or brewed as a tea (known 
as an edible), smoked in concentrated resins, or taken in a pill form for medical purposes 
(APA, 2013). When marijuana is consumed in foods or beverages, however, the effects 
of THC appear later, usually in 30 minutes to 1 hour, and can last over 4 hours (“Drug 
Facts: Marijuana,” 2016).  
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Effects on the Brain  
THC binds to specific cannabinoid receptors found within the endocannabinoid 
system in the body which is located throughout the brain [cannabinoid-1 receptors] and 
the peripheral nervous system [cannabinoid-2 receptors] (Julien, Advokat, & Comaty, 
2011). THC can bind to these receptors because it mimics the actions of an endogenous 
cannabinoid, a fatty acid called anandamide (Julien et al., 2011). There are highly 
concentrated areas of cannabinoid receptors in several areas of the brain, including the 
hippocampus, cerebellum, basal ganglia, and cerebral cortex (Julien, 2013). These areas 
would be the most affected by marijuana, given the high volume of cannabinoid receptors 
found in those brain regions. Therefore, marijuana use would result in impairments to 
coordination, movement, sensation, the perception of time and space, appetite, pleasure, 
judgment, learning, and memory for the user (Julien, 2013). These impairments typically 
outlast the high and are present for up to three days after use (Julien et al., 2011). The 
half-life of marijuana (the time required for the concentration of marijuana to decrease by 
half) is about 30 hours, and regular users may test positive for marijuana for as much as 
30 days after use (Julien, 2013).  
Other Health Effects  
Similar to alcohol, THC can interfere with attention mechanisms, analgesia, short-
term memory, motor movements, postural control, and sensory awareness (Julien et al., 
2011). However, unlike alcohol, high doses of THC do not produce depressive 
respiratory functioning and are not lethal (Julien et al., 2011). Some of the common 
physical effects that accompany marijuana use include red eyes, droopy eyelids, dry 
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mouth and throat, impaired coordination, mixed bronchial effects (i.e., dilation of blood 
vessels and irritation), increased heart rate, blood pressure, and muscle relaxation, as well 
as decreased reflexes, body temperature, and sex hormones (i.e., sperm count and 
ovulation; Julien, 2013).  
Marijuana use may also pose risks to an individual’s circulatory and respiratory 
health. For instance, using marijuana is typically accompanied by an increase in both 
heart rate and blood pressure (Julien, 2013). Normally, the resting heart rate of a healthy 
individual is between 70 to 80 beats per minute (Spodick, Raju, Bishop, & Rifkin, 1992). 
When marijuana is used, however, typical increases in heart rate can range anywhere 
from 20 to 50 beats more per minute and can last up to 3 hours after use (“Drug Facts: 
Marijuana,” 2016). If heart rate reaches over 100 beats per minute, this is considered too 
fast, and the person is exhibiting tachycardia (Spodick et al., 1992). Similarly, blood 
pressure also increases, which can be intensified if additional drugs are taken (Julien, 
2013). This increase in heart rate and blood pressure forces the heart to work harder, 
placing a greater strain on the circulatory system. Additionally, smoking marijuana may 
impact respiratory health (“Drug Facts: Marijuana,” 2016). Specifically, individuals may 
experience similar breathing and lung issues (e.g., daily cough, increased lung infection 
risk) as tobacco smokers because marijuana smoke irritates the lungs as well. However, it 
should be noted that, unlike tobacco, marijuana use has not currently been associated 
with an increased risk for lung cancer (“Drug Facts: Marijuana,” 2016). 
Additionally, there are some risks associated with using marijuana while 
pregnant. Specifically, THC can pass through the placental barrier to the fetus which 
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means that the fetus is also affected by marijuana every time the mother uses (Julien, 
2013). This effect of the substance on the fetus is potentially problematic because the 
mother may risk changing the developing brain of the fetus which could potentially 
impact the child’s attention, memory, and problem-solving abilities later in life (“Drug 
Facts: Marijuana,” 2016).  
In addition, previous research indicates a link between marijuana use and 
numerous mental health outcomes including substance use disorders, mood disorders, and 
anxiety (Gerra, Zaimovic, & Gerra, 2010; Johns, 2001; Malone, Hill, & Rubino, 2010; 
Moore et al., 2007). However, an issue with this past research is that it is unclear whether 
there is a causal relationship between marijuana use and these disorders or if common 
contributing factors are shared between those who typically use marijuana and have these 
disorders. A new study analyzed data from a recent large-scale longitudinal dataset (i.e., 
the National Epidemiological Survey on Alcohol and Related Conditions) which sheds 
new light on this issue, by controlling for common underlying sociodemographic factors 
(e.g., age) that may predict marijuana use (Blanco et al., 2016). This study used data 
taken from nearly 35,000 participants in two waves (wave 1, 2001 – 2002; wave 2, 2004 
– 2005) and initially found similar associations with a wide range of psychiatric 
disorders. However, after controlling for sociodemographic characteristics, the only 
significant associations left were with Substance Use Disorders (e.g., Alcohol use, 
Nicotine Dependence, Cannabis Use Disorder, etc.; Blanco et al., 2016). These findings 
make the link between marijuana use and various mental health outcomes somewhat 
unclear, requiring further investigation.  
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Addiction and Dangerousness  
Marijuana is considered an addictive substance with an estimated 1 out of 11 
marijuana users becoming addicted (Anthony, Warner, & Kessler, 1994; Robson, 2011). 
However, this proportion is relatively low when compared to other substances such as 
alcohol (15%), cocaine (17%), and heroin (23%; Robson, 2011). Genetic, interpersonal, 
and environmental factors can play a role in whether a person becomes addicted to 
marijuana (“Drug Facts: Marijuana,” 2016). In addition to addiction, individuals who use 
marijuana may experience withdrawal symptoms when they stop using the drug which 
can last for several days to a few weeks after quitting (APA, 2013). Many are prone to 
relapse during this time because people crave the drug to relieve symptoms. These 
symptoms include irritability, restlessness, sleeplessness, anger or aggression, lack of 
appetite, depressed mood, weight loss, and anxiety (APA, 2013).  
Despite the physical health consequences of marijuana, it is very unlikely that an 
individual could overdose from using marijuana (“Drug Facts: Marijuana,” 2016). 
However, marijuana does impact judgment, perception, and coordination which can 
increase the likelihood of individuals partaking in riskier behaviors (e.g., driving under 
the influence of the drug) possibly resulting in injury or death (“Drug Facts: Marijuana,” 
2016). Driving or riding with someone who is using marijuana is unsafe because it may 
impair alertness, concentration, coordination, and reaction time, making it difficult to 
judge distances and react to sounds or signals on the road (Lenne et al., 2010; Hartman & 
Huestis, 2013). In fact, marijuana is the most common illegal drug involved with 
impaired drivers (Hartman & Huestis, 2013). A meta-analysis by Li and colleagues 
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(2012) on the impact of marijuana on driving examined nine epidemiologic studies which 
indicated that marijuana users were 2.66 times more likely to be involved in an auto crash 
than non-users. However, it should be noted that individuals were given a urine screening 
or self-report to detect drug use which means that individuals who tested positive were 
marijuana users generally, not necessarily someone who had used marijuana just prior to 
driving (Li et al., 2012). In a large case-control study, Compton and Berning (2015) 
sought to investigate this further and looked into other factors that may account for this 
increased risk of auto crashes. Similar to Li and colleagues (2012), they found that 
marijuana users have a 25% higher risk of car accidents than drivers who show no 
evidence of having marijuana in their systems, however, after controlling for other factors 
(i.e., age, gender, ethnicity, and alcohol use) this increased risk was significantly reduced 
(Compton & Berning, 2015). Another study examined the effects of alcohol use in 
combination with marijuana use; they found the most intense effects on performance 
when it was combined with alcohol, which can be observed in both driving and non-
driving tasks (Ronen et al., 2010). 
Additionally, people may experience extreme anxiety (e. g., panic attacks) or 
psychotic reactions after using marijuana (“Drug Facts: Marijuana,” 2016). Although the 
likelihood of dying from marijuana is low, approximately 461,028 emergency room visits 
in 2011 involved the use of marijuana as stated in the medical record. Thus, Marijuana 
accounted for about 39.4% of the total amount of emergency room visits involving illicit 
drugs in 2011 (SAMHSA, 2013). This number is roughly a 21 percent increase since 
2009 alone (SAMHSA, 2013), however, it is unclear that marijuana played a role in these 
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visits because mentioning marijuana in the medical records does not necessarily mean 
these emergencies were directly related to marijuana intoxication.  
Legality of Marijuana Use 
Under Federal law, it is illegal to buy, sell, or carry marijuana because it has been 
classified as a Schedule 1 controlled substance (Controlled Substances Act of 1970, 
2012). This means that the Federal Government considers marijuana to have no 
medicinal uses and has a high risk for abuse (“Drug Facts: Marijuana,” 2016). With 
marijuana being classified as a Schedule 1 controlled substance, there have been many 
roadblocks to researching its potential medicinal effects. The challenges to scientific 
research on this substance are especially disappointing given the 489 chemical 
compounds that are found in marijuana that could have potential therapeutic benefits 
(Baron, 2015; Elsohly & Slade, 2005; Hill et al., 2012). However, as mentioned above, 
the attitudes and state laws for adult marijuana use are changing. As of the 2016 
November election, twenty-nine states and the District of Columbia have legalized 
marijuana in some capacity. Seven of those states (i.e., Alaska, California, Colorado, 
Maine, Massachusetts, Nevada, Oregon, and Washington) and the District of Columbia 
have more progressive laws which allow for both medical and recreational use of 
marijuana for any adult over the age of 21 (Steinmetz, 2016). The legalization of 
marijuana within a few US states means that nearly one-quarter of people in the U.S. live 




Shifts in Public Opinion of Marijuana Legalization  
Marijuana use is often perceived as being deviant on a societal level (Bottorff et 
al., 2013). However, there has been a favorable shift in public opinion on marijuana 
legalization in recent years (Pew Research, 2015). The Pew Research Center (2015) 
conducted a national survey of 1,500 adults examining public perceptions regarding 
marijuana legalization. Findings indicate the majority of Americans (53%) are in support 
for marijuana legalization, showing a 21% increase in favorability since 2006 alone (Pew 
Research, 2015). Nevertheless, not all groups are equally as supportive towards the 
legalization of marijuana. For instance, nearly every generation has shown sharp rises in 
support for legalization over the past decade, with the exception of the Silent Generation 
(born 1925-1945). Millenials (born 1982-2004) are the most supportive of marijuana 
legalization with over two-thirds (68%) reporting positive views on legalization (Pew 
Research, 2015). However, only 29% of individuals from the Silent Generation (born 
1925-1945) share this positive view of legalization. Additionally, a little under a two-
thirds of Republicans (61%) and Hispanics (60%) would prefer that marijuana remains 
illegal for sale or use within the United States.  
Additionally, researchers took this a step further and asked individuals to describe 
in their own words why they either opposed or favored legalization (Pew Research, 
2015). Medical benefits (41%) and the belief that marijuana is no worse than other drugs 
(36%) are the most frequently cited reason for supporting marijuana legalization (Pew 
Research, 2015). Opponents, on the other hand, most often cite the belief that marijuana 
hurts society and is dangerous for individuals as their primary objection to legalization 
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(Pew Research, 2015). Finding the reasoning behind why each side holds these different 
perspectives could be helpful in determining what information would be useful within the 
psychoeducational module.   
Medical/Therapeutic Benefits of Marijuana 
The use of marijuana for medicinal purposes is becoming more prevalent in 
industrialized nations (Szaflarski & Bebin, 2014), although using marijuana medicinally 
is not a new concept (Deitch, 2003). Currently, marijuana has been found to have 
medicinal properties when prescribed in THC pill form. The two FDA-approved 
medications for the treatment of nausea in cancer patients (Green, Nathwani, Goldberg, 
& Kennedy, 1989) and appetite enhancement for patients with human immunodeficiency 
virus/acquired immunodeficiency syndrome (HIV/AIDS; Einhorn, Nagy, Furnas, & 
Williams, 1981; Lane et al., 1991) include dronabinol (Marinol®) and nabilone 
(Cesamet®). Another common chemical found in marijuana that has sparked recent 
research interests in the applicability of marijuana for medicinal purposes is cannabidiol 
(CBD; Julien 2013). This chemical does not have any mind-altering effects and has 
shown promising results in the treatment of seizures for children with severe epilepsy 
(Hussain et al., 2015; Maa & Figi, 2014). Additionally, several countries outside of the 
United States have started using a combination of THC and CBD as part of an oral spray 
in treating the symptoms of multiple sclerosis (Novotna et al., 2011).  
Problematic Marijuana Use  
However, marijuana use can have negative effects as well, especially for 
individuals with problematic marijuana use. The American Psychiatric Association 
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Diagnostic and Statistical Manual of Mental Disorders fifth edition (DSM-5) outline five 
marijuana-related disorders; these include marijuana use disorder, marijuana intoxication, 
marijuana withdrawal, other marijuana-induced disorder, and unspecified marijuana-
related disorder (APA, 2013). Marijuana use disorder is characterized by an individual 
presenting “a troublesome pattern of use that leads to impairments or hardships of clinical 
significance happening within a 12-month period” (APA, 2013). The adversity 
experienced by the individual must manifest itself through at least two of eleven criteria 
to be considered clinically significant. The DSM-V criteria include (i) increasing 
marijuana use or use over a longer period than what was initially planned, (ii) reoccurring 
urge or unsuccessful attempts at cutting back use, (iii) increasing amounts of time used 
trying to get more, use, or recover from marijuana, (iv) stronger cravings or urges to use 
marijuana, (v) reoccurring use of marijuana interfering with executing a major role 
obligation, (vi) continuing use despite ongoing or reoccurring social or interpersonal 
issues due to or intensified by use, (vii) previously important activities abandoned or 
greatly decreased because of marijuana use, (viii) repeatedly using marijuana in 
potentially physically harmful situations, (ix) continuing marijuana use despite knowing 
the impact of use on physical or mental health likely caused by use, (x) exhibiting 
tolerance of marijuana, and (xi) displaying withdrawal syndrome (APA, 2013). This 
withdrawal can cause significant distress in the patient and can add to the difficulty in 
quitting or relapsing. It may be difficult to distinguish between nonproblematic marijuana 
use and cannabis use disorder because of social, behavioral, or psychological problems 
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(APA, 2013), but this distinction is important when considering the effects of recreational 
marijuana use.  
Focus of the Current Study 
Although the rates of problematic use apply to a small percentage of the 
population, there are still a significant number of individuals consuming marijuana 
regularly in the United States who may be subject to public stigmatization impacting their 
lives, making it a prominent issue in our society. Addressing the reduction of stigma 
through anti-stigma intervention programs will help in the reduction of negative 
consequences associated with stigma for these individuals. Additionally, it is important to 
distinguish between recreational and medicinal marijuana use because the differences 
between these users remain unclear (Roy-Byrne et al., 2015). Given this, assessing 
problematic use is out of the scope of the current study which will instead focus on 
general recreational use. The current study will focus on recreational marijuana use, 
specifically because of the prevalence rates of use for this drug as compared to other 
illegal substances and the current climate of legalization in the United States.  
Current Study 
In the current study, we focus on expanding current anti-stigma research by pilot-
testing a psychoeducational module designed to reduce public stigma surrounding 
recreational marijuana use. This module seeks a balance of providing factual information 
while still maintaining a brief time commitment. As mentioned above, there is currently a 
huge gap for successful anti-stigma intervention programs for substance use stigma. The 
25-minute interactive psychoeducational module could contribute to a reduction in stigma 
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by increasing knowledge and familiarity with marijuana and its uses. This module was 
adapted, with permission (NIDA Info, personal communication, May 29, 2015), from 
information about marijuana use provided by the National Institute of Drug Abuse 
(NIDA) website for teens (“Drug Facts: Marijuana,” 2015). The treatment group received 
the module, while the control group viewed a neutral nature documentary similar to 
documentaries used in prior research as controls (Medalia, Aluma, Tyron, & Merriam, 
1998). Secondly, we examined the relationship between the levels of contact or 
familiarity with recreational marijuana users and their stigma level (i.e., preferred social 
distance, perceived dangerousness, and negative affect). Furthermore, we examined 
whether certain characteristics (i.e., sex, age, and current marijuana use) moderated the 
relationship between the level of contact or level of familiarity and stigma. Finally, we 
assessed the potential impacts this education could have on the likelihood of future 
recreational marijuana use of the participant.  
Stigma is measured using preferred social distance, perceived dangerousness, and 
negative affect, all of which have been used in previous mental illness stigma research 
(Feldman & Crandall, 2007; Link, Cullen, Frank, & Wozniak, 1987) and substance use 
stigma research (Brown, 2011; Mackert, Mabry, Hubbard, Grahovac, & Holleran Steiker, 
2014). Preferred social distance refers to the willingness of an individual to interact with 
another person in different situations.  Perceived dangerousness addresses the extent to 
which people perceive others as threatening to them. People are more willing to reject an 
individual if they perceive them to be more dangerous (Corrigan & Watson, 2002; 
Feldman & Crandall, 2007). Negative affect refers to a person’s negative feelings and 
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aversive mood states (i.e., anger, contempt, disgust, nervousness, fear, guilt; Watson, 
Clark, & Tellegen, 1988) towards users of the substance (i.e., marijuana).  
This study has two unique components adding to the literature. First, the use of a 
short, interactive module that provides information regarding marijuana is unique to the 
substance use stigma field. The psychoeducational module was developed in an attempt 
to devise a simple, practical, and cost-effective technique that can be easily applied to any 
anti-stigma intervention program. The module is meant to be fun and informative for the 
audience and is aimed at engaging participants by providing pop quizzes, educational 
videos, and a variety of pictures, ultimately, promoting active learning (Bonwell & Eison, 
1991; Prince, 2004). Promoting active learning may help individuals become more 
engaged, making them more familiar with the information, and more likely to remember 
the information later (Bonwell & Eison, 1991). A second unique contribution is the 
examination of individual differences factors in the form of moderator variables (i.e., sex, 
current marijuana use, and age) of the relationship between levels of contact/familiarity 
and stigma; these moderators can shed light on specific groups to target for future anti-
stigma intervention programs. Identification of such characteristics could aid future 
research and help anti-stigma intervention programs target specific groups that may be 
more subject to stigmatization. Examining specific characteristics and components that 






We hypothesized that individuals receiving the psychoeducational module about 
marijuana would report increased knowledge regarding marijuana and less stigmatized 
views (i.e., less preference for social distance, less perceived dangerousness, and fewer 
negative affect) toward marijuana use. Specifically, we expected to find (1a) an increase 
in the pre- to post-knowledge score for the experimental group (that receives the 
psychoeducational module) and no increase in post-test score for knowledge among 
participants in the control group. We also expected to find (1b) a decrease in pre- to post-
test preferred social distance for the experimental group and no decrease for the control 
group and (1c) a decrease in pre- to post-test perceived dangerousness for the 
experimental group and no decrease for the control group. Finally, we expected (1d) a 
decrease in pre- to post-test negative affect for the experimental group and no decrease 
for the control group. A 2 x 2 mixed factorial analysis of variance (ANOVA) with one 
within-person repeated measures factor (i.e., pre- and post-stigma) and one between 
person factor (i.e., experimental group vs. control group) was used with SPSS. We 
expected a significant interaction, such that knowledge and stigma would be the same for 
the control group from pre- to post- measure. However, the experimental group would 
show an increase in knowledge and a decrease in stigma. 
Hypothesis 2 
We expected to find a relationship between the level of contact, the level of 
familiarity, and stigma measures, such that there would be less stigmatized views (i.e., 
preference for social distance, perceived dangerousness, and negative affect) toward 
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marijuana use for individuals who have had higher levels of contact or familiarity with 
marijuana users. Specifically, regardless of the group (i.e., experimental or control), we 
expected that individuals who have had higher levels of contact with marijuana users 
would predict lower pre- and post-test ratings for (2a-1; 2a-2) preferred social distance, 
(2b-1; 2b-2) perceived dangerousness, and (2c-1; 2c-2) negative affect regarding 
recreational marijuana users. Similarly, regardless of group (i.e., experimental or control), 
we expected individuals who are more familiar with marijuana users would predict lower 
pre- and post-test ratings of (2d-1; 2d-2) preferred social distance, (2e-1; 2e-2) perceived 
dangerousness, and (2f-1; 2f-2) negative affect regarding recreational marijuana users. 
Additionally, regardless of group (i.e., experimental or control), individuals with more 
knowledge about marijuana would predict lower pre- and post-test ratings for (2g-1; 2g-
2) preferred social distance, (2h-1; 2h-2) perceived dangerousness, and (2i-1; 2i-2) 
negative affect regarding recreational marijuana users. A regression analysis was 
conducted to examine the relationships between the level of familiarity, the level of 
contact, the degree of knowledge about marijuana, preferred social distance, perceived 
dangerousness, and negative affect regarding marijuana users.  
Hypothesis 3 
We also expected to find that sex, current marijuana use, and age differences 
would moderate the relationship of contact/familiarity with stigma. Specifically, we 
expected females in the control group would have greater levels of pre- and post-test (3a-
1; 3a-2) preferred social distance, (3b-1; 3b-2) perceived dangerousness, and (3c-1; 3c-2) 
negative affect regarding marijuana users when the level of contact is low. However, 
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females in the experimental group would have greater levels of pre- and post-test (3a-3; 
3a-4) preferred social distance, (3b-3; 3b-4) perceived dangerousness, and (3c-3; 3c-4) 
negative affect regarding marijuana users when the level of contact is low. Similarly, we 
expected females in the control group would have greater levels of pre- and post-test (3d-
1; 3d-2) preferred social distance, (3e-1; 3e-2) perceived dangerousness, and (3f-1; 3f-2) 
negative affect regarding marijuana users when the level of familiarity is low. However, 
females in the experimental group would have greater levels of pre- and post-test (3d-3; 
3d-4) preferred social distance, (3e-3; 3e-4) perceived dangerousness, and (3f-3; 3f-4) 
negative affect regarding marijuana users when the level of familiarity is low. 
Additionally, we expected non-users in the control group would have greater levels of 
pre- and post-test (3g-1; 3g-2) preferred social distance, (3h-1, 3h-2) perceived 
dangerousness, (3i-1; 3i-2) negative affect regarding marijuana users when the level of 
contact is low. Non-users in the experimental group, on the other hand, would have 
greater levels of pre- and post-test (3g-3; 3g-4) preferred social distance, (3h-3; 3h-4) 
perceived dangerousness, and (3i-3; 3i-4) negative affect regarding marijuana users when 
the level of contact is low. Similarly, we expected non-users in the control group would 
have greater levels of pre- and post-test (3j-1; 3j-2) preferred social distance, (3k-1, 3k-2) 
perceived dangerousness, (3l-1; 3l-2) negative affect regarding marijuana users when the 
level of familiarity is low. Non-users in the experimental group, on the other hand, would 
have greater levels of pre- and post-test (3j-3; 3j-4) preferred social distance, (3h-k; 3k-4) 
perceived dangerousness, and (3l-3; 3l-4) negative affect regarding marijuana users when 
the level of familiarity is low. Furthermore, we expected 18-year-olds in the control 
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group would have greater levels of pre- and post-test (3m-1; 3m-2) preferred social 
distance, (3n-1; 3n-2) perceived dangerousness, and (3o-1; 3o-2) negative affect 
regarding marijuana users when the level of contact is low. However, 18-year-olds in the 
experimental group would have greater levels of pre- and post-test (3m-3; 3m-4) 
preferred social distance, (3n-3; 3n-4) perceived dangerousness, and (3o-3; 3o-4) 
negative affect regarding marijuana users when the level of contact is low. Similarly, we 
expected 18-year-olds in the control group will have greater levels of pre- and post-test 
(3p-1; 3p-2) preferred social distance, (3q-1; 3q-2) perceived dangerousness, and (3r-1; 
3r-2) negative affect regarding marijuana users when the level of familiarity is low. 18-
year-olds in the experimental group, on the other hand, would have greater levels of pre- 
and post-test (3p-3; 3p-4) preferred social distance, (3q-3; 3q-4) perceived 
dangerousness, and (3r-3; 3r-4) negative affect regarding marijuana users when the level 
of familiarity is low. We used linear moderated regression analysis (Champoux & Peters, 
1987; Shieh, 2009) using SPSS, fitting each moderation into separate models.  
Research Question 1 
Additionally, we explored whether there was a significant difference on the 
likelihood of future use across the experimental versus the control group. We explored 
this possible relationship by comparing the means of the two independent groups (i.e., 
experimental vs. control group) to determine whether the means were significantly 




Research Question 2 
Furthermore, we explored whether there was a relationship between the level of 
familiarity, the level of contact, and the likelihood of future use. After establishing this 
relationship, we examined whether sex, any past marijuana use, and age would moderate 
this potential relationship. Again, we used linear moderated regression analysis 






The current study employed an experimental research design. For the ANOVA-
based analyses, a 2 X 2 mixed factorial ANOVA with one within-subjects factor and one 
between subjects factor was conducted for each outcome. The time of measurement was 
the within-subjects (repeated measures) factor (assessed at pre and post), and the group 
(intervention and control) was the between-subjects factor. The independent variables are 
the groups (i.e., psychoeducational module group versus control group) and time of 
measurement (pre and post assessment); the dependent variables are the knowledge and 
level of stigma (i.e., preferred social distance, perceived dangerousness, and negative 
emotions). For all regression-based analyses, the predictor variables were the level of 
contact and level of familiarity and the outcome variables were all stigma measures (i.e., 
preferred social distance, perceived dangerousness, and negative emotions). Additionally, 
the likelihood of future use was also explored as a dependent variable. Furthermore, we 
examined the moderating role of participant sex, any past marijuana use, and age in the 
relation between the level of contact, the level of familiarity, and the level of stigma. 
Furthermore, we conducted exploratory analyses examining the same moderators in the 
relation between the level of contact, the level of familiarity, and the likelihood of ever 




An a priori power analysis was conducted with G*Power statistical software 
(Faul, Erdfelder, Lang, & Buchner, 2007), using an expected medium effect size (f2 = 
.15), alpha = .05, and power = .95 for each statistical test. The projected sample size 
needed for conducting a two-way repeated measures, within-between group interaction 
ANOVA with this effect size, alpha, and power is approximately N = 54 per group 
(Appendix N). The projected sample size needed for conducting a two-way repeated 
measures, between factors ANOVA with this effect size, alpha, and power is 
approximately N = 158 overall (Appendix N). The projected sample size needed for 
conducting a linear multiple regression with one number of tested predictors and five 
total number of predictors with this effects size, alpha, and power is approximately N = 
89 per group (Appendix N). Based on this power analysis, we proposed to collect a 
sample of 180 participants to ensure adequate analyses for each test.   
The sample consisted of 201 undergraduate students (ages 18-25 years) from the 
University of Northern Iowa. The participants were predominately female (66% female), 
18 years old (51%), freshman (75%), and primarily of Caucasian descent (92%). 
Approximately 37% of participants (N = 75) have used marijuana at some point in the 
past, and approximately 27% of those individuals who have used in the past have used 
marijuana in the last 30 days. Participants were recruited using SONA (an online 
participant recruiting website), from a variety of introductory psychology courses and 
were issued the survey using Qualtrics in a computer lab on campus. Upon completion, 
students received 1.0 credit toward fulfilling the psychology department’s course 
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Researchers created a demographics measure consisting of 8 questions for this 
study (Appendix B). We assessed sex, age, race/ethnicity, major, grade level, household 
income level, use of marijuana in the last 30 days, and whether or not participants sought 
substance use treatment in their life.  Researchers defined drug use in terms of usage over 
the last 30 days before the survey because the National Survey on Drug Use and Health 
(NSDUH) often defines current drug use in these terms (SAMHSA, 2014). Additionally, 
participants were provided with a description of marijuana use (Appendix C). This 
description included a picture and brief description of marijuana, its short-term effects, 
and how it is typically used; this was used to ensure that all participants were familiar 
with the specific substance in question.   
Level of Familiarity Questionnaire 
 The level of familiarity questionnaire (Corrigan et al., 2003; see Appendix D) 
determines the level of familiarity an individual has with marijuana users by asking 
participants whether they have experienced any of the 11 levels of familiarity with users 
of marijuana. We used a modified version of the Level of Familiarity Questionnaire 
targeted at mental illness (Corrigan et al., 2003). In the current measure, “a severe mental 
illness” was replaced with “a person who uses marijuana.” Levels range from 1 = “I have 
never observed a person who used marijuana” to 11 = “I have used marijuana.” 
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Typically, the highest level indicated based on the ordinal ranking system is documented 
as that individual’s level of familiarity. However, in the current study, we took a sum of 
the total number of instances the individual endorsed with higher scores indicating a 
higher level of familiarity. In a pilot study, we found acceptable reliability for using the 
measure in this way (α = .73; Strong et al., 2015). The current study found acceptable 
reliability for the measure as well (α = .70).  
Substance Use Contact Scale (SUCS) 
 The Substance Use Contact Scale (SUCS; Brown, 2011; Appendix E) is a two-
part measure: the first section uses a 4-point Likert scale measuring the amount of 
previous contact an individual has had with a marijuana user in the last year in various 
settings (e.g., “where you live”), and the second section has a 5-point Likert scale 
measuring whether their overall impression was favorable. Responses on the first section 
range from 0 = “never” to 3 = “often”. Responses to the second section range from 1 = 
“very unfavorable” to 5 = “very favorable”. The items in the first section were averaged 
to obtain a scale score. The items in the second section were averaged to obtain a 
favorability score. Pilot study results indicated acceptable reliability (α=.78; Strong et al., 
2015). The current study found acceptable reliability for the measure as well (α = .75). 
Pre-/Post-Test Knowledge Regarding Marijuana 
The pre-/post-test knowledge regarding marijuana (see Appendix F) is a self-
created test examining current knowledge regarding marijuana based on the information 
presented directly in the psychoeducational module; the module was adapted from 
information found on the NIDA marijuana drug facts website for teens (“Drug Facts: 
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Marijuana,” 2015). The knowledge test consisted of 25 questions and included 
information regarding what marijuana is, how it is used, what effects it has on the brain, 
body, health, and driving, whether someone can become addicted or die from marijuana 
use, and medical uses of marijuana. This knowledge test included multiple-choice and 
true/false type questions. To ensure that participants would not memorize correct answers 
to the questions, we did not provide feedback to participants about correct responses to 
the pre-test measure. However, participants received feedback about their scores from 
both tests after completing the post-test of knowledge. All the content used in the test was 
covered in the psychoeducational module that half of the participants received. The 
number of correct responses were added together to create a total knowledge sum score. 
All questions from this test were given to undergraduate research assistants to ensure 
clarity and readability. The current study found a reliability score of α = .27 before 
receiving the module or video and acceptable reliability after having received the module 
or video for the measure (α = .78).  
Likelihood of Future Use 
To determine likelihood of future use (see Appendix F), participants answered 
four questions before and after the module which related to how likely they would be to 
use marijuana in the next week, month, year, or ever. This 6-point Likert scale has 
responses ranging from 1 = “very unlikely” to 6 = “very likely”, with higher scores 
indicating greater likelihood of future use. The single responses to these questions were 




Affect Scale-Substance Use 
The Affect Scale-Substance Use (AS-SU; adapted from Penn et al., 1994; 
Appendix G) is a 7-point Likert scale measuring how people would feel if they interacted 
with someone who smokes marijuana heavily; higher scores indicated more negative 
emotions. Individuals were presented with 10 pairs of bipolar dimensions (e.g., 
“empathetic—angry”, “supportive—resentful”), and asked to rate them. Items 1, 4, 6, 7, 
and 8 were recoded. The items scores were averaged to obtain a scale score. In past 
research, the AS-SU displayed excellent reliability (α=.92; Brown, 2011). Pilot study 
results indicated excellent reliability as well (α=.97; Strong et al., 2015). The current 
study found excellent reliability for the measure, both before (α = .97) and after (α = .98) 
receiving the module or video. 
Social Distance Scale 
The Social Distance Scale (SDS-SU; adapted from Link et al., 1987; Appendix H) 
is a standardized measure for substance use stigma measuring an individual’s willingness 
to interact with a marijuana user across seven different situations (e.g., “How would you 
feel having someone like John as a neighbor?”) on a 4-point Likert scale. This type of 
scale has been used in the past in conjunction with hypothetical vignettes in the mental 
illness stigma field (Feldman & Crandall, 2007; Link et al., 1999). Responses ranged 
from 1 = “definitely willing” to 4 = “definitely unwilling” with higher scores indicating a 
greater preferred social distance. The items scores were averaged to obtain a scale score. 
An example item is, “How would you feel about renting a room in your home to someone 
like John?” In past research, the SDS-SU displays good reliability (α=.85) and good 
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construct validity when compared to the adapted version of the level of familiarity 
questionnaire taken from the mental illness stigma research (Brown, 2011). This 
comparison also helps in addressing issues of convergent validity because these are both 
constructs that we would expect to be related and results indicate that they are related. 
Pilot study results indicated excellent reliability as well (α=.95; Strong et al., 2015). In 
the current study, we found excellent reliability for the measure both before (α = .92) and 
after (α = .93) receiving the module or video. 
Dangerousness Scale 
           The Dangerousness Scale (DS-SU; adapted from Link, et al., 1987; Appendix I) 
measures the extent to which people perceive marijuana users as threatening to them 
(e.g., “One important thing about someone like John is that you cannot tell what they will 
do from one minute to the next”) on a 6-point Likert scale. This type of scale has been 
used in the past in conjunction with hypothetical vignettes in the mental illness stigma 
field (Feldman & Crandall, 2007; Link et al., 1999). Adaptations for the mental illness 
stigma version include changing the terms, “former patients with a severe mental illness,” 
“patients with a severe mental illness”, and “severe mental illness” were substituted for 
the name of the person depicted in the vignette, as marijuana use disorder is implied in 
the vignettes. Responses ranged from 1 = “strongly agree” to 6 = “strongly disagree”. 
Items 1, 3, 4, 6, and 7 are to be recoded. Higher scores indicated a greater preferred social 
distance. An example item is, “If someone like John lived nearby, I would not allow my 
children to go to the movie theater alone.” The items scores were averaged to obtain a 
scale score. In past research, the DS-SU displays acceptable reliability (α=.71) and good 
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construct validity when compared to the adapted version of the level of familiarity 
questionnaire taken from the mental illness stigma research (Brown, 2011). This 
comparison also helps in addressing issues of convergent validity. Pilot study results 
indicated good reliability as well (α=.91; Strong et al., 2015). The measure had good 
reliability in the current study both before (α = .86) and after (α = .87) receiving the 
module or video. 
Procedure 
 The study was submitted to the University Institutional Review Board (IRB) for 
their approval prior to data collection. Participants recruited on the SONA program were 
invited to a computer lab on campus to control the setting in which they completed the 
survey. Participants were randomly assigned to one of two groups before beginning the 
study. The first group was the experimental group. Participants in the experimental group 
received a psychoeducational module, designed to increase knowledge about marijuana 
and reduce stigma toward recreational marijuana users. This module was pilot-tested on 
undergraduate research assistants to ensure readability/clarity and determine the average 
completion time (M = 21 minutes). Findings indicated that the module did not exceed 30 
minutes. The second group was the control group. Participants in the control group 
watched a 25-minute neutral video clip from Episode 10: Seasonal Forest taken from the 
Planet Earth TV series produced by the British Broadcasting Corporation (BBC) Natural 
History Unit (Fothergill, 2006). This video depicts seasonal forests and wildlife from 
around the world. It should be noted that the video does not have any extreme acts of 
violence between animals, and humans only appear twice in the video climbing a tree. 
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Permission to use the clip was requested and approved by BBC (BBC Worldwide 
Learning, personal communication, June 11, 2015).  
The study session was approximately 45-60 minutes and began with participants 
reviewing and signing an informed consent form (Appendix A). All individuals began the 
session answering demographic questions (Appendix B) and the description of marijuana 
(Appendix C), followed by the level of familiarity questionnaire (adapted from Corrigan 
et al., 2003; Appendix D), the Substance Use Contact Scale (Brown, 2011; Appendix E), 
pre-test knowledge measure (Appendix F), and the Likelihood of Future Use Questions 
(Appendix G). Participants then answered questions taken from the Social Distance 
Scale-Substance Use (adapted from Link et al., 1987; Appendix I), the Dangerousness 
Scale-Substance Use (adapted from Link et al., 1987; Appendix J), and the Affect Scale-
Substance Use (Appendix H; adapted from Penn et al., 1994). After completing these 
measures, those in the first group were given a website link to the psychoeducational 
module (Appendix K) and asked to spend 20-30 minutes on the site. However, those in 
the second group watched an embedded 25-minute neutral video clip (Fothergill, 2006). 
Following the module and the video clip all participants completed the post-test stigma 
and post-test knowledge measures.  
All participants were provided with contact information at the end of the survey 
for the primary investigator and the UNI counseling center, in the event that the 
participant felt distressed at the end of the survey. Additionally, no specific identifiers 
were requested from participants beyond basic demographic information (such as age, 
gender, race, and year in school) that are necessary to determine key hypotheses. 
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However, even if any identifying information was accidently collected, researchers 
deleted it before any data were analyzed or disseminated in scholarly conferences and 
publications.  
Initial Data Checks and Attention Checks 
A codebook was created that detailed the variable names, descriptions, and 
formats of study variables. Furthermore, to ensure easy readability and understanding, the 
researchers had undergraduate research assistants review the questionnaire before data 
collection. Additionally, any missing values in the data, which could be due to 
participants being told they are free to skip any question they do not want to answer, were 
assigned the specific value of 99. If more than 10% of the cases were missing data and 
the data were missing at random (MAR) or missing completely at random (MCAR), 
another program (AMOS) would be used, since it uses Full Information Maximum 
Likelihood (FIML) to handle missing cases (Enders & Bandalos, 2001; Graham, 2003; 
Little, 1988). However, a small proportion of cases were missing (6%), hence listwise 
deletion was used for analyses, and the AMOS program was not required.  
To ensure quality data, Peer, Vosgerau, and Acquisti (2014) recommend the use 
of attention check questions (ACQ’s). ACQ’s ensure that participants are paying attention 
to items within the survey. This study included three ACQ’s (Appendix K). The first was 
an instructional manipulation (adapted from Oppenheimer, Meyvis, & Davidenko, 2009), 
inserted directly after the description of marijuana giving instructions within a lengthy 
text asking participants to ignore the response options pertaining to sports within the 
question and simply click ‘Next.' The second ACQ was presented after the 
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psychoeducational module or neutral video clip depending on the participant's group. 
Here, participants will be asked to respond to the question “While watching TV, have you 
ever had a fatal heart attack?” The correct response to this item is “Never.” The last ACQ 
(adapted from Peer et al., 2014), prior to completion of the study, required participants to 
answer the question, “What was this survey about?” The instructions provided here ask 
participants not to mark “Marijuana use” or “Perceptions,” but instead to choose “Other” 
and type in “Psychology” in the text box. Again, this is to ensure participants are paying 
attention throughout the study. If participants answered any of these attention check 
questions incorrectly, their data was deleted from the dataset and not used for analysis as 
it was unclear whether or not they paid attention throughout the rest of the study.  
Data Coding and Plan of Analysis 
All scales were coded where higher numbers imply a more negative outcome (e.g. 
a 1 for preferred social distance is positive, whereas a 4 is negative and implies 
participants have more stigma). Researchers first cleaned the data and calculated how 
much data was missing in order to determine whether another program (AMOS) would 
be needed to analyze the data. However, the use of this program is unwarranted given the 
low number of missing data (6%). Next, researchers deleted cases with incorrect 
responses to the Attention Check Questions. After deleting the cases with incorrect 
responses to the Attention Check Questions, researchers computed frequencies to 
examine patterns in the data and probed for outliers. If outliers existed beyond 3 standard 
deviations, those cases were not included in our analyses. Next, descriptive statistics were 
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computed to analyze the characteristics of the obtained sample. Following this, specific 
analyses were run for each hypothesis. 
Hypothesis 1  
We expected to find pre- to post-test differences in knowledge about marijuana 
and stigma (i.e., preferred social distance, perceived dangerousness, and negative 
emotionality) between those who received the psychoeducation module and those in the 
control group. We utilized a two-way repeated measures, within-between groups 
interaction ANOVA for each outcome using SPSS. The significant interaction for the 
ANOVA would indicate that the control group will report no change on the outcome 
measures (i.e., knowledge and stigma). However, we expected that the experimental 
group that receives the psychoeducational module would report an increase in knowledge 
and decrease in stigma. 
Hypothesis 2 
We expected to find a relationship between the level of contact/familiarity and 
stigma; specifically, there would be less stigmatized views (i.e., preference for social 
distance, perceived dangerousness, and negative emotionality) toward marijuana use for 
individuals who have had higher levels of contact with marijuana users. A regression 
analysis was conducted to examine the relationships between the level of familiarity, the 
level of contact, the degree of knowledge about marijuana, preferred social distance, 
perceived dangerousness, and negative emotions regarding marijuana users. The 
unstandardized and standardized beta, n value, significance level, confidence intervals, 




We also expected to find that sex, current marijuana use, and age differences 
would moderate the relationship between contact/familiarity with stigma. We used linear 
moderated regression analysis (Champoux & Peters, 1987; Shieh, 2009) with SPSS. Each 
moderation test was fit into separate models. This process utilized centered predictors 
entered in the first step, centered moderators entered in the second step, and the 
interaction term of centered predictors and moderator in the final step. The Aiken and 
West (1991) procedure for simple slopes tests was conducted to determine the main and 
interaction effects. Specifically, we assessed whether the relationship between the 
predictors and the outcomes are significant at both low (-1SD) and high levels (+1SD) of 
the moderator. Beta values, significance levels, adjusted R-squares, significance of the 
slopes, confidence intervals, and overall model statistics were reported. 
Research Question 1  
Additionally, we also wanted to explore whether there was a significant difference 
in the likelihood to ever use marijuana in the future across the experimental versus the 
control groups. We explored this possible relationship using independent samples t-tests 
for each model. This procedure compared the means of the two independent groups (i.e., 
experimental vs. control group) to determine whether the population means were 
significantly different from one another. T-values, significance levels, means, and 




Research Question 2 
Furthermore, we explored whether there was a relationship between the level of 
familiarity, the level of contact, and the likelihood of future use. After establishing this 
relationship, we examined whether sex, any past marijuana use, and age would moderate 
this potential relationship. Using the same linear moderated regression analysis 
(Champoux & Peters, 1987; Shieh, 2009) and Aiken and West (1991) procedure 
mentioned above, each moderation test was fit into separate models. This procedure 
utilized centered predictors entered in the first step, centered moderators in the second 
step, and the interaction term of centered predictors and moderator in the final step. Beta 
values, significance levels, adjusted R-squares, the significance of the slopes, confidence 
intervals, and overall model statistics were reported. 
Validity 
There are many potential threats to internal and construct validity that could occur 
due to the design of this study. However, researchers tried to address many of these 
threats before implementing the study. These threats include response styles (i.e., 
acquiescence bias, demand characteristics, extreme responding, and social desirability 
bias), mortality, attrition, testing, and maturation threats as well as the high potential for 
missing data. There will always be limitations and threats to the validity of any study; 
researchers just need to consider these threats and find ways minimize their impact.  
Understanding how each of these common method biases can influence validity 
may help to minimize the impact of their effects (Podsakoff, MacKenzie, Lee, & 
Podsakoff, 2003). In order to understand the influence of response styles on validity, it is 
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essential to understand the differences in the four main response styles. For instance, 
acquiescence bias response style occurs when a respondent tends to agree (or disagree) 
with most questionnaire items, despite the content (Podsakoff et al., 2003). Researchers 
may try to combat this bias by reverse coding certain items. Additionally, demand 
characteristics response style may also play a role in an individual’s response style. 
Demand characteristics are subtle cues that could alert participants to what the 
experimenter expects to find or how they are expected to behave resulting in the 
participant altering their response or behavior (Morling, 2012). In addition, extreme 
responding response style occurs when respondents use the more extreme values on the 
edges of a rating scale rather than clustering around midpoint values, creating more 
dichotomized responses (Podsakoff et al., 2003). These differences in scores between 
participants might reflect something other than what the questionnaire was designed to 
measure. Furthermore, an individual may try to respond in a way that is socially desirable 
meaning an individual unconsciously or consciously “fakes good” because they are too 
shy, embarrassed, or worried about giving an unpopular opinion (Morling, 2012).   
In the current study, we addressed many of these biases by including an 
appropriate comparison group (i.e., control group receiving neutral video clip), however, 
other biases required a more specific plan to help control their impact. For instance, 
certain response styles (i.e., acquiescence bias, demand characteristics, extreme 
responding, and social desirability) required more than just including a comparison 
group. Specifically, response style biases were addressed using multiple methods which 
included reverse scoring on particular measures, telling respondents answers would be 
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kept strictly confidential, and placing attention checks throughout the survey to determine 
if the participants were susceptible to patterned responding (Morling, 2012).  
Additionally, the post-test knowledge response options were automatically 
randomized to reduce the likelihood of order-effects as well as threats to mortality, 
maturation, and attrition. Mortality, maturation, and attrition threats would be more likely 
in this study because participants are asked to remain focused throughout the entire 45-60 
minute appointment. Specifically, maturation may occur if the experimental group 
improves over time due to either spontaneous or natural development (Morling, 2012). 
Mortality threat, on the other hand, occurs when participants may experience boredom or 
fatigue effects due to the length of the survey which could influence the accuracy of their 
responses (Morling, 2012). Similarly, attrition occurs when an individual drops out of the 
study before completing all components of the study (Morling, 2012). Researchers tried 
to address the issue of mortality by implementing a brief psychoeducational module that 
was designed to last no more than 30 minutes (Morling, 2012). Researchers tried to 
address maturation and attrition threats to validity by utilizing a comparison group and 
scheduling both the pre- and post-test knowledge and stigma measures to be completed 
on the same day (Morling, 2012). Attrition rates were very low (2%), with roughly 5 
individuals not completing the entire study. The individuals who did drop out did not do 
so systematically and their responses were removed from the study so it is unlikely that 
the attrition rates effected the internal validity of the study. Furthermore, testing threats 
may also be an issue for this study and can occur when an individual’s scores change 
over time because they have taken the test multiple times (Morling, 2012). Researchers 
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tried to address this threat by not providing feedback on the correct responses to the 
knowledge questions until after the post-test was completed. The question order and 
response-option order were also randomized on the post-test in order to reduce some of 
these practice effects. Lastly, there is a potential for missing data because participants 
may also skip any questions that make them feel uncomfortable or may stop at any time 
(Morling, 2012). However, there was only a small proportion of cases that were missing 
(6%).   
Researchers should try to address most threats to validity before starting a study, 
however, common method bias is unavoidable. For instance, there may be common 
method bias that occurs from external biases of an individual’s response options based on 
the measurement method (e.g., self-report) rather than the constructs the measure 
represents (Podsakoff et al., 2003). This study, for instance, only employs the use of self-
report measures. This may bias the data to a certain degree because using self-report 
questionnaires relies on an individual answering the questions honestly. The degree to 
which individuals are honest on a questionnaire may relate to the topic of the 
questionnaire, their introspective ability, and their understanding or interpretation of 
particular questions (Morling, 2012). Additionally, almost all self-report measures 
produce ordinal data which tells you the order of the units but not the distance between 
them (Wilcox, 2012). The issue with using ordinal data is that it is common practice to 
use parametric statistical techniques that are based on assumptions about the distribution 
of the data. However, these assumptions cannot always be met with ordinal data (Wilcox, 
2012). Incorrect interpretations of the data may then occur because of the deviations from 
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these assumptions (Wilcox, 2012). Even with these issues, using self-reporting was the 
most efficient way to collect this data and is commonly used in behavioral research 
(Morling, 2012). Researchers determined that the benefits of using self-report outweigh 
the potential limitations. However, these limitations of self-reporting should still be kept 
in mind when interpreting the current studies findings.  
Low external validity is expected, due to the use of a convenience sampling 
method. The actual sample may be unrepresentative of the theoretical population of 
college students in the U.S., as this study only examines students from one medium-
sized, public Midwestern university. Participation in the study was voluntary, and not 
everyone who met the inclusion criteria on campus were sampled. However, steps were 
taken to ensure as much as external validity as possible, by employing data collection at 
different times throughout the week and semester so that data collection timing would not 
influence the results. Furthermore, to help minimize dropout rates, participants received 
compensation (1.0 research credits) for participating.  
Ethics 
Participants were recruited from introductory psychology courses at the university 
and had no relationship to the principal investigator. This recruiting strategy minimized 
the threats of coercion, undue influence, and unjustifiable pressure. Sign-up was 
completely confidential for participants. In the informed consent and start of the study, 
participants were reminded that the study is voluntary, and they had the right to withdraw 
their participation at any time without penalty. Responses were anonymous as all 
identifying information, if any, was deleted before starting data analysis and blinders 
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were used around the computer stations to help ensure more anonymity in responding. 
Additionally, participants were randomly assigned a participant number that was not 
linked to their identity. Completed data and informed consents have been stored in the 
faculty advisor’s locked research lab. 
An ethical concern about this investigation must be addressed in regards to asking 
participants about their marijuana use. We asked participants whether or not they have 
used marijuana in the last 30 days to determine whether or not the participant is a current 
marijuana user. This question may have produced discomfort or distress in some 
individuals since we are asking about illegal activities. This could be seen as going 
against Standard 3.04 in the American Psychological Association Ethics Code regarding 
avoiding harm (2010). However, participants used blinders at their workstations to 
maintain anonymity and were informed multiple times that they are free to skip any 
question or withdraw their participation at any time during the survey. Additionally, 
participants were provided with information about UNI Student Counseling Center 
services in the informed consent, and again, at the end of the study, if they experienced 
distress after the study. Furthermore, a research assistant was present in the lab with the 
participants at all times so they could ask them any questions or get additional helping 
information if needed. Thus, researchers ensured that the benefits of this study 






An extensive review of the literature revealed no existing experimental findings 
on the investigation of interactive knowledge-based internet modules and their effect on 
the stigma associated with recreational marijuana use and knowledge regarding 
marijuana. The purpose of this study was to pilot test a brief psychoeducational module 
designed to increase knowledge and reduce stigma towards recreational marijuana users. 
Additionally, this study sought to reestablish the link between the level of familiarity and 
the level of contact with stigma while also examining the moderating role of gender, age, 
and past personal use of marijuana. Furthermore, exploratory analyses were conducted to 
examine the relation between the level of contact and the level of familiarity with the 
likelihood of future use, as well as the role of moderators discussed above.  
Preliminary Analysis 
 Various descriptive and inferential analyses were performed prior to analysis.  
Specifically, descriptive statistics were run for each group together (Table 2) and then 
separately (Table 3-4) which were examined to see how much they differed from one 
another and the overall means. Additionally, correlations between the key study variables 
were examined with the merged data (Table 5) and for each group separately (Table 6-7). 
As expected, the merged data suggests strong positive associations with the level of 
familiarity and level of contact (r = .55, p < .01; see Table 5). Similarly, in the 
psychoeducational module (r = .63, p < .01; see Table 6) and control group (r = .46, p < 
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.01; see Table 7) there were positive associations as well between the level of familiarity 
and level of contact.  
Additionally, the merged data indicated strong positive associations between pre- 
and post-test preferred social distance (r = .94, p < .01; see Table 5), pre- and post-test 
perceived dangerousness (r = .92, p < .01; see Table 5), and pre- and post-test negative 
emotionality (r = .95, p < .01; see Table 5). Similarly, the psychoeducational module 
indicated strong positive associations between pre- and post-test preferred social distance 
(r = .94, p < .01; see Table 6), pre- and post-test perceived dangerousness (r = .93, p < 
.01; see Table 6), and pre- and post-test negative emotionality (r = .94, p < .01; see Table 
6). Likewise, the control group indicated strong positive associations between pre- and 
post-test preferred social distance (r = .96, p < .01; see Table 7), pre- and post-test 
perceived dangerousness (r = .92, p < .01; see Table 7), and pre- and post-test negative 
emotionality (r = .97, p < .01; see Table 7).  
In addition, the merged data findings indicate negative associations between the 
level of contact and all stigma measures with the Pearson-r correlation values ranging 
from -.28 to -.46 (p < .01; see Table 5). Likewise, the psychoeducational module group 
findings indicate negative associations between the level of contact and all stigma 
measures with the Pearson-r correlation values ranging from -.43 to -.60 (p < .01; see 
Table 6). Similarly, the control group findings indicate negative associations between the 
level of contact and all stigma measures with the Pearson-r correlation values ranging 
from -.09 to -.30 (see Table 7). Furthermore, the merged data findings indicate negative 
associations between the level of familiarity and all stigma measures with the Pearson-r 
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correlation values ranging from -.46 to -.58 (p < .01; see Table 5). Similarly, the 
psychoeducational module group findings indicate negative associations between the 
level of familiarity and all stigma measures with the Pearson-r correlation values ranging 
from -.47 to -.61 (p < .01; see Table 6). Likewise, the control group findings indicate 
negative associations between the level of familiarity and all stigma measures with the 
Pearson-r correlation values ranging from -.44 to -.56 (p < .01; see Table 7).  
Assumptions of ANOVAs and Moderated Regressions 
Although the sample size was large, preliminary data screening was still 
conducted to assess violations of the assumptions to the ANOVAs. An examination of a 
histogram for the pre- and post-test knowledge scores in the overall sample showed that 
the distribution was symmetric enough. Additionally, we examined the histogram for the 
pre- and post-test knowledge scores by the experimental and control groups. The pre-test 
experimental and control groups, as well as the post-test control groups, were quite 
symmetric. However, the distribution for the experimental group post-test knowledge 
measure was slightly negatively skewed as indicated by the histogram, the P-P plot, the 
Q-Q plot, and the skewness values (-1.48). We also examined the Z-scores and the 
boxplots of the four groups of the knowledge measure. The results revealed slightly 
extreme values for the post-test experimental group. However, upon further examination 
of the Z-scores, there were no values greater than 3.29. This suggests that there were no 
outliers.  The Levene’s test showed that the variances were equal across the two groups 
for the pre-test knowledge scores, F(1, 199) =  0.62, p = .43, whereas the variances were 
not equal for the post-test scores across the two groups, F(1, 199) =  4.79, p = .03.  
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However, the Levene’s test is usually violated when sample sizes are large (Zimmerman, 
2004). Based on Keppel’s (1991) guidelines for assessing equality of variances (the 
largest variance was divided by the smallest variance), we found that this ratio was less 
than three (pre-test = 1.36; post-test = 1.49). This suggests that the variances were not 
unequal based on the criteria mentioned above.  
Additionally, an examination of the histograms for the pre- and post-test stigma 
(i.e., preferred social distance, perceived dangerousness, and negative emotions regarding 
marijuana) scores in the overall sample showed that the distribution was sufficiently 
symmetric. Additionally, we examined the histogram for the pre- and post-test stigma 
scores by the experimental and control groups. The pre- and post-test experimental and 
control groups were quite symmetric as indicated by the histograms, the P-P plots, the Q-
Q plots, and the skewness values. We also examined the Z-scores and the boxplots of the 
groups. The results revealed the majority of stigma measures fell within a normal range, 
with the exception of one post-test perceived dangerousness score from the control group 
having a slightly extreme value. However, upon further examination of the Z-scores, 
these values did not exceed 3.29. This suggests that there were no outliers.   
Additionally, the Levene’s test was used to assess the homogeneity of the 
variance in each stigma measure. Looking specifically at preferred social distance, the 
Levene’s test showed that the variances were equal across the two groups for both the 
pre-test (F(1, 198) =  0.10, p = .75) and post-test scores (F(1, 198) =  0.06, p = .81). In 
addition, the Levene’s test for perceived dangerousness revealed that the variances were 
equal across the two groups for the pre-test dangerousness scores, F(1, 198) =  0.27, p = 
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.61 whereas the variances were not equal for the post-test scores across the two groups, 
F(1, 199) =  4.63, p = .03. However, again, the Levene’s test is often violated when 
sample sizes are large (Zimmerman, 2004). We found that the suggested guidelines for 
assessing equality of the variances (dividing the largest variance by the smallest variance) 
provided a value less than three (pre-test = 1.33; post-test = 1.45) indicating that the 
variances were not unequal based on the criteria mentioned above. Furthermore, the 
Levene’s test for negative emotions regarding marijuana showed equal variances across 
the two groups for both pre-test (F(1, 199) =  0.38, p = .54) and post-test scores (F(1, 
199) =  0.07, p = .79).  
Further preliminary data screening was also conducted to assess violations of the 
assumptions for Regressions. Outliers were tested for by plotting the standardized 
residuals from the regression against the standardized predicted values. However, the 
graphs showed no indication of outliers, patterns, trends, or heteroscedasticity. This 
suggests that the assumptions required for linear and moderated regressions (i.e., 
linearity, independence of errors, homoscedasticity, normally distributed errors, and 
multicollinearity of predictors) have been reasonably well met.  
Impact of the Psychoeducational Module 
Given the general lack of existing experimental findings on the investigation of 
interactive knowledge-based internet modules and their effect on the stigma associated 
with recreational marijuana use and knowledge regarding marijuana, this study is 
primarily exploratory in nature. Researchers are mainly interested in possible interactions 
that may occur due to exposure to the psychoeducational module. Four 2x2 mixed-
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factorial ANOVAs were performed using SPSS GLM to assess whether there was a 
change in knowledge or stigma regarding marijuana or stigma from pre- to post-test 
across the experimental and control groups.  
Hypothesis 1a 
Based on our hypothesis, it was expected that the control group would show little 
to no increase in knowledge from pre- to post-test, whereas the experimental group would 
show a substantial increase in pre- to post-test knowledge. As expected, there was a 
statistically significant time (pre- vs. post-test) by experimental condition (experimental 
vs. control group) interaction: F aXb = (1, 199) = 421.39, p < .001. The corresponding 
partial eta square (0.68) indicated a strong effect. The Table of cell means (see Table 8) 
indicated that the post-test knowledge scores for the experimental group were much 
higher than the other three groups (M = 22.39, SD = 2.20);this was a significant 
increment in knowledge scores from the pre-test of the module group (M = 15.12, SD = 
2.43). In contrast, the control group did not show any change in knowledge from pre- (M 
= 14.93, SD = 2.84) to post-test (M = 15.05, SD = 2.68).  
We conducted planned contrasts to assess whether the module group differences 
were significant for the pre- and post-test separately. For the pre-test, there was not a 
statistically significant difference in means between the experimental and control groups: 
t (189.63) = 0.50, p = .62. For the post-test, however, there was a statistically significant 
difference in knowledge across the module groups as indicated by the t-statistic (t 
(185.86) = 21.15, p < .001). These findings were consistent with the hypotheses such that 
there was no initial difference in knowledge for the experimental and control groups at 
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pre-test. However, there was a significant difference in the post-test knowledge scores 
with the module group showing a much higher level of understanding the effects of 
marijuana than the control group.  
Hypothesis 1b-1d 
In addition to increased knowledge, researchers hypothesized that there would be 
a reduction in stigma (i.e., preferred social distance, perceived dangerousness, and 
negative emotionality) from pre- to post-test for the individuals who received the 
psychoeducational module as compared to the control group. Three additional 2x2 mixed 
factorial ANOVA were performed using SPSS GLM to assess whether there was a 
change in preferred social distance, perceived dangerousness, and negative emotions 
from pre- to post-test across the experimental and control groups.   
Based on our hypothesis, it was expected that the control group would show little 
to no decrease in preferred social distance from pre- to post-test, whereas the 
experimental group would show a substantial increase in pre- to post-test preferred social 
distance. Despite our predictions, there was not a statistically significant time (pre- vs. 
post-test) by experimental condition (experimental vs. control group) interaction: F aXb = 
(1, 197) = 3.16, p = .08, although it was trending toward significance. The corresponding 
partial eta square (0.02) indicated minimal effects, however. Similarly, we assessed both 
perceived dangerousness and negative emotions regarding marijuana. Specifically, we 
hypothesized there would be substantial decreases for the experimental group in pre- to 
post-test perceived dangerousness or negative emotions whereas the control group would 
show little to no change in perceived dangerousness or negative emotions. However, 
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upon examination there was not a statistically significant time (pre- vs. post-test) by 
experimental condition (experimental vs. control group) interaction: F aXb = (1, 197) = 
0.25, p = .62 and F aXb = (1, 197) = 0.63, p = .43 respectively.    
We also conducted planned contrasts to assess whether the module group 
differences were significant for the pre- and post-test separately for each stigma measure. 
For both the pre-test and post-test scores on preferred social distance, there was not a 
statistically significant difference in means across the experimental and control groups: t 
(197.36) = -0.84, p = .40 and t (197.97) = -0.22, p = .83. Similarly, scores for the 
perceived dangerousness on both the pre- and post-test were not significantly different in 
means across the experimental and control groups: t (196.96) = -1.12, p = .27 and t 
(198.42) = 0.53, p = .60. Furthermore, both the pre-test and post-test scores on negative 
emotions regarding marijuana were not significantly different in means across the 
experimental and control groups: t (198.99) = -1.04, p = .30 and t (198.25) = -1.28, p = 
.20. These findings were inconsistent with the hypotheses that there would be a reduction 
in stigma (i.e., preferred social distance, perceived dangerousness, and negative 
emotionality) from pre- to post-test for the individuals who received the 
psychoeducational module as compared to the control group. Specifically, results indicate 
that there was little to no change in stigma for the experimental and control groups at pre- 




Stigma related to the Level of Contact and the Level of Familiarity 
Hypothesis 2a-1 – 2i-2 
It was hypothesized that regardless of what group participants were in, relations 
exist between the level of contact, level of familiarity, level of knowledge and each 
aspect of stigma. Specifically, there would be less stigmatized views (i.e., preference for 
social distance, perceived dangerousness, and negative emotions) toward marijuana use 
for individuals who have a higher level of knowledge regarding marijuana, or for those 
individuals who had higher levels of contact or higher levels of familiarity with 
marijuana users. Using standard regression analysis, statistically significant associations 
(p < .05) between all predictor variables (i.e., level of familiarity, level of contact, and 
degree of knowledge) and all outcome variables (i.e., preferred social distance, perceived 
dangerousness, and negative emotions regarding marijuana users) were determined, with 
the exception of increased knowledge predicting lower pre-test negative emotionality (see 
Tables 12-14). Specifically, the level of contact functioned as a significant predictor of 
pre- and post-test preferred social distance (β = -.43, p < .001, R2 = 0.19 and β = -.46, p 
< .001, R2 = 0.21 respectively), perceived dangerousness (β = -.28, p < .001, R2 = 0.08 
and β = -.29, p < .001, R2 = 0.09), and negative emotionality (β = -.37, p < .001, R2 = 
0.14 and β = -.36, p < .001, R2 = 0.13). Similarly, the level of familiarity functioned as a 
significant predictor of pre- and post-test preferred social distance (β = -.57, p < .001, R2 
= 0.32 and β = -.58, p < .001, R2 = 0.34 respectively), perceived dangerousness (β = -.47, 
p < .001, R2 = 0.23 and β = -.46, p < .001, R2 =0.21), and negative emotionality (β = -
.51, p < .001, R2 = 0.26 and β = -.50, p < .001, R2 =0.25).  
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Furthermore, analyses were performed to examine the predictive role of 
knowledge regarding marijuana on each stigma measure. Findings indicate knowledge 
regarding marijuana functioned as a significant predictor of both pre-and post-test 
preferred social distance (β = -.16, p < .05, R2 = 0.03 and β = -.14, p < .05, R2 = 0.02) 
and perceived dangerousness (β = -.19, p < .01, R2 = 0.04 and β = -.14, p < .05, R2 = 
0.02). However, knowledge regarding marijuana functioning as a predictor for negative 
emotionality was only significant at post-test (β = -.17, p < .05, R2 = 0.03) but was still 
trending toward significance at the pre-test (β = -.13, p = .08, R2 = 0.02).   
Exploratory Analyses  
Additional exploratory analyses were performed to examine the role of the level 
of familiarity and the level of contact in predicting knowledge regarding marijuana. 
Results suggest limited support for the level of familiarity or the level of contact 
accurately predicting knowledge with the only significant result occurring with the level 
of familiarity predicting the degree of knowledge regarding marijuana at pre-test (β = 
0.18, p < .05, R2 = 0.03; see Table 12-13).  
The Moderating Role of Gender, Current Use, and Age 
It was also hypothesized that sex, any past personal marijuana use, and age would 
moderate the relation between the level of contact, level of familiarity, and stigma such 
that females, non-users, and 18-year-olds would have higher levels of stigma. Using 
linear moderated regression analysis (Champoux & Peters, 1987; Shieh, 2009) in SPSS, 
each moderation was fit into separate models utilizing centered predictors entered in the 
first step, centered moderators entered in the second step, and the interaction term of 
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centered predictors and moderator in the final step. The Aiken and West (1991) 
procedure for simple slopes tests was conducted to determine the main and interaction 
effects. Specifically, we assessed whether the relationship between the predictors and the 
outcomes are significant at both low (-1SD) and high levels (+1SD) of the moderator.  
Hypotheses 3a-1 – 3r-4 
Findings indicate that there was relatively limited support for sex, any prior 
personal marijuana use, and age as moderators for the relation between the level of 
familiarity and stigma (i.e., preferred social distance, perceived dangerousness, and 
negative emotions; see Tables 26-28). Results show there was only one path analysis 
model for the control group that displayed a significant interaction between the level of 
familiarity with marijuana users and participant gender in the prediction of stigma (i.e., 
post-preferred social distance; β = -0.18, p < .05; see Table 15). Specifically, there was a 
significant negative association between the level of familiarity and post-preferred social 
distance for females (p < .001; see Figure 6). This suggests that the females who reported 
higher levels of familiarity with marijuana users tended to report lower preferred social 
distance at the post-test for those in the control group. However, the control group 
females who had reported lower levels of familiarity tended to report higher preferred 
social distance at the post-test. The overall model explained 40% percent of the variance 
while the interaction accounted for 3% in the outcome. All other models for the control 
group and the experimental group did not indicate any significant interactions between 
the level of contact (see Appendix O Tables 1-12) or level of familiarity (see Appendix O 
Tables 13-23) and participant gender in the prediction of stigma (i.e., preferred social 
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distance, perceived dangerousness, negative emotions) at either pre- or post-test and, 
thus, will not be discussed further.  
Participant age was also examined as a moderator variable between the level of 
familiarity and stigma (i.e., preferred social distance, perceived dangerousness, and 
negative emotions). Findings indicate there were two path analysis models for the control 
group that displayed a significant interaction between the level of familiarity with 
marijuana users and participant age in the prediction of preferred social distance at both 
pre- and post-test (β = 0.23, p < .05, see Table 16; β = 0.23, p < .05, see Table 17). 
Specifically, the control groups showed there was a significant negative association 
between the level of familiarity and preferred social distance for participants who were 
over 18 years of age at both pre-test (p < .001; see Figure 7) and post-test (p < .001; see 
Figure 8). The overall pre- and post-test model explained 43% percent of the variance. 
The interaction itself for the pre-test accounted for 4% in the outcome, and the interaction 
for the post-test accounted for 3% in the outcome. This suggests that when an individual 
is over 18 years old, they tend to report higher levels of preferred social distance when 
their level of familiarity with marijuana users is low. However, when their level of 
familiarity is high, there are virtually no differences. Additionally, there were no 
associations found among individuals who were 18 years old. They reported a low/high 
preferred social distance irrespective of the level of familiarity. All other models for the 
control group and the experimental group did not indicate any significant interactions 
between participant age and the level of contact (see Appendix O Tables 48-59) or level 
of familiarity (see Appendix O Tables 60-69) in the prediction of stigma (i.e., preferred 
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social distance, perceived dangerousness, negative emotions) at either pre- or post-test 
and, thus, will not be discussed further.  
Likewise, any past personal use was also analyzed as a moderator variable 
between the level of familiarity and each stigma measure. However, there were no 
significant interactions found at pre- or post-test for either the experimental or control 
groups (see Appendix O Tables 36-47). Furthermore, the association between the level of 
contact and each stigma measure with the same moderator variables (i.e., sex, any past 
personal use, and participant age) was also tested; however, no significant interactions 
were found (see Appendix O Tables 24-35). These results will not be discussed further 
due to the lack of significant findings.  
Additional Analyses: Likelihood of Future Use 
Research Questions 1 and 2 
Additional analyses were performed to determine whether there was a significant 
difference on the likelihood of future use across the experimental versus the control 
group. This was determined using an independent samples t-test. Furthermore, we 
explored whether there was a relationship between the level of familiarity, the level of 
contact, and the likelihood of future use. After establishing this relationship, we 
examined whether sex, any past marijuana use, and age would moderate this potential 
relationship. Using moderated regression analysis, the role of gender and participant age 
as moderator variables were assessed between the level of contact and each stigma 
measure and the level of familiarity and each stigma measure. However, no significant 
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interactions were found. These results will not appear in the appendices nor be discussed 
further. 
Any past marijuana use was also examined as a moderator variable between the 
level of contact, the level of familiarity, and each stigma measure in each group (i.e., 
experimental vs. control) with more success. Findings indicate that there was a significant 
interaction between the level of contact and the likelihood of using marijuana 
recreationally in the future at both pre-test (β = 0.15, p < .05, see Table 18) and post-test 
(β = -0.14, p < .05, see Table 20) for those in the experimental group who have a past 
history of marijuana use. The pre- and post-test interaction explained 2% of the variance 
in the likelihood of future use (the pre-test total model explained 58% of the variance and 
the post-test total model explained 65% of the variance). However, among individuals 
who had never reported past marijuana use, there was no association. They reported a low 
likelihood of future usage regardless of the level of contact. This suggests that at both 
pre- and post-test individuals who have used marijuana in the past tend to report a higher 
likelihood of future marijuana use when contact is high as compared to those who had a 
low level of contact or had high contact but reported no past usage.  
In addition to significant interactions being found for the level of contact, there 
were also significant associations between the level of familiarity and pre-test likelihood 
of future recreational marijuana use (p < .001; see Figures 11 and 15) for those who had 
ever used marijuana recreationally in the past in both the experimental (β = -0.20, p < 
.001, see Table 19) and control groups (β = 0.31, p < .001, see Table 22). However, 
among individuals who had never reported past marijuana use, there was no association. 
68 
 
They reported a low likelihood of future usage irrespective of the level of familiarity. The 
overall model for the experimental group explained 71% percent of the variance while 
the interaction accounted for 4% in the outcome. The overall model for the control group, 
on the other hand, explained 48% percent of the variance while the interaction accounted 
for 7% in the outcome. A similar pattern was identified at post-test as well (p < .001, see 
Figures 12 and 16) for both the experimental (β = -0.21, p < .001, see Table 21) and 
control groups (β = 0.29, p < .001, see Table 23). This indicates that individuals with a 
high level of familiarity and had used marijuana at some point in the past reported the 
highest likelihood of using marijuana recreationally in the future as compared to those 
who had a low level of familiarity or had high familiarity but reported no past usage. The 
post-test total model for the experimental group explained 67% of the variance while the 
interaction explained 4% of the variance. The post-test total model for the control group, 
however, explained 52% of the variance while the interaction explained 7% of the 







The extensive review of the literature revealed no existing experimental findings on 
the investigation of interactive knowledge-based internet modules and their effect on the 
stigma associated with recreational marijuana use and knowledge regarding marijuana. 
To try to address this gap, the current study focused on pilot-testing a psychoeducational 
module designed to increase knowledge and reduce stigma towards recreational 
marijuana users.  
Findings indicate partial support for the first hypothesis regarding the use of the 
psychoeducational module to increase knowledge and reduce the stigma of recreational 
marijuana users. Specifically, the module was shown to increase knowledge regarding 
marijuana. However, there was little to no impact on stigma (i.e., preferred social 
distance, perceived dangerousness, negative emotions regarding marijuana use). These 
findings are somewhat consistent with the literature on substance use stigma as relatively 
few anti-stigma interventions for substance use disorders have been shown to work in the 
reduction of stigma for the general public (Livingston et al., 2011). This could signify 
that the construct of stigma is more difficult to change and the presentation of knowledge 
may not be enough to reduce stigma given the study’s findings. Using educational 
information to reduce stigma of people with mental illness has been used in the past by 
presenting individuals with factsheets and asking them to read though them or through 
extensive education courses, however, this has only produced small effects (Luty et al., 
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2009; Mayville & Penn, 1998; Penn & Martin, 1998). In the current study, we attempted 
to take the implementation of this type of educational or factual information a step further 
by providing multiple sources, colorful representations, and easily readable information 
which was meant to make it more enjoyable to the participant. Making the information 
more enjoyable, yet maintaining a brief time commitment, promotes active learning 
(Bonwell & Eison, 1991; Prince, 2004). Promoting active learning may help individuals 
become more engaged, making them more familiar with the information, and more likely 
to remember the information later (Bonwell & Eison, 1991). The increase in knowledge 
at post-test indicates that active learning was occurring for those who went through the 
module, but it was not enough to change the more ingrained stigmatizing attitudes. Future 
research may instead target the specific negative attitudes and perceptions regarding users 
and include personal narratives from recreational marijuana users recounting their life 
experiences. These personal narratives do not necessarily have to be done in-person 
either; they could be videotaped and easily added to the current psychoeducational 
module. This could help non-users discount any misconceptions that may have about 
recreational marijuana users (Mayville & Penn, 1998; Penn & Martin, 1998) and could 
incorporate areas such as how recreational marijuana use has impacted their life or how 
they think using marijuana impacts their mind and body. 
Additionally, findings indicate support for hypothesis two which examined the 
association of the level of familiarity and level of contact with stigmatized views towards 
recreational marijuana users. Consistent with past substance use stigma research (Brown, 
2011; Corrigan & Watson, 2002; Feldman & Crandall, 2007), findings indicate strong 
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associations between the level of familiarity, the level of contact, and stigma. 
Specifically, as the level of familiarity or level of contact increases, less stigmatization 
occurs. Reestablishing this important relationship is an essential step in the development 
of successful anti-stigma interventions as prior research lacks an understanding of 
whether this relationship holds across specific substances (e.g., marijuana) and it provides 
a focus area for the intervention research. Again, the next steps in the development of a 
successful intervention may be to expose individuals to people from the stigmatized 
group as this has been shown to decrease the level of stigma (Corrigan & Watson, 2002). 
As mentioned above, perhaps the best way to incorporate this idea into an online module 
would be to create videotaped testimonials that depict a recreational marijuana user. An 
incorporation of multiple avenues for changing stigma (i.e., protest, more education, and 
contact) could be the best option for reducing stigma. Future research should focus on 
integrating these more when developing anti-stigma interventions. 
While incorporating multiple avenues for change is one idea for improving anti-
stigma interventions, researchers should also identify specific individual characteristics 
that may impact stigma so they can target anti-stigma interventions to those individuals 
who need it most. The current study attempted to address this in hypothesis 3 by 
identifying several specific characteristics (i.e., gender, past marijuana use, and age) that 
had the potential to impact stigma. However, limited support was found for hypothesis 
three examining the moderating role of gender, past marijuana use, and age on the 
established association between the level of familiarity and level of contact on stigma 
levels. Specifically, we expected that females, non-users, and older emerging adults 
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would have greater levels of stigma when contact/familiarity are low, but when they are 
high we expected no differences. Although there was limited support for these factors on 
the relationship between the level of familiarity and level of contact on stigma, this 
should not discourage future researcher from trying to identify other factors that may 
impact this well-established connection. Anti-stigma interventions may work better if we 
use a preventative model and specifically target them to a particular population or 
subgroup that may hold more stigma towards the outgroup members.     
Furthermore, given the controversial topic of marijuana use in general, 
exploratory analyses were performed examining the extent to which the 
psychoeducational module may impact the likelihood of future recreational marijuana 
use. Specifically, the study explored whether there was a significant difference on the 
likelihood of future use across the experimental versus the control group. Additionally, 
we explored whether there was a relationship between the level of familiarity, the level of 
contact, and the likelihood of future use. After establishing this relationship, we 
examined whether sex, any past marijuana use, and age would moderate the established 
relationship. Findings indicate limited support for the moderating role of sex and age in 
the relationship between the level of familiarity and the level of contact on the likelihood 
of future use. However, a history of past marijuana use does appear to moderate this 
relationship. Specifically, when the level of familiarity is high, individuals rated their 
likelihood to use marijuana in the future higher when they have a history of marijuana 
use. However, when their level of familiarity is low, there are little to no differences in 




The current study is unique in three ways and contributes to the substance use 
stigma literature by providing information about specific aspects that may need to be 
included for successful, specifically targeted anti-stigma intervention programs. First, this 
study seeks to examine whether an interactive psychoeducational module is effective in 
increasing knowledge and reducing the stigma of recreational marijuana use. Using a 
module that is internet based may also be an efficient intervention medium because many 
people are familiar with the internet and use it often. The boundless use of technology in 
daily life makes it a potentially powerful agent of change for clinical psychology science 
and practice (Dimeff, Paves, Skutch, & Woodcock, 2010). We have seen shifts towards 
the use of technology in many areas of clinical psychology research (Caspar, 2004). For 
instance, an evidence-based treatment for anxiety disorders in youth and adolescents 
incorporates the use of a CD-ROM version of Coping Cat as a computer-assisted 
Cognitive-Behavioral Therapy (CBT; Khanna & Kendall, 2008); this would not be a 
standalone treatment, but, rather, an enhancement of the skills already learned during 
therapy (Khanna & Kendall, 2008). Its purpose is to reduce the costs of traditional CBT, 
make data collection easier for researchers and patients, and include a wide variety of 
stimuli (Khanna & Kendall, 2008). These were also the goals with the psychoeducational 
module; devising a simple, practical, cost-effective technique that can be easily applied to 
any anti-stigma intervention program. The module is also meant to be fun and interactive 




Additionally, providing information in an interactive manner that does not require 
extensive educational courses is also unique to the substance use stigma literature. Using 
educational information to reduce stigma of people with mental illness has been used in 
the past by presenting individuals with factsheets and asking them to read through them 
or through extensive education courses, however, this has only produced small effects 
(Luty et al., 2009; Mayville & Penn, 1998; Penn & Martin, 1998). Also, testing this 
psychoeducational module may help in identifying how time intensive the program must 
be to reduce stigma. Current, successful interventions for mental illness stigma often last 
multiple days (Bahora et al., 2008) to weeks (Bland et al., 2001) and are not typically 
targeted at the general public, but rather persons providing services to stigmatized 
individuals, whereas the current module takes less than 30 minutes, and is aimed to 
impact a larger audience. However, given our findings, we know that the 25-minute 
psychoeducational module has had limited success in the reduction of stigma and, 
therefore, may need to be adjusted to a larger time commitment. The amount of time 
needed to change the negative attitudes and perceptions that have been ingrained remains 
unclear and is a limitation of the current study. However, it may be that the 
psychoeducational module cannot be used as a standalone treatment option, similar to the 
Coping Cat CD-ROM used for the treatment of anxiety (Khanna & Kendall, 2008). 
Instead, future researchers could try using the psychoeducational module in conjunction 
with a current anti-stigma intervention program as an additive component of treating 
stigma. Additional research is needed to determine the simplest, most practical, and cost-
effective method for reducing the stigma surrounding recreational marijuana users. 
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Future research may want to branch out beyond psychoeducation about marijuana and 
include more avenues for change (i.e., protest, more education, and contact; Corrigan & 
Penn, 1999) that have worked well in past research (Luty et al., 2009; Mayville & Penn, 
1998; Penn & Martin, 1998). Also, the best way to determine how long the effects of the 
anti-stigma interventions last or the lasting effects on knowledge, researchers should 
include a 6-month or 12-month follow-up. 
Furthermore, this study is unique in that we examine specific characteristics or 
traits that may impact the level of stigma, highlighting the need for intervention programs 
targeted at public stigma of marijuana users. Examining specific characteristics and 
components that vary the level of stigma is an essential step toward implementing 
targeted anti-stigma intervention programs. Even though our findings did not indicate that 
these particular characteristics are moderators (i.e., gender, past marijuana use, and age), 
other characteristics such as sex or race/ethnicity of the marijuana user or race/ethnicity 
of the participant could be examined. Identifying these characteristics would be an 
important stepping stone in the investigation of substance use stigma.  
Limitations 
 All research has its limitations; this study is no different. One limitation of this 
study resulted from how the study itself was designed to only encompass recreational 
marijuana use specifically. Given that this study only focuses on stigma surrounding 
recreational marijuana use, the results can only be interpreted for recreational marijuana 
use exclusively as it is singularly featured in the current study. However, previous 
findings indicate that marijuana may be stigmatized less than other illegal substances 
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(Palamar et al., 2012). It may be harder to find results regarding stigma levels if levels of 
stigma towards marijuana users has a floor effect. However, if this is the case, future 
research should still focus on identifying characteristics and traits of individuals who are 
more likely to stigmatize towards individuals who use other illegal substances instead.  
Another limitation is relying on self-report measures from the same person. This 
brings up several issues. First, self-report does not always give us the most accurate 
representation of an individual’s actions due to social desirability or inaccurate accounts. 
Social desirability occurs when individuals fake good, thereby making themselves “look 
better” than they are and  is a common issue with self-report measures because it can 
decrease the construct validity of the survey (Morling, 2012). Individuals who are “faking 
good” may not be consciously aware of what they are doing either so it is difficult to 
gauge this issue in the study (Morling, 2012). Future research may want to include 
questions like “My table manners at home are as good as when I eat out in a restaurant” 
or “I am always a good listener, no matter who I am talking to” to better gauge whether 
individuals are responding in a more positive way because people who agree with these 
questions are assumed to respond in a highly socially desirable manner (Crowne & 
Marlowe, 1960). Implementing a more objective method such as an Implicit Association 
Test (IAT; Greenwald, Nosek, & Mahzarin, 2003) could also help address this issue. 
However, due to the limited scope of the current project, this is not feasible.  
Also, the generalizability of the study must be considered. Given that the sample 
consisted of young adults in introductory to psychology courses at a moderately sized 
public Midwestern university in the United States, results can only be generalized to this 
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subset population. Generalizability to different populations such as private institutions, or 
other regions is not feasible due to the limited sample tested. Additionally, given that we 
sampled college students, this may be impacting the level of reported stigma towards 
marijuana use because college students often hold more liberal and positive views 
towards use. Given the limited sample, the study’s results are only generalizable to young 
adults in public universities in a Midwestern region of the United States. Future research 
should try to focus on sampling individuals from a variety of backgrounds to ensure more 
generalizable findings to a larger subset of individuals. Additionally, due to how this 
study was designed, it is unclear how long effects on knowledge or stigma would last. 
Future research may want to include a 6-month or 12-month follow-up to discover how 
lasting these effects on stigma or knowledge may be.    
Implications 
Research on the detrimental consequences of substance use stigma highlights the 
need for successful, specifically targeted anti-stigma intervention programs. Substance 
using behaviors have been criminalized at a societal level as a deterant of use (Livingston 
et al., 2011), however, criminalizing substance use only exacerbates stigma by making 
people more prone to devalue and exclude individuals who use illegal substances (Room, 
2005). Additionally, substance use stigma lowers societal support for much needed 
intervention programs (Capitanio & Herek, 1999) and often discourages individuals from 
seeking treatment for their substance use (Fortney et al., 2004; Kushner & Sher, 1991). 
These consequences hinder the stigmatized individual’s ability to receive adequate 
treatment for their disorder, potentially impacting their life even further. As substance use 
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disorders are one of the most stigmatized health conditions (Corrigan et al., 2005; Rao et 
al., 2009; Ronzani et al., 2009; Room, 2005; Schomerus et al., 2011), it is important to 
understand how a reduction in stigma through an intervention program could improve the 
overall quality of life and ability to receive treatment services for marijuana users. The 
current psychoeducational module is a stepping-stone for future anti-stigma interventions 
aimed at the reduction of stigma towards marijuana users which may greatly improve 
their overall quality of life and ability to seek treatment services.  
Future Directions 
Thus, more research is needed in the substance use stigma field, especially 
research surrounding anti-stigma intervention programs. The next logical step for future 
research may be trying to incorporate more ways of changing stigma into the module 
itself (i.e., protest, more education, and contact; Corrigan & Penn, 1999). As noted in the 
literature review, protesting has had very little research assessing the impact of protest 
campaigns on discrimination and stigma (Corrigan & Watson, 2002) which could make it 
harder to implement. However, this does not mean we should deter from using this 
strategy and is a suggested avenue for future research efforts (Corrigan & Watson, 2002). 
Adding more education about marijuana and addressing common misconceptions through 
facts could potentially strengthen the psychoeducational module (Corrigan & Penn, 
1999). However, overburdening participants with too much information may only serve 
to confuse or fatigue them (Morling, 2012), therefore, researchers should seek to find a 
balance. Another option is for researchers to include trying to expose individuals to 
people from the stigmatized group as this has been shown to decrease the level of stigma 
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(Corrigan & Watson, 2002). This known link between level of familiarity and level of 
contact in predicting stigma may play an interesting role in the future of marijuana use 
stigma as marijuana is one of the most commonly used illegal substances. This 
commonality may indicate a greater chance of previous contact and familiarity with 
marijuana users more so than other illicit substance. Additionally, it should also be 
highlighted that findings from the 2013 NSDUH survey indicate an upward trend in 
marijuana use from 2007-2013. These findings suggest a greater chance of contact with 
marijuana users, potentially reducing stigma towards marijuana use. As mentioned above, 
perhaps the best way to incorporate this idea into an online module would be to create 
videotaped testimonials that depict a recreational marijuana user. There are many options 
for improvements to the current module. Each of these options may add to the length of 
the overall module itself but seems like a logical next step, especially because the module 
does seem to be increasing knowledge of the participants but has not significantly 
improved the reduction of stigma. Therefore, including more ways to increase protesting, 
education, or contact in the anti-stigma intervention may propel participants to have a 
greater understanding of substance users, producing a reduction of stigma.  
Furthermore, future research should seek to examine other potential 
characteristics that may influence the relationship between the level of familiarity and 
contact with stigma levels such as other age groups and education levels. Another area 
for future research should assess substance use stigma at the individual level for each 
substance to increase the generalizability of the findings. Additionally, researchers may 
find it beneficial to branch out to other illicit substances beyond recreational marijuana 
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use that are also largely stigmatized by society. Each substance is different and using 
psychoeducation to increase knowledge and reduce the stigma surrounding a particular 
substance may vary for across substances.  
Additionally, there is currently a huge gap in the literature for interventions 
targeted at kids and adolescents (Livingston et al., 2011). One of the biggest challenges to 
the legalization of marijuana is the perceived consequence of what these new laws would 
do for the likelihood of future marijuana use, especially for youth, and how it may impact 
stigma. Recently, researchers found evidence of stigma reduction amongst eighth- and 
10th-grade students in Washington, after the legalization of recreational marijuana (Cerda 
et al., 2016). However, they also found an increase in the likelihood of using amongst 
these youth as well (Cerda et al., 2016). Another study by Mason and colleagues (2015) 
examined a similar issue examining perceptions, knowledge, and parent-child discussions 
for low-income families in the state of Washington since the legalization of recreational 
marijuana. Findings indicate that the participant's attitudes and behaviors regarding 
marijuana changed little and many were still unclear about what was legal and illegal in 
their state (Mason, Hanson, Fleming, Ringle, & Haggerty, 2015). This emphasizes the 
importance of developing anti-stigma interventions aimed at youth. Earlier detection for 
those at-risk for stigmatization and identification of the best, most efficient practices for 
the reduction of stigma could promote more of a preventative model. A preventative 
model is not a new concept to the field of clinical psychology, however. Autism 
Spectrum Disorder (ASD) is a childhood developmental disorder where prior research 
has shown that interventions before the age of five have promising results and better 
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overall outcomes for these individuals across the lifespan (Smith & Iadarola, 2015). 
Although proposing an anti-stigma intervention aimed at kids before the age of five may 
not be feasible yet, targeting individuals early and providing them with facts about 
marijuana and its use can allow them to make an informed decision and hopefully reduce 
stigmatization of the substance.  
Furthermore, given the unique and controversial issue of marijuana use in the 
U.S. today, it might be interesting to examine how recreational marijuana use stigma in 
Iowa compares to other states that have already legalized marijuana for recreational use. 
However, very little research has compared stigma across different states. The most 
recent research is trending towards the idea that stigmatization of marijuana is becoming 
less in many states, especially amongst those that have already legalized marijuana 
(Cerda et al., 2016). For example, Cerda and colleagues (2016) assessed the perceived 
harmful effects and self-reported marijuana use before and after legalization in 
Washington and Colorado. Findings indicate eighth- and 10th-grade students in the state 
of Washington perceived that harm has significantly decreased since the enactment of 
recreational marijuana laws. However, there was no decrease in perceived harm amongst 
similar grade in the state of Colorado (Cerda et al., 2016). These findings indicate that 
numerous differences in stigma may exist across states and regions and what works 
effectively for the reduction of stigma in one area, may not work in another. This 
emphasizes the importance of working with people from a diverse background and how 





Substance use stigma and successful anti-stigma interventions are a vastly 
underexplored topic. By pilot testing a psychoeducational module about marijuana, the 
study aims to devise a simple, practical, cost-effective technique that can be easily 
applied to an anti-stigma intervention program and easily replicated to other substances 
or disorders. It can be concluded that the psychoeducational module increased knowledge 
regarding marijuana and its uses but had limited impact on stigma itself. Although this 
study produced limited support for changing stigma after receiving the psychoeducational 
module, researchers should not be discouraged from contributing to this ever-growing 
field. Livingston and colleagues (2011) highlighted the limited research on anti-stigma 
interventions in the substance use stigma field and sounded a call to action for further 
research. Integration of multiple avenues for change in stigma (i.e., protest, more 
education, and contact) may help with targeting the more ingrained attitudes and 
behaviors that accompany stigma. Additionally, exploring what factors influence change 
in stigma and developing successful, specifically targeted anti-stigma interventions is 
paramount to the progress of the field and an essential next step in reducing public stigma 
associated with substance use. Findings from the current study have implications for 
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Table 1  
Demographic Characteristics of Participants 
 
Variables Merged Sample 
(N = 201) 
Module Group  
(N = 104) 
Control Group 
(N = 97) 
% M (SD) % M (SD) % M (SD) 
Age  18.81(1.25)  18.73(0.90)  18.90(1.54) 
     18 years old 51.2  51.0  51.5  
     19 years old 30.8  30.8  30.9  
     20 years old 11.4  12.5  10.3  
     21+ years old 6.5  5.8  7.8  
Ethnicity  1.18(0.71)  1.30(0.91)  1.05(0.33) 
     White 91.5  86.5  96.9  
     Black 4.0  5.8  2.1  
     Asian/Pacific      
     Islander 1.0  1.9  1.0  
     Hispanic/ 
     Latino 3.0  4.8  --  
     Other 0.5  1.0  --  
Sex  0.66(0.48)  0.66(0.47)  0.65(0.48) 
     Males 34.3  33.7  35.1  
     Female 65.7  66.3  64.9  
Year in School  1.39(0.77)  1.44(0.85)  1.34(0.69) 
     Freshman 75.1  74.0  76.3  
     Sophomore 13.9  12.5  15.5  
     Junior 7.5  8.7  6.2  
     Senior 3.5  4.8  2.1  
Ever Used 
Marijuana  1.63(0.49)  1.59(0.50)  1.67(0.47) 
     Yes 37.3  41.3  33.0  
     No 62.7  58.7  67.0  
Current use of 
Marijuana in Past 
30 days (N = 75; 
N = 43; N = 32) 
 1.73(0.45)  1.70(0.47)  1.78(0.42) 
     Yes 26.7  30.2  21.9  
     No 73.3  69.8  78.1  
Note. Standard deviation is presented in parentheses.
 
 
Table 2   




N Range Minimum Maximum M SD 
Level of Familiarity 201 0.73 0.09 0.82 0.44 0.20 
Level of Contact 201 2.67 0.00 2.67 1.10 0.62 
Preferred Social Distance       
     Pre- 200 2.86 1.14 4.00 2.90 0.76 
     Post- 200 3.00 1.00 4.00 2.91 0.76 
Perceived Dangerousness       
     Pre- 200 4.57 1.00 5.57 3.06 1.03 
     Post- 201 5.00 1.00 6.00 3.16 1.09 
Negative Emotions       
     Pre- 201 6.00 1.00 7.00 3.99 1.47 
     Post- 201 6.00 1.00 7.00 3.99 1.47 
Knowledge       
     Pre- 201 15.00 7.00 22.00 15.02 2.63 
     Post- 201 19.00 6.00 25.00 18.85 4.41 
Likelihood of Future Use        
     Pre- 201 5.00 1.00 6.00 2.34 1.84 




Table 3   




N Range Minimum Maximum M SD 
Level of Familiarity 104 0.73 0.09 0.82 0.44 0.22 
Level of Contact 104 2.67 0.00 2.67 1.07 0.63 
Preferred Social Distance       
     Pre- 104 2.86 1.14 4.00 2.86 0.77 
     Post- 103 3.00 1.00 4.00 2.91 0.78 
Perceived Dangerousness       
     Pre- 104 4.57 1.43 6.00 4.02 1.03 
     Post- 104 5.00 1.00 6.00 3.81 1.15 
Negative Emotions       
     Pre- 104 6.00 1.00 7.00 3.88 1.52 
     Post- 104 6.00 1.00 7.00 3.86 1.48 
Knowledge       
     Pre- 104 11.00 10.00 21.00 15.12 2.43 
     Post- 104 11.00 14.00 25.00 22.39 2.20 
Likelihood of Future Use        
     Pre- 104 5.00 1.00 6.00 2.46 1.98 




Table 4   




N Range Minimum Maximum M SD 
Level of Familiarity 97 0.73 0.09 0.82 0.43 0.18 
Level of Contact 97 2.67 0.00 2.67 1.13 0.62 
Preferred Social Distance       
     Pre- 96 2.57 1.43 4.00 2.95 0.75 
     Post- 97 2.57 1.43 4.00 2.93 0.75 
Perceived Dangerousness       
     Pre- 96 4.43 1.57 6.00 3.85 1.02 
     Post- 97 4.71 1.29 6.00 3.89 1.02 
Negative Emotions       
     Pre- 97 6.00 1.00 7.00 4.10 1.41 
     Post- 97 6.00 1.00 7.00 4.13 1.46 
Knowledge       
     Pre- 97 15.00 7.00 22.00 14.93 2.84 
     Post- 97 15.00 6.00 21.00 15.05 2.68 
Likelihood of Future Use        
     Pre- 97 5.00 1.00 6.00 2.22 1.67 




Table 5   
Correlations Between Key Study Variables in Merged Sample 
 
Merged Sample 













Knowledge Likelihood of 
Future Use 
Pre- Post- Pre- Post- Pre- Post- Pre- Post- Pre- Post- 
Level of Familiarity --            
Level of Contact .55** --           
Preferred Social 
Distance 
 Pre- -.57** -.44** --          
 Post- -.58** -.46** .94** --         
Perceived 
Dangerousness 
 Pre- -.47** -.28** .75** .74** --        
 Post- -.46** -.30** .72** .75** .92** --       
Negative 
Emotions 
 Pre- -.51** -.37** .77** .77** .72** .67** --      
 Post- -.50** -.36** .78** .78** .73** .70** .95** --     
Knowledge 
 Pre- .18 .08 -.16 -.12 -.19** -.15 -.13 -.12 --    
 Post- .06 -.04 -.14 -.11 -.14 -.04 -.15 -.17 .32** --   
Likelihood of 
Future Use  
 Pre- .63** .24** -.62** -.61** -.57** -.54** -.55** -.58** .24** .16 --  
 Post- .65** .29** -.62** -.60** -.56** -.51** -.56** -.58** .15 .10 .92** -- 





Table 6   
Correlations Between Key Study Variables in Psychoeducation Module Sample 
 














Knowledge Likelihood of 
Future Use 
Pre- Post- Pre- Post- Pre- Post- Pre- Post- Pre- Post- 
Level of Familiarity --            
Level of Contact .63** --           
Preferred Social 
Distance 
 Pre- -.58** -.56** --          
 Post- -.61** -.60** .94** --         
Perceived 
Dangerousness 
 Pre- -.50** -.46** -.78** -.77** --        
 Post- -.47** -.43** -.73** -.77** .93** --       
Negative 
Emotions 
 Pre- -.48** -.51** .74** .73** -.71** -.64** --      
 Post- -.47** -.48** .76** .77** -.73** -.70** .94** --     
Knowledge 
 Pre- .18 .20 -.08 .01 .11 .08 -.06 -.04 --    
 Post- -.01 .00 -.14 -.15 .07 .02 -.18 -.20* .13 --   
Likelihood of 
Future Use  
 Pre- .72** .40** -.59** -.57** .54** .51** -.47** -.50** .18 .05 --  
 Post- .70** .43** -.55** -.55** .50** .49** -.46** -.50** .10 .02 .93** -- 







Table 7   
Correlations Between Key Study Variables in Control Sample 
 
Control Sample 













Knowledge Likelihood of 
Future Use 
Pre- Post- Pre- Post- Pre- Post- Pre- Post- Pre- Post- 
Level of Familiarity --            
Level of Contact .46** --           
Preferred Social 
Distance 
 Pre- -.56** -.30** --          
 Post- -.55** -.30** .96** --         
Perceived 
Dangerousness 
 Pre- -.44** -.09 -.72** -.71** --        
 Post- -.44** -.13 -.72** -.74** .92** --       
Negative 
Emotions 
 Pre- -.55** -.21 .82** .82** -.74** -.73** --      
 Post- -.54** -.23 .79** .79** -.73** -.72** .97** --     
Knowledge 
 Pre- .18 -.03 -.24 -.24 .27** .24 -.19  --    
 Post- .18 -.01 -.20 -.21 .21 .24 -.14 -.15 .83** --   
Likelihood of 
Future Use 
 Pre- .48** .05 -.66** -.66** .60** .58** -.67** -.67** .31** .33** --  
 Post- .57** .12 -.70** -.66** .63** .54** -.69** -.68** .19 .18 .91** -- 






Table 8  
Pre-/Post- Mean and Standard Deviation Differences for Knowledge and Stigma 
Measures 
 
Variable M SD 
Pre- Post- Pre- Post- 
Knowledge 
Module Group  15.12 22.40 2.43 2.20 
Control Group 14.93 15.05 2.84 2.68 
Preferred Social 
Distance 
Module Group 2.87 2.91 0.77 0.78 
Control Group 2.95 2.93 0.75 0.75 
Perceived 
Dangerousness 
Module Group 3.15 3.11 1.02 1.02 
Control Group 2.98 3.19 1.03 1.15 
Negative 
Emotions 
Module Group 3.88 3.86 1.52 1.48 
Control Group 4.10 4.13 1.41 1.46 
 
 
Table 9  





df F p ηp2 
Knowledge 
Time 1375.13 1375.13 1.00 451.04 .000** 0.70 
Time*Group 1284.74 1284.74 1.00 421.39 .000** 0.68 
Error(Time) 3.05 606.71 199.00 -- -- -- 
Preferred Social 
Distance 
Time 0.01 0.01 1.00 0.22 .64 0.01 
Time*Group 0.10 0.10 1.00 3.16 .08 0.02 
Error(Time) 0.03 6.31 197.00 -- -- -- 
Perceived 
Dangerousness 
Time 0.14 0.14 1.00 1.56 .21 0.01 
Time*Group 0.02 0.02 1.00 0.25 .62 0.00 
Error(Time) 0.09 17.29 197.00 -- -- -- 
Negative 
Emotions 
Time 0.01 0.01 1.00 0.06 .81 0.00 
Time*Group 0.06 0.06 1.00 0.63 .43 0.01 
Error(Time) 0.10 19.99 199.00 -- -- -- 





Table 10  





df F p ηp2 
Knowledge 
Intercept 114299.67 114299.67 1.00 11593.24 .000** 0.98 
Group 1422.97 1422.97 1.00 144.33 .000** 0.42 
Error 9.86 1961.98 199.00 -- -- -- 
Preferred Social 
Distance 
Intercept 3372.99 3372.99 1.00 2980.29 .000** 0.94 
Group 0.30 0.30 1.00 0.26 .61 0.01 
Error    -- -- -- 
Perceived 
Dangerousness 
Intercept 1019.23 1019.23 1.00 503.22 .000** 0.72 
Group 0.16 0.16 1.00 0.08 .79 0.00 
Error 2.03 399.01 197.00 -- -- -- 
Negative 
Emotions 
Intercept 6402.50 6402.50 1.00 1516.47 .000** 0.88 
Group 5.80 5.80 1.00 1.37 .24 0.01 
Error 4.22 840.17 199.00 -- -- -- 










Table 11  
Two-way Repeated Measures, Within-Between Group Interaction ANOVAs  










Pre- 15.12 0.26 14.61 15.63 
Post- 22.39 0.24 21.92 22.87 
Control Group 
Pre- 14.93 0.27 14.40 15.46 




Pre- 2.87 0.08 2.72 3.01 
Post- 2.91 0.08 2.76 3.05 
Control Group 
Pre- 2.95 0.08 2.80 3.11 




Pre- 2.98 0.10 2.79 3.17 
Post- 3.19 0.10 2.99 3.40 
Control Group 
Pre- 3.15 0.10 2.95 3.35 




Pre- 3.88 0.14 3.60 4.39 
Post- 3.86 0.14 3.58 4.42 
Control Group 
Pre- 4.10 0.15 3.80 4.17 




Table 12  




 Coefficients 95% Confidence 
Interval 
t-value p-value Total 
𝑅𝑅2 




(Constant) 3.48 0.10 -- 3.29 3.68 35.47 .001*** 
0.19 
SUCS -0.09 0.01 -0.43 -0.11 -0.06 -6.78 .001*** 
Post- 
(Constant) 3.53 0.10 -- 3.34 3.72 36.32 .001*** 
0.21 




(Constant) 3.56 0.14 -- 3.28 3.84 25.16 .001*** 
0.08 
SUCS -0.08 0.02 -0.28 -0.12 -0.04 -4.05 .001*** 
Post- 
(Constant) 3.71 0.15 -- 3.42 4.09 24.87 .001*** 
0.09 




(Constant) 4.95 0.20 -- 4.56 5.33 25.29 .001*** 
0.14 
SUCS -0.15 0.03 -0.37 -0.20 -0.10 -5.66 .001*** 
Post- 
(Constant) 4.92 0.20 -- 4.53 5.31 24.96 .001*** 
0.13 
SUCS -0.14 0.03 -0.36 -0.19 -0.09 -5.41 .001*** 
*Knowledge 
Pre- 
(Constant) 14.69 0.38 -- 13.94 15.43 39.05 .001*** 
0.01 
SUCS 0.05 0.05 0.07 -0.05 0.15 1.04 .300 
Post- 
(Constant) 19.20 0.63 -- 17.95 20.44 30.37 .001*** 
0.00 
SUCS -0.05 0.08 -0.05 -0.22 0.11 -0.63 .529 





Table 13  








t-value p-value Total 
𝑅𝑅2 





(Constant) 3.86 0.11 -- 3.65 4.07 35.94 .001*** 
0.32 
LOF -0.20 0.02 -0.57 -0.24 -0.16 -9.74 .001*** 
Post- 
(Constant) 3.89 0.11 -- 3.68 4.10 36.58 .001*** 
0.34 




(Constant) 4.13 0.16 -- 3.83 4.44 26.65 .001*** 
0.23 
LOF -0.22 0.03 -0.47 -0.28 -0.17 -7.58 .001*** 
Post- 
(Constant) 4.25 0.17 -- 3.92 4.58 25.61 .001*** 
0.21 




(Constant) 5.62 0.22 -- 5.19 6.05 25.86 .001*** 
0.26 
LOF -0.34 0.04 -0.51 -0.42 -0.26 -8.25 .001*** 
Post- 
(Constant) 5.61 0.22 -- 5.18 6.04 25.70 .001*** 
0.25 
LOF -0.34 0.04 -0.50 -0.42 -0.26 -8.14 .001*** 
*Knowledge 
Pre- 
(Constant) 14.01 0.44 -- 13.14 14.89 31.61 .001*** 
0.03 
LOF 0.21 0.08 0.18 0.05 0.38 2.51 .013* 
Post- 
(Constant) 18.25 0.75 -- 16.76 19.73 24.20 .001*** 
0.00 
LOF 0.13 0.14 0.06 -0.16 0.41 0.88 .380 




Table 14  








t-value p-value Total 
𝑅𝑅2 





(Constant) 16.62 0.71 -- 15.22 18.03 23.32 .001*** 
0.03 
Know -0.54 0.24 -0.16 -1.01 -0.07 -2.26 .025* 
Post- 
(Constant) 21.27 1.20 -- 18.90 23.64 17.69 .001*** 
0.02 




(Constant) 16.53 0.57 -- 15.41 17.64 29.27 .001*** 
0.04 
Know -0.48 0.18 -0.19 -0.82 -0.13 -2.73 .007** 
Post- 
(Constant) 20.78 0.96 -- 18.89 22.67 21.71 .001*** 
0.02 




(Constant) 15.93 0.53 -- 14.87 16.98 29.21 .001*** 
0.02 
Know -0.23 0.13 -0.13 -0.47 0.02 -1.79 .075 
Post- 
(Constant) 20.89 0.89 -- 19.14 22.65 23.47 .001*** 
0.03 
Know -0.51 0.21 -0.17 -0.92 -0.10 -2.44 .015* 
Note. *. XXXX is significant at the 0.05 level (2-tailed); **. XXXX is significant at the 0.01 level (2-tailed); ***. XXXX is 








Table 15  
Hypothesis 3d-2: Path Analysis Model Examining the Moderating Effects of Female on 
the Level of Familiarity and Preferred Social Distance After Receiving Video Clip 
Control Sample 







B Std. Error Beta   
Level of Familiarity -0.22 0.03 -0.56 .001 0.30 
Female 0.44 0.13 0.28 .001 0.07 
Interaction -0.13 0.06 -0.18 .035* 0.03 
Total     0.40 
Note: Interaction is defined as Level of Familiarity x Female. 
Dependent Variable: Post-Preferred Social Distance 






Table 16  
Hypothesis 3p-1: Path Analysis Model Examining the Moderating Effects of Age on the 
Level of Familiarity and Preferred Social Distance Before Receiving Video Clip 
Control Sample 







B Std. Error Beta   
Level of Familiarity -2.19 0.36 -0.51 .001 0.32 
Age -0.20 0.05 -0.42 .001 0.07 
Interaction 0.64 0.27 0.23 .021* 0.04 
Total     0.43 
Note: Interaction is defined as Level of Familiarity x Age. 
Dependent Variable: Pre-Preferred Social Distance 




Table 17  
Hypothesis 3p-2: Path Analysis Model Examining the Moderating Effects of Age on the 
Level of Familiarity and Preferred Social Distance After Receiving Video Clip 
Control Sample 







B Std. Error Beta   
Level of Familiarity -2.05 0.34 -0.49 .001 0.30 
Age -0.22 0.05 -0.45 .001 0.10 
Interaction 0.63 0.27 0.23 .019* 0.03 
Total     0.43 
Note: Interaction is defined as Level of Familiarity x Age. 
Dependent Variable: Post-Preferred Social Distance 







Table 18  
Exploratory Path Analysis Model Examining the Moderating Effects of Ever Personally 
Using Marijuana on the Level of Contact and the Likelihood of Using Marijuana in the 
Future Before Receiving Module 
Psychoeducational 







B Std. Error Beta   
Level of Contact 0.08 0.03 0.17 .018 0.16 
Ever Used 2.34 0.25 0.65 .001 0.40 
Interaction 0.15 0.07 0.15 .030* 0.02 
Total     0.58 
Note: Interaction is defined as Level of Contact x Ever Used. 
Dependent Variable: Pre-Likelihood to Ever Use 








Table 19  
Exploratory Path Analysis Model Examining the Moderating Effects of Ever Personally 
Using Marijuana on the Level of Familiarity and the Likelihood of Using Marijuana in 
the Future Before Receiving Module 
Psychoeducational 







B Std. Error Beta   
Level of Familiarity 2.96 0.74 0.33 .001 0.52 
Ever Used -1.91 0.34 -0.48 .001 0.15 
Interaction -5.21 1.53 -0.20 .001** 0.04 
Total     0.71 
Note: Interaction is defined as Level of Familiarity x Ever Used. 
Dependent Variable: Pre-Likelihood to Ever Use 
* p <0.05, two-tailed test ** p <0.001, two-tailed test 
Table 20  
Exploratory Path Analysis Model Examining the Moderating Effects of Ever Personally 
Using Marijuana on the Level of Contact and the Likelihood of Using Marijuana in the 
Future After Receiving Module 
Psychoeducational 







B Std. Error Beta   
Level of Contact 0.09 0.03 0.18 .007 0.18 
Ever Used -2.66 0.24 -0.69 .001 0.45 
Interaction -0.15 0.06 -0.14 .021* 0.02 
Total     0.65 
Note: Interaction is defined as Level of Contact x Ever Used. 
Dependent Variable: Post-Likelihood to Ever Use 











Table 22  
Exploratory Path Analysis Model Examining the Moderating Effects of Ever Personally 
Using Marijuana on the Level of Familiarity and the Likelihood of Using Marijuana in 
the Future Before Receiving Video Clip 
Control Sample 







B Std. Error Beta   
Level of Familiarity 2.01 0.83 0.21 .018 0.23 
Ever Used 1.21 0.36 0.33 .001 0.18 
Interaction 6.39 1.81 0.31 .001** 0.07 
Total     0.48 
Note: Interaction is defined as Level of Familiarity x Ever Used. 
Dependent Variable: Pre-Likelihood to Ever Use 
* p <0.05, two-tailed test ** p <0.001, two-tailed test 
Table 21  
Exploratory Path Analysis Model Examining the Moderating Effects of Ever Personally 
Using Marijuana on the Level of Familiarity and the Likelihood of Using Marijuana in 
the Future After Receiving Module 
Psychoeducational 







B Std. Error Beta   
Level of Familiarity 2.68 0.75 0.31 .001 0.49 
Ever Used -1.78 0.35 -0.47 .001 0.14 
Interaction -5.20 1.55 -0.21 .001** 0.04 
Total     0.67 
Note: Interaction is defined as Level of Familiarity x Ever Used. 
Dependent Variable: Post-Likelihood to Ever Use 







Hypothesis 1 and Results 
 Hypothesis Supported 
1a 
↑ in pre to post Knowledge for Psychoeducational Module 
Group with no change to Control Group  
Supported 
1b 
↓ in pre to post Preferred Social Distance for Psychoeducational 
Module Group with no change to Control Group 
Not Supported 
1c 
↓ in pre to post Perceived Dangerousness for Psychoeducational 
Module Group with no change to Control Group 
Not Supported 
1d 
↓ in pre to post Negative Emotionality for Psychoeducational 







Table 23  
Exploratory Path Analysis Model Examining the Moderating Effects of Ever Personally 
Using Marijuana on the Level of Familiarity and the Likelihood of Using Marijuana in 
the Future After Receiving Video Clip 
Control Sample 







B Std. Error Beta   
Level of Familiarity 3.46 0.82 0.35 .001 0.32 
Ever Used 1.00 0.35 0.27 .005 0.13 
Interaction 6.31 1.82 0.29 .001** 0.07 
Total     0.52 
Note: Interaction is defined as Level of Familiarity x Ever Used. 
Dependent Variable: Post-Likelihood to Ever Use 
* p <0.05, two-tailed test ** p <0.001, two-tailed test 
117 
 
Table 25  
Hypothesis 2 and Results 
 Hypothesis Supported 
2a-1 
↑ Level of Contact predicts ↓ Pre-Preferred Social Distance, 
regardless of group   
Supported 
2a-2 
↑ Level of Contact predicts ↓ Post-Preferred Social Distance, 
regardless of group   
Supported 
2b-1 
↑ Level of Contact predicts ↓ Pre-Perceived Dangerousness, 
regardless of group   
Supported 
2b-2 
↑ Level of Contact predicts ↓ Post-Perceived Dangerousness, 
regardless of group   
Supported 
2c-1 
↑ Level of Contact predicts ↓ Pre-Negative Emotionality, 
regardless of group   
Supported 
2c-2 
↑ Level of Contact predicts ↓ Post-Negative Emotionality, 
regardless of group   
Supported 
2d-1 
↑ Level of Familiarity predicts ↓ Pre-Preferred Social Distance, 
regardless of group   
Supported 
2d-2 
↑ Level of Familiarity predicts ↓ Post-Preferred Social Distance, 
regardless of group   
Supported 
2e-1 
↑ Level of Familiarity predicts ↓ Pre-Perceived Dangerousness, 
regardless of group   
Supported 
2e-2 
↑ Level of Familiarity predicts ↓ Post-Perceived 
Dangerousness, regardless of group   
Supported 
2f-1 
↑ Level of Familiarity predicts ↓ Pre-Negative Emotionality, 
regardless of group   
Supported 
2f-2 
↑ Level of Familiarity predicts ↓ Post-Negative Emotionality, 











Table 26  
Hypothesis 2 Exploratory Analyses and Results 
 Hypothesis Supported 
2g-1* 
↑ Knowledge predicts ↓ Pre-Preferred Social Distance, 
regardless of group   
Supported 
2g-2* 
↑ Knowledge predicts ↓ Pre-Preferred Social Distance, 
regardless of group   
Supported 
2h-1* 
↑ Knowledge predicts ↓ Pre-Perceived Dangerousness, 
regardless of group   
Supported 
2h-2* 
↑ Knowledge predicts ↓ Post-Perceived Dangerousness, 
regardless of group   
Supported 
2i-1* 
↑ Knowledge predicts ↓ Pre-Negative Emotionality, regardless 
of group   
Not Supported 
2i-2* 
↑ Knowledge predicts ↓ Post-Negative Emotionality, regardless 
of group   
Supported 




Table 27  
Hypothesis 3a through 3d and Results 
 Grp Hypothesis Supported 
3a-1 CG 
↑ Pre-Preferred Social Distance when Level of Contact ↓ 
for females  
Not Supported 
3a-2 CG 




↑ Pre-Preferred Social Distance when Level of Contact ↓ 
for females  
Not Supported 
3a-4 PM 




































↑ Pre-Preferred Social Distance when Level of Familiarity 
↓ for females 
Not Supported 
3d-2 CG 
↑ Post-Preferred Social Distance when Level of Familiarity 
↓ for females 
Supported 
3d-3 PM 
↑ Pre-Preferred Social Distance when Level of Familiarity 
↓ for females 
Not Supported 
3d-4 PM 
↑ Post-Preferred Social Distance when Level of Familiarity 




Table 28  
Hypothesis 3e through 3h and Results 
 Grp Hypothesis Supported 
3e-1 CG 
↑ Pre-Perceived Dangerousness when Level of Familiarity 
↓ for females 
Not Supported 
3e-2 CG 
↑ Post-Perceived Dangerousness when Level of Familiarity 
↓ for females 
Not Supported 
3e-3 PM 
↑ Pre-Perceived Dangerousness when Level of Familiarity 
↓ for females 
Not Supported 
3e-4 PM 
↑ Post-Perceived Dangerousness when Level of Familiarity 
↓ for females 
Not Supported 
3f-1 CG 
















↑ Pre-Preferred Social Distance when Level of Contact ↓  
for non-users   
Not Supported 
3g-2 CG 
↑ Post-Preferred Social Distance when Level of Contact ↓ 
for non-users   
Not Supported 
3g-3 PM 
↑ Pre-Preferred Social Distance when Level of Contact ↓ 
for non-users   
Not Supported 
3g-4 PM 
↑ Post-Preferred Social Distance when Level of Contact ↓ 
for non-users   
Not Supported 
3h-1 CG 
↑ Pre-Perceived Dangerousness when Level of Contact ↓ 
for non-users   
Not Supported 
3h-2 CG 
↑ Post-Perceived Dangerousness when Level of Contact ↓ 
for non-users   
Not Supported 
3h-3 PM 
↑ Pre-Perceived Dangerousness when Level of Contact ↓ 
for non-users   
Not Supported 
3h-4 PM 
↑ Post-Perceived Dangerousness when Level of Contact ↓ 







Table 29  
Hypothesis 3i through 3l and Results 
 Grp Hypothesis Supported 
3i-1 CG 
↑ Pre-Negative Emotionality when Level of Contact ↓ for 
non-users   
Not Supported 
3i-2 CG 
↑ Post- Negative Emotionality when Level of Contact ↓ for 
non-users   
Not Supported 
3i-3 PM 
↑ Pre-Negative Emotionality when Level of Contact ↓ for 
non-users   
Not Supported 
3i-4 PM 
↑ Post- Negative Emotionality when Level of Contact ↓ for 
non-users   
Not Supported 
3j-1 CG 
↑ Pre-Preferred Social Distance when Level of Familiarity ↓ 
for non-users   
Not Supported 
3j-2 CG 
↑ Post-Preferred Social Distance when Level of Familiarity 
↓ for non-users   
Not Supported 
3j-3 PM 
↑ Pre-Preferred Social Distance when Level of Familiarity ↓ 
for non-users   
Not Supported 
3j-4 PM 
↑ Post-Preferred Social Distance when Level of Familiarity 
↓ for non-users   
Not Supported 
3k-1 CG 
↑ Pre-Perceived Dangerousness when Level of Familiarity ↓ 
for non-users   
Not Supported 
3k-2 CG 
↑ Post-Perceived Dangerousness when Level of Familiarity 
↓ for non-users   
Not Supported 
3k-3 PM 
↑ Pre-Perceived Dangerousness when Level of Familiarity ↓ 
for non-users   
Not Supported 
3k-4 PM 
↑ Post-Perceived Dangerousness when Level of Familiarity 
↓ for non-users   
Not Supported 
3l-1 CG 
↑ Pre- Negative Emotionality when Level of Familiarity ↓ 
for non-users   
Not Supported 
3l-2 CG 
↑ Post- Negative Emotionality when Level of Familiarity ↓ 
for non-users   
Not Supported 
3l-3 PM 
↑ Pre- Negative Emotionality when Level of Familiarity ↓ 
for non-users   
Not Supported 
3l-4 PM 
↑ Post- Negative Emotionality when Level of Familiarity ↓ 







Table 30  
Hypothesis 3m through 3l and Results 




↑ Pre-Preferred Social Distance when Level of Contact ↓ for 





↑ Post-Preferred Social Distance when Level of Contact ↓ 





↑ Pre-Preferred Social Distance when Level of Contact ↓ for 





↑ Post-Preferred Social Distance when Level of Contact ↓ 
for people over age 18 
Not Supported 
3n-1 CG 
↑ Pre-Perceived Dangerousness when Level of Contact ↓ for 
people over age 18 
Not Supported 
3n-2 CG 
↑ Post-Perceived Dangerousness when Level of Contact ↓ 
for people over age 18 
Not Supported 
3n-3 PM 
↑ Pre-Perceived Dangerousness when Level of Contact ↓ for 
people over age 18 
Not Supported 
3n-4 PM 
↑ Post-Perceived Dangerousness when Level of Contact ↓ 
for people over age 18 
Not Supported 
3o-1 CG 
↑ Pre-Negative Emotionality when Level of Contact ↓ for 
people over age 18 
Not Supported 
3o-2 CG 
↑ Post- Negative Emotionality when Level of Contact ↓ for 
people over age 18 
Not Supported 
3o-3 PM 
↑ Pre-Negative Emotionality when Level of Contact ↓ for 
people over age 18 
Not Supported 
3o-4 PM 
↑ Post- Negative Emotionality when Level of Contact ↓ for 
people over age 18 
Not Supported 
3p-1 CG 
↑ Pre-Preferred Social Distance when Level of Familiarity ↓ 
for people over age 18 
Supported 
3p-2 CG 
↑ Post-Preferred Social Distance when Level of Familiarity 
↓ for people over age 18 
Supported 
3p-3 PM 
↑ Pre-Preferred Social Distance when Level of Familiarity ↓ 
for people over age 18 
Not Supported 
3p-4 PM 
↑ Post-Preferred Social Distance when Level of Familiarity 










Table 31  
Hypothesis 3q through 3r and Results 
 Grp Hypothesis Supported 
3q-1 CG 
↑ Pre-Perceived Dangerousness when Level of Familiarity ↓ 
for people over age 18 
Not Supported 
3q-2 CG 
↑ Post-Perceived Dangerousness when Level of Familiarity 
↓ for people over age 18 
Not Supported 
3q-3 PM 
↑ Pre-Perceived Dangerousness when Level of Familiarity ↓ 
for people over age 18 
Not Supported 
3q-4 PM 
↑ Post-Perceived Dangerousness when Level of Familiarity 
↓ for people over age 18 
Not Supported 
3r-1 CG 
↑ Pre- Negative Emotionality when Level of Familiarity ↓ 
for people over age 18 
Not Supported 
3r-2 CG 
↑ Post- Negative Emotionality when Level of Familiarity ↓ 
for people over age 18 
Not Supported 
3r-3 PM 
↑ Pre- Negative Emotionality when Level of Familiarity ↓ 
for people over age 18 
Not Supported 
3r-4 PM 
↑ Post- Negative Emotionality when Level of Familiarity ↓ 
























Note. Values given represent the between group interaction. 
Figure 1. Hypothesis 1a two-way within-between groups interaction ANOVA analyses 









































F = 425.04 























Note. Values given represent the between group interaction. 
Figure 2. Hypothesis 1b two-way within-between groups interaction ANOVA analyses 

















































F = 3.156 
























Note. Values given represent the between group interaction. 
Figure 3. Hypothesis 1c two-way within-between groups interaction ANOVA analyses 



















































F = 18.01 























Note. Values given represent the between group interaction. 
Figure 4. Hypothesis 1d two-way within-between groups interaction ANOVA analyses 
examining change in negative emotions regarding recreational marijuana users from pre- 












































F = .632 




Figure 5. Moderation model for the pathway between the level of familiarity/contact and 





Figure 6. The control group simple slopes analysis of females and the level of familiarity 

































β = -.18 
p < .05* 





Figure 7. The control group simple slopes analysis of age and the level of familiarity to 




Figure 8. The control group simple slopes analysis of age and the level of familiarity to 





























































β = .23 
p < .05* 
𝑟𝑟2 = .43 
β = .23 
p < .05* 




Figure 9. Exploratory moderation model examining the moderating effects of ever 
personally using marijuana on the pathway between the level of familiarity/contact and 





Figure 10. The psychoeducational module group simple slopes Exploratory Path 
Analysis examining the moderating effects of ever personally using marijuana on the 








































β = .15 
p < .05* 














Figure 11. The psychoeducational module group simple slopes Exploratory Path 
Analysis examining the moderating effects of ever personally using marijuana on the 
level of familiarity and the likelihood of using marijuana in the future before receiving 
module.  
 
Figure 12. The psychoeducational module group simple slopes Exploratory Path 
Analysis examining the moderating effects of ever personally using marijuana on the 













































































β = -.20 
p < .001*** 
𝑟𝑟2 = .71 
β = -.14 
p < .05* 
𝑟𝑟2 = .65 
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 Figure 13. The psychoeducational module group simple slopes Exploratory Path 
Analysis examining the moderating effects of ever personally using marijuana on the 
level of familiarity and the likelihood of using marijuana in the future after receiving 
module.  
 
Figure 14. The control group simple slopes Exploratory Path Analysis examining the 
moderating effects of ever personally using marijuana on the level of familiarity and the 











































































β = -.21 
p < .001*** 
𝑟𝑟2 = .67 
β = .31 
p < .001*** 




Figure 15. The control group simple slopes Exploratory Path Analysis examining the 
moderating effects of ever personally using marijuana on the level of familiarity and the 






































β = 29 
p < .001*** 




University of Northern Iowa  
Human Participants review 
Informed Consent  
Project Title: Perceptions of Substance Use 
 Investigators: Stephanie J. Strong and Dilbur D. Arsiwalla. 
Invitation to Participate: You are invited to participate in a research project conducted 
through the University of Northern Iowa. The University requires that you give your 
signed agreement to participate in this project. The following information is provided to 
help you make an informed decision about whether or not to participate.  
Nature and Purpose: The purpose of this study is to examine your overall perceptions of 
marijuana and your perceptions toward those who use it recreationally. 
Explanation of Procedures: During this 45-60 minute appointment, you will be asked to 
complete a questionnaire about your general perceptions towards marijuana, your current 
knowledge about marijuana, the level of familiarity you’ve had with it, and the level of 
contact with those who use it.  Additionally, you will also be asked to view a video or a 
website for approximately 20-25 minutes. Furthermore, in the section about your current 
knowledge regarding marijuana, we ask that you please do not look up any answers to the 
questions online. This is in order to guarantee we get the most accurate representation of 
your current knowledge regarding marijuana.  
Discomfort and Risks: Risks are minimal and similar to those typically encountered in 
your day to day life. You may feel some discomfort answering some of the more 
sensitive questions about your own use of marijuana. Please remember that you are free 
to skip any question you feel uncomfortable with. You are also free to withdraw from the 
study at any time during data collection.  
Confidentiality: Information obtained during this study will be kept strictly confidential. 
Data from this research may be published in an academic journal or presented at a 
scholarly conference. However, given that we are asking about illegal behaviors it is 
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possible, but highly unlikely, that your information could be subpoenaed. Again, please 
remember that you are free to skip any question you feel uncomfortable with. You are 
also free to withdraw from the study at any time during data collection. Any identifying 
information will be removed, and answers to your questions will never be reported 
individually. All data collected will be used only for research purposes. 
Right to Refuse or Withdraw: Your participation in this study is completely voluntary. 
You have the right to skip any question you wish, withdraw from participation at any 
time, or to choose not to participate at all. There will be no penalties or loss of benefits 
for withdrawal from the study.  
Questions: The research assistants or primary investigator will answer any questions 
about the study or your participation. If you have further questions or seek additional 
information, you may contact the principal investigator Stephanie Strong at 
strongs@uni.edu. You may also contact Dr. Dilbur Arsiwalla at 319-273-7707 or 
dilbur.arsiwalla@uni.edu.  Additionally, you may also contact the office of Research and 
Sponsored Programs, Director of Research, Anita Gordon at 319-273-6148, for answers 
to questions about the rights of research participants and the participant review process. 
You may also contact the UNI counseling center at (319) 273-2676 if you feel upset 
following the study.  
 
I am fully aware of the nature and extent of my participation in this project as stated 
above and the possible risks arising from it. I hereby agree to participate in this project. I 
acknowledge that I have received a copy of this consent statement. I am 18 years of age 
or older.  
________________________________________ 
Print Name    Date 
________________________________________ 





What is your sex? 
1. Male  
2. Female   
What is your age?   _______ 
Which race/ethnicity do you identify yourself with? 
1. Caucasian (white, non-Hispanic origin)  
2. African- American/Black   
3. Asian/Pacific Islander 
4. Hispanic/Latino 
5. Middle Eastern  
6. Other 
What is your major? 
1. Natural Science (Biology, chemistry, etc.) 
2. Social Science (Psychology, sociology, etc.) 
3. Education 
4. Arts (Music, drama, etc.)  
5. Languages and Literature (Spanish, French, etc.) 
6. Business 
7. Undecided 
8. Other ______  
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What year are you in school?  
1. Freshman  
2. Sophomore  
3. Junior  
4. Senior 
5. Other _____ 
Have you ever used marijuana? 
1. Yes 
2. No 
Have you used marijuana in the last 30 days? 
1. Yes 
2. No 
How often do you use marijuana? 
1. Once a month 
2. 2-3 times a month 
3. Once a week 
4. 2-3 times a week 
5. 4-5 times a week 
6. Everyday 
Have you sought out substance use treatment in your life?  




DESCRIPTION OF MARIJUANA USE 
Marijuana Use 
Marijuana (aka cannabis, pot, weed, etc.) is a dry, shredded green and brown mix of 
flowers, stems, seeds, and leaves derived from the hemp plant Cannabis sativa. Marijuana 






LEVEL OF FAMILIARITY 
Please read each of the following statements carefully. After you have read all of the 
statements below, please select EVERY statement that represents your experience with 
persons who use marijuana.  
 _____ I have watched a movie or television show in which a character depicted a 
person who uses marijuana.  
 
 _____ My job involves providing services/treatment for persons who use 
marijuana.  
 
 _____ I have observed, in passing, a person I believe uses marijuana.  
 _____ I have observed persons who use marijuana on a frequent basis. 
 _____ I have used marijuana.  
 _____ I have worked with a person who used marijuana.  
 _____ I have never observed a person who used marijuana.  
 _____ A friend of the family uses marijuana.  
 _____ I have a relative who uses marijuana.  
 _____ I have watched a documentary on television about using marijuana.  
 _____ I live with a person who uses marijuana.  
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APPENDIX E 
SUBSTANCE USE CONTACT SCALE- MARIJUANA 
During the last year, please indicate how often you interacted with someone you knew (or 
suspected) uses in each of the settings listed below, either during the school year and/or 
the summer months. In those settings you have had contact, rate your impression of 
that/those person(s). 
    1                    2               3                    4         
Never            Rarely        Occasionally                  Often 
During the last year, please indicate how often you interacted with individual(s) who use 
marijuana WHERE YOU LIVE? Where you live refers to those interactions where you 
live (e.g., roommates, family members). 
    1                    2               3                    4         
During the last year, please indicate how often you interacted with individual(s) who use 
marijuana AT WORK? At work refers to those interactions at work (e.g., coworkers, 
supervisor, customers).  
    1                    2               3                    4         
During the last year, please indicate how often you interacted with individual(s) who use 
marijuana AT SCHOOL? At school refers to those interactions at school (e.g., other 
students, instructors, staff). 
    1                    2               3                    4         
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During the last year, please indicate how often you interacted with individual(s) who use 
marijuana at SOCIAL EVENTS? Social events refers to those interactions where you 
spend time with friends and acquaintances.  
    1                    2               3                    4         
 
During the last year, please indicate how often you interacted with individual(s) who use 
marijuana at FAMILY EVENTS? Family events refers to those interactions with family 
members and relatives (visiting, holidays), with the exception of those you live with. 
    1                    2               3                    4         
During the last year, please indicate how often you interacted with individual(s) who use 
marijuana in THE GENERAL POPULATION? The general population refers to those 
interactions where you don’t know the person well (e.g., neighbor, mailperson, grocer, 
stranger). 
    1                    2               3                    4         
____________________________________________________________________ 
      1                    2                                3                      4                      5 
   Very             Unfavorable         Neutral                  Favorable            Very 
Unfavorable                      Favorable 
If you have had contact, what was your overall impression of the individuals (s) WHERE 
YOU LIVE? 




If you have had contact, what was your overall impression of the individual(s) AT 
WORK 
      1                    2                                3                          4                    5 
If you have had contact, what was your overall impression of the individual (s) AT 
SCHOOL? 
      1                    2                                3                          4                    5 
If you have had contact, what was your overall impression of the individual (s) at 
SOCIAL EVENTS? 
      1                    2                                3                          4                    5 
If you have had contact, what was your overall impression of the individual(s) at 
FAMILY EVENTS? 
      1                    2                                3                          4                    5 
If you have had contact, what was your overall impression of the individual (s) in THE 
GENERAL POPULATION?  






PRE-/POST-TEST KNOWLEDGE REGARDING MARIJUANA 
The following section will be asking questions related to your current knowledge about 
marijuana. In order to guarantee we get the most accurate representation of your 
knowledge regarding marijuana, we ask that you please do not look up any of answers to 
the following questions online in this section. If you do not know the answer, that is fine. 
Just take your best guess. 
Total points possible: 25 
1. What chemical in marijuana produces mind-altering effects? (1 point) 
a. Cannabinoids 
b. THC 
c. Cannabis Sativa 
d. HTC  
2. What are four nicknames for marijuana? (up to 4 points) 
“weed,”, “cannabis,” “pot,” “bud,” “grass,” “herb,” “Mary Jane,” “MJ,” 
“reefer,” “skunk,” “boom,” “gangster,” “kif,” “chronic,” and “ganja”  
3. What class of drugs does the Federal Government consider marijuana to be? (1 point) 
a. Schedule 3 (Moderate to low potential for psychological or physical 
dependence and lower potential for abuse)  
b. Schedule 2 (Some medical use, high potential for abuse, potentially severe 
psychological or physical dependence) 
c. Schedule 4 (Low potential for abuse and dependence) 
d. Schedule 1 (No accepted medical use, high potential for abuse, potentially 
severe psychological or physical dependence) 
4. How many states have laws allowing the use of marijuana as a treatment for certain 
medical conditions? (1 point) 
a. 11-20 states 
b. 1-10 states 
c. 21-30 states 
d. No states 
5. How is marijuana most commonly used? (1 point) 
a. Smoked using pipes, water pipes called “bongs”, or hand-rolled 
cigarettes called “joints” or “nails.” 
b. Mixed with food, sometimes called edibles 
c. Injected through a vein 
d. Used as a patch, similar to nicotine patches 
6.  Which one of these is not a way that marijuana can be used? (1 point) 
a. Cannabis patches, similar to nicotine patches 
b. Edibles 
c. Pill form 
d. Injected directly into the vein 
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7. True or False: The effects of smoking marijuana begin almost immediately and 
usually last 1 to 3 hours. (1 point) TRUE 
8. Where does the THC attach to on the neuron? (1 point) 
a. THC neurotransmitter 
b. Cannabinoid receptor 
c. Neighboring neurons 
d. Lipid receptor 
9. Marijuana triggers an increase in the activity of the endocannabinoid system, which 
causes the release of ______________in the brain's reward centers, creating the 









d. Learning and Memory 
11. Which of these is not an area of the brain affected by using marijuana? (1 point) 
a. Hippocampus 
b. Cerebellum 
c. Basil ganglia 
d. Cerebral cortex 
e. None of the above 
12. Can THC, the psychoactive ingredient in marijuana, pass through the placental 
barrier to a fetus? (1 point) 
a. No, the baby will not be affected by it 
b. No, but the baby can still be affected by it 
c. Yes, the baby can be affected by it 
d. Yes, but the baby will not be affected by it 
13. What are some respiratory problems associated with using marijuana? (1 point) 
a. Lung cancer 
b. Daily cough 
c. Greater risk for lung infections 
d. All of the above 
e. Only b & c 
14. True or False: Driving while under the influence of marijuana is completely safe but 
illegal. (1 point) FALSE 





d. Reaction time 
e. All of the above 
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16. True or False: You cannot become addicted to marijuana? (1 point) FALSE 
17. True or False: People who use marijuana can experience withdrawal symptoms when 
they try to stop using. (1 point) TRUE 
18. What are the withdrawal symptoms experienced by someone who stops using 
marijuana? (1 point) 
a. Irritability, sleeplessness, lack of appetite, weight loss, anxiety, and drug 
cravings 
b. Irritability, increased appetite, daytime sleepiness, weight gain, anxiety, and 
drug cravings 
c. Extreme cheerfulness, waking frequently, bad dreams, weight loss, and drug 
cravings 
d. None of the above; people who use marijuana do not experience withdrawal 
symptoms when they try to stop using 
19. True or False: You can die from using marijuana if you use too much, also known as 
overdosing. (1 point) FALSE 
20. Has the Food and Drug Administration (FDA) approved any medications made from 
active chemicals found in the marijuana plant? (1 point) 
a. Yes, THC mixed with food, sometimes called edibles has been approved to 
increase appetite in some patients with AIDS. 
b. Yes, cannabis patches have been approved to treat nausea (feeling sick) in 
cancer patients. 
c. Yes, pill versions of THC have been approved to treat nausea (feeling 
sick) in cancer patients and to increase appetite in some patients with 
AIDS. 
d. No, the FDA has not approved any medications made from active chemicals 
found in the marijuana plant. 
21. There is some early evidence that ____________, a chemical component found in 
marijuana that does not have mind-altering effects, may be useful in treating seizures 
in children with severe epilepsy. (1 point) 
a. Cannabinoids (CBN) 
b. Cannabis Sativa (CBS) 
c. THC 
d. Cannabidiol (CBD) 
22. What is one of the biggest issues with using marijuana as a medicine? (1 point) 
a. Older individuals, over 65, are seeking this treatment and marijuana can 
impact their driving ability more than younger individuals  
b. Ingredients vary a lot from plant to plant, so there is no way to get a 
precise dose every time or even know what dose you are getting 
c. The variety of plants available makes it difficult to determine which plant 
would be best to use for a particular disorder 






LIKELIHOOD OF FUTURE USE QUESTIONS 
 
1. How likely are you to use marijuana recreationally in the next week? 
a. Very unlikely  
b. Unlikely 
c. Somewhat unlikely 
d. Somewhat likely 
e. Likely 
f. Very likely  
2. How likely are you to use marijuana recreationally in the next month? 
a. Very unlikely  
b. Unlikely 
c. Somewhat unlikely 
d. Somewhat likely 
e. Likely 
f. Very likely  
3. How likely are you to use marijuana recreationally in the next year? 
a. Very unlikely  
b. Unlikely 
c. Somewhat unlikely 
d. Somewhat likely 
e. Likely 
f. Very likely  
4. How likely are you to EVER use marijuana recreationally? 
a. Very unlikely  
b. Unlikely 
c. Somewhat unlikely 
d. Somewhat likely 
e. Likely 






AFFECT SCALE-SUBSTANCE USE 




 Pessimistic 1         2         3         4         5         6         7 Optimistic 
 
 Tranquil  1         2         3         4         5         6         7 Anxious 
 
 Supportive 1         2         3         4         5         6         7 Resentful 
 
 Fearful  1         2         3         4         5         6         7 Confident 
 
 Empathic 1         2         3         4         5         6         7 Angry 
 
 Disgusted 1         2         3         4         5         6         7 Sympathetic 
 
 Apprehensive 1         2         3         4         5         6         7 Comfortable 
 
 Irritable  1         2         3         4         5         6         7 Patient 
 
 Relaxed  1         2         3         4         5         6         7 Tense 
 
Calm   1         2         3         4         5         6         7 Nervous 
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APPENDIX I 
SOCIAL DISTANCE SCALE-SUBSTANCE USE 
Please rate the statements below on the following scale: 
 
1 = Definitely willing 
2 = Probably willing 
3 = Probably unwilling 
4 = Definitely unwilling 
 
1. How would you feel about renting a room in your home to someone who uses 
marijuana recreationally? 
 
2. How about as a worker on the same job as someone who uses marijuana 
recreationally? 
 
3. How would you feel having someone who uses marijuana recreationally as a 
neighbor? 
 
4. How about as the caretaker of your children for a couple of hours? 
 
5. How about having your children marry someone who uses marijuana 
recreationally? 
 
6. How would you feel about introducing someone who uses marijuana 
recreationally to a young person you are friendly with? 
 
7. How would you feel about recommending someone who uses marijuana 
recreationally for a job working for a friend of yours? 
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APPENDIX J 
DANGEROUSNESS SCALE (ADAPTED) 
Please rate the statements below on the following scale: 
 
1 = Strongly agree 
2 = Agree 
3 = Not sure but probably agree 
4 = Not sure but probably disagree 
5 = Disagree 
6 = Strongly disagree 
 
1. If someone who uses marijuana recreationally lived nearby, I would not allow my 
children to go to the movie theater alone. 
 
2. If someone who uses marijuana recreationally applied for a teaching position at a 
grade school and was qualified for the job, I would recommend hiring him or her. 
 
3. One important thing about someone who uses marijuana recreationally is that you 
cannot tell what they will do from one minute to the next.  
 
4. If I knew someone who uses marijuana recreationally, I would be less likely to 
trust him or her. 
 
5. If someone who uses marijuana recreationally lived nearby, I would not hesitate 
to allow young children under my care to play on the sidewalk. 
 
6. Although someone who uses marijuana recreationally may seem all right, it is 
dangerous to forget for a moment that they use marijuana. 
 
7. There should be a law forbidding someone who uses marijuana recreationally the 
right to obtain a hunting license. 
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APPENDIX K 
INFORMATION IN PSYCHOEDUCATIONAL MODULE ABOUT MARIJUANA 
The majority of the information in this module comes directly from the NIDA website 
http://teens.drugabuse.gov/drug-facts/marijuana. Permission has been sought to use these 
materials for research. Additionally, researcher created video clips will be used to 
enhance the information. The citation is listed in the reference section. 
The link to the website for this module is: 
https://sites.google.com/a/uni.edu/stephaniestrongthesis2/home  
You must be signed in to your UNI account to access the site.  
I. What is marijuana? 
a. Description: Marijuana is a mixture of the dried and shredded leaves, 
stems, seeds, and flowers of Cannabis sativa or Cannabis indica hemp 
plant. The mixture can be green, brown, or gray. Stronger forms of the 
drug include sinsemilla (sin-seh-me-yah), hashish (“hash” for short), and 
hash oil. 
b. Nicknames: weed, pot, bud, grass, herb, Mary Jane, MJ, reefer, skunk, 
boom, gangster, kif, chronic, and ganja 
c. Why does Marijuana have mind-altering effects? Of the approximately 
400 chemicals in marijuana, delta-9-tetrahydrocannabinol, known as THC, 
is responsible for many of the drug’s psychotropic (mind-altering) effects. 
It is this chemical that changes how the brain works, distorting how the 
mind perceives the world. 
d. What are the major variety types of marijuana? The two most 
commonly grown species of the Cannabis genus are Cannabis indica and 
Cannabis sativa. There is a third species of marijuana, known as Cannabis 
ruderalis, that is very short. This species is not commonly grown for 
industrial, recreational or medicinal use, however, due to these plants only 
having trace amounts of delta-9-tetrahydrocannabinol (THC) (Small & 
Cronquist, 1976). 
e. Legality: It is illegal to buy, sell, or carry marijuana under Federal law. 
The Federal Government considers marijuana a Schedule I substance—
having no medicinal uses and high risk for abuse. However, across the 
United States, marijuana state laws for adult use are changing. As of 2014, 
23 states and the District of Columbia have passed laws allowing the use 
of marijuana as a treatment for certain medical conditions. 
i. In addition, four states and the District of Columbia have legalized 
marijuana for adult recreational use. Because of concerns over the 
possible harm to the developing teen brain and the risk of driving 
under the influence, marijuana use by people under age 21 is 
prohibited in all states. 
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f. Pop Quiz 
II. How is marijuana used? 
a. Marijuana is commonly smoked using pipes, water pipes called “bongs,” 
or hand-rolled cigarettes called “joints” or “nails.” It is sometimes also 
combined with tobacco in partially hollowed-out cigars, known as 
“blunts.”  
b. Recently vaporizers, that use heat without burning to produce a vapor, 
have increased in popularity.  
c. Marijuana can also be brewed as tea or mixed with food, sometimes called 
edibles. 
d. In addition, concentrated resins containing high doses of marijuana’s 
active ingredients, including honey-like “hash oil,” waxy “budder,” and 
hard amber-like “shatter,” are increasingly popular among both 
recreational and medical users. 
e. Pill versions of THC have been approved to treat nausea (feeling sick) in 
cancer patients and to increase appetite in some patients with AIDS 
f. Recently, cannabis patches, similar to nicotine patches, have also become 
a popular way to use marijuana. The 10 mg patch adheres to the skin 
anywhere. Once placed, the patch has lasting effects for 8-12 hours.  
g. Pop Quiz 
III. How does marijuana effect the brain? 
a. The main chemical in marijuana that effects the brain is delta-9-
tetrahydrocannabinol (THC). When marijuana is smoked, THC quickly 
passes from the lungs into the bloodstream, which carries it to organs 
throughout the body, including the brain. Its effects begin almost 
immediately and can last 1 to 3 hours. If marijuana is consumed in foods 
or beverages, however, the effects of THC appear later, usually in 30 
minutes to 1 hour, and can last over 4 hours. As it enters the brain, THC 
attaches to brain cells, or neurons, with specific kinds of receptors called 
cannabinoid receptors. Normally, these receptors are activated by 
chemicals that occur naturally in the body. They are part of a 
communication network in the brain called the endocannabinoid system. 
This system is important for normal brain development and function.  
(Craig, Scherbarth, Krause, & Brichacek, 2012;  
b. Most of the cannabinoid receptors are found in parts of the brain that 
influence pleasure, memory, thinking, concentration, sensory and time 
perception, and coordinated movement. Marijuana triggers an increase in 
the activity of the endocannabinoid system, which causes the release of 
dopamine in the brain's reward centers, creating the pleasurable feelings or 
“high.” Other effects include changes in perceptions and mood, lack of 
coordination, difficulty with thinking and problem solving, and disrupted 
learning and memory. 
c. Certain parts of the brain have a lot of cannabinoid receptors. These areas 
are the hippocampus, the cerebellum, the basal ganglia, and the cerebral 
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cortex. The functions that these brain areas control are the ones most 
affected by marijuana:  
i. Learning and memory. The hippocampus plays a critical role in 
certain types of learning. Disrupting its normal functioning can 
lead to problems studying, learning new things, and recalling 
recent events. A recent study followed people from age 13 to 38 
and found that those who used marijuana a lot in their teens had up 
to an 8 point drop in IQ, even if they quit in adulthood (Meier et. 
al., 2012; Zalesky et. al., 2012). 
ii. Coordination. THC affects the cerebellum, the area of our brain 
that controls balance and coordination, and the basal ganglia, 
another part of the brain that helps control movement. These 
effects can influence performance in such activities as sports, 
driving, and video games. 
iii. Judgment. Since THC affects areas of the frontal cortex involved 
in decision making, using it can case you to do things you might 
not do when you are not under the influence of drugs—such as 
engaging in risky sexual behavior, which can lead to sexually 
transmitted diseases (STDs) like HIV, the virus that causes 
AIDS—or getting in a car with someone who’s been drinking or is 
high on marijuana. 
d. Pop Quiz 
IV. What are the other effects of marijuana? 
a. Effects on health 
i. THC can produce impairment of short-term memory, interruptions 
in attention mechanisms, analgesia, and altered control of motor 
movements, postural control, and sensory awareness (Julien, 
2013).  
ii. Increased heart rate and blood pressure. When someone uses 
marijuana, heart rate—normally 70 to 80 beats per minute—may 
increase by 20 to 50 beats per minute or, in some cases, even 
double. Additionally, blood pressure increases as well (Julien, 
2013). This effect can be greater if other drugs are taken with 
marijuana. Once heart rate reaches over 100 beats per minute, this 
is too fast and the person is considered to have tachycardia. The 
increased heart rate and blood pressure forces the heart to work 
extra hard to keep up. 
iii. Respiratory (lung and breathing) problems. Smoke from 
marijuana irritates the lungs, causing breathing and lung problems 
among regular users similar to those experienced by people who 
smoke tobacco—like a daily cough and a greater risk for lung 
infections such as pneumonia. However, research is inconclusive 




iv. Increased risk for mental health problems. Marijuana use has 
been linked with depression and anxiety, as well as suicidal 
thoughts among adolescents. In addition, research has suggested 
that in people with a genetic risk for developing schizophrenia, 
smoking marijuana during adolescence may increase the risk for 
developing psychosis and developing it at an earlier age. 
Researchers are still learning exactly what the relationship is 
between these mental health problems and marijuana use. 
v. Increased risk of problems for an unborn baby. THC, the 
psychoactive ingredient in marijuana, can pass through the 
placental barrier to the fetus (Julien, 2013).  This means the fetus is 
also affected by marijuana every time the mother uses. Pregnant 
women who use marijuana may risk changing the developing brain 
of the unborn baby. These changes could contribute to problems 
with attention, memory, and problem solving. 
vi. Impaired driving. It is unsafe to drive while under the influence 
of marijuana. Marijuana affects a number of skills required for safe 
driving—alertness, concentration, coordination, and reaction 
time—so it is not safe to drive high or to ride with someone who’s 
been smoking. Marijuana makes it hard to judge distances and 
react to signals and sounds on the road. Marijuana is the most 
common illegal drug involved in auto fatalities.  
b. Pop Quiz 
V. Can you get addicted to marijuana? 
a. Yes, marijuana is addictive. A user may feel the urge to smoke marijuana 
again and again to re-create the “high.” Repeated use could lead to 
addiction—which means the person has trouble controlling their drug use 
and often cannot stop even though they want to. 
b. It is estimated that about 1 in 6 persons who start using this substance as a 
teen, and 25% to 50% percent of those who use it every day, become 
addicted to marijuana. What causes one person to become addicted to 
marijuana and not another depends on many factors—including their 
family history (genetics), the age they start using, whether they also use 
other drugs, their family and friend relationships, and whether they take 
part in positive activities like school or sports (environment). 
c. People who use marijuana may also experience withdrawal symptoms 
when they stop using the drug. Withdrawal symptoms may include 
irritability, sleeplessness, and lack of appetite, which can lead to weight 
loss, anxiety, and drug cravings. These effects can last for several days to 
a few weeks after drug use is stopped. Relapse (returning to the drug after 
you’ve quit) is common during this period because people also crave the 
drug to relieve these symptoms. 
d. Pop Quiz 
VI. Can you die if you use marijuana? 
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a. It is very unlikely for a person to overdose and die from marijuana use. 
However, people can and do injure themselves and die because of 
marijuana's effects on judgment, perception, and coordination, for 
example when driving under the influence of the drug. Also, people can 
experience extreme anxiety (panic attacks) or psychotic reactions (where 
they lose touch with reality and may become paranoid). 
b. Although the likelihood of dying from marijuana is low, approximately 
461,028 emergency room visits in 2011 involved marijuana. This is about 
39.4% of the total amount of emergency room visits involving illicit drugs 
in 2011 (SAMHSA, 2013).  
VII. What is medical or therapeutic marijuana? 
a. The term medical marijuana refers to using the whole, unprocessed 
marijuana plant or its basic extracts to treat a disease or symptom. 
b. The marijuana plant contains chemicals that may be useful for treating a 
range of illnesses or symptoms. A growing number of states (23 as of 
August 2014) have legalized the plant’s use for certain medical conditions. 
Although it is not legal or considered medicine by the Federal 
Government, a few medications made from active chemicals in the plant 
called cannabinoids have been approved by the U.S. Food and Drug 
Administration (FDA). One of these cannabinoids, THC, has some 
medicinal properties in addition to its mind-altering effects. Pill versions 
of THC have been approved to treat nausea (feeling sick) in cancer 
patients and to increase appetite in some patients with AIDS. 
c. Another cannabinoid chemical called cannabidiol, which doesn’t have 
mind-altering effects, is also being studied for its possible uses as 
medicine. A new medication with a combination of THC and cannabidiol 
is available in several countries outside the United States as a mouth spray 
for treating symptoms of multiple sclerosis. There is some early evidence 
that cannabidiol may be useful in treating seizures in children with severe 
epilepsy, so a cannabidiol-based drug for that is also now being studied. 
d. It is important to remember that because marijuana is often smoked, it can 
hurt lung health; these health risks as well as the way it impairs mental 
functioning may outweigh its value as a medical treatment, especially for 
people that are not very sick with cancer or other life-threatening diseases. 
Another problem with smoking or eating marijuana plant material is the 
ingredients vary a lot from plant to plant, so there is no way to get a 
precise dose every time or even know what dose you are getting. Hence, 
scientists are busy studying safe ways that THC, cannabidiol, and other 
chemicals can be extracted from the marijuana plant to create safe 
medicines. 
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ATTENTION AND MANIPULATION CHECK QUESTIONS  
ACQ #1: Most modern theories of decision making recognize the fact that decisions do not 
take place in a vacuum. Individual preferences and knowledge, along with situational 
variables, can greatly impact the decision process. In order to facilitate our research on 
decision making, we are interested in knowing certain factors about you, the decision 
maker. Specifically, we are interested in whether you actually take the time to read the 
directions; if not, then some of our manipulations that rely on changes in the instructions 
will be ineffective. So, in order to demonstrate that you have read the instructions, please 
ignore the sports items listed below. Instead, simply click on the 'next' button to proceed to 
the next screen. Thank you very much. 
 
1. Skiing    5. Hockey  9. Basketball 
2. Soccer   6. Football  10. Cycling 
3. Snowboarding  7. Swimming  11. Next 
4. Running   8. Tennis 
ACQ #2: While watching TV, have you ever had a fatal heart attack?  
1. Five times  3. Two times 5. One time 
2. Three times  4. Never   
ACQ #3: The correct response to this question is to choose "other" and then type in 
"psychology" when you see a space to fill in information. 
What was this survey about? 
 
1. Cannabis use  3. Personality 5. Other (type-in) 




MCQ#1: Do you believe you learned a lot, a little, or nothing about marijuana after 
participating in this study? 
 
a. A lot 
b. A little 
c. Nothing 
MCQ#2: How much did you know about marijuana before participating in this study? 
1. A lot 
2. A little 
3. Nothing 





3. Not sure 
MCQ#4: Do you believe you have fewer negative thoughts or feelings about individuals 
who use marijuana recreationally after participating in this study? 
1. Yes 
2. No 
3. Not sure 
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Figure 1: A priori power analysis for a two-way repeated measures, within-between 
interaction ANOVA when statistical power = .95, alpha = .05, and ES (f2) = .15, 










Figure 2: A priori power analysis for a two-way repeated measures, between factors 
ANOVA when statistical power = .95, alpha = .05, and ES (f2) = .15, showing a 












Figure 3: A priori power analysis for linear multiple regression analysis when 
statistical power = .95, alpha = .05, and ES (f2) = .15, showing a needed sample size 





NON-SIGNIFICANT MODERATION TABLES FROM HYPOTHESIS 3 
Appendix O Table 1  
Hypothesis 3a-1: Path Analysis Model Examining the Moderating Effects of Female on 
the Level of Contact and Preferred Social Distance Before Receiving Video Clip. 
Control Sample 







B Std. Error Beta   
Level of Contact -0.07 0.02 -0.35 .001 0.09 
Female 0.56 0.15 0.36 .001 0.12 
Interaction -0.04 0.04 -0.08 .378 0.01 
Total     0.22 
Note: Interaction is defined as Level of Contact x Female. 
Dependent Variable: Pre-Preferred Social Distance 







Appendix O Table 2  
Hypothesis 3a-2: Path Analysis Model Examining the Moderating Effects of Female on 
the Level of Contact and Preferred Social Distance After Receiving Video Clip. 
Control Sample 







B Std. Error Beta   
Level of Contact -0.07 0.02 -0.35 .001 0.09 
Female 0.59 0.14 0.38 .001 0.14 
Interaction -0.05 0.04 -0.13 .169 0.02 
Total     0.25 
Note: Interaction is defined as Level of Contact x Female. 
Dependent Variable: Post-Preferred Social Distance 
* p <0.05, two-tailed test ** p <0.001, two-tailed test 
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Appendix O Table 3  
Hypothesis 3a-3: Path Analysis Model Examining the Moderating Effects of Female on 
the Level of Contact and Preferred Social Distance Before Receiving Module. 
Psychoeducational 







B Std. Error Beta   
Level of Contact -0.11 0.02 -0.56 .001 0.32 
Female 0.16 0.13 0.10 .228 0.01 
Interaction -0.02 0.03 -0.04 .654 0.00 
Total     0.33 
Note: Interaction is defined as Level of Contact x Female. 
Dependent Variable: Pre-Preferred Social Distance 






Appendix O Table 4  
Hypothesis 3a-4: Path Analysis Model Examining the Moderating Effects of Female on 
the Level of Contact and Preferred Social Distance After Receiving Module. 
Psychoeducational 







B Std. Error Beta   
Level of Contact -0.12 0.02 -0.59 .001 0.36 
Female 0.22 0.13 0.13 .106 0.02 
Interaction -0.02 0.04 -0.05 .540 0.00 
Total     0.38 
Note: Interaction is defined as Level of Contact x Female. 
Dependent Variable: Post-Preferred Social Distance 




Appendix O Table 5  
Hypothesis 3b-1: Path Analysis Model Examining the Moderating Effects of Female on 
the Level of Contact and Perceived Dangerousness Before Receiving Video Clip. 
Control Sample 







B Std. Error Beta   
Level of Contact 0.03 0.03 0.12 .235 0.01 
Female -0.59 0.21 -0.27 .007 0.07 
Interaction 0.08 0.06 0.14 .174 0.02 
Total     0.10 
Note: Interaction is defined as Level of Contact x Female. 
Dependent Variable: Pre-Perceived Dangerousness 







Appendix O Table 6  
Hypothesis 3b-2: Path Analysis Model Examining the Moderating Effects of Female on 
the Level of Contact and Perceived Dangerousness After Receiving Video Clip. 
Control Sample 







B Std. Error Beta   
Level of Contact 0.04 0.03 0.16 .114 0.02 
Female -0.53 0.21 -0.25 .016 0.06 
Interaction 0.02 0.06 0.04 .706 0.00 
Total     0.08 
Note: Interaction is defined as Level of Contact x Female. 
Dependent Variable: Post-Perceived Dangerousness 




Appendix O Table 7  
Hypothesis 3b-3: Path Analysis Model Examining the Moderating Effects of Female on 
the Level of Contact and Perceived Dangerousness Before Receiving Module. 
Psychoeducational 







B Std. Error Beta   
Level of Contact -0.12 0.02 -0.44 .001 0.21 
Female 0.45 0.19 0.21 .020 0.04 
Interaction -0.02 0.05 -0.03 .764 0.00 
Total     0.25 
Note: Interaction is defined as Level of Contact x Female. 
Dependent Variable: Pre-Perceived Dangerousness 







Appendix O Table 8  
Hypothesis 3b-4: Path Analysis Model Examining the Moderating Effects of Female on 
the Level of Contact and Perceived Dangerousness After Receiving Module. 
Psychoeducational 







B Std. Error Beta   
Level of Contact -0.12 0.03 -0.40 .001 0.18 
Female 0.54 0.22 0.22 .015 0.05 
Interaction -0.02 0.06 -0.04 .694 0.00 
Total     0.23 
Note: Interaction is defined as Level of Contact x Female. 
Dependent Variable: Post-Perceived Dangerousness 




Appendix O Table 9  
Hypothesis 3c-1: Path Analysis Model Examining the Moderating Effects of Female on 
the Level of Contact and Negative Emotions Regarding Recreational Marijuana Users 
Before Receiving Video Clip. 
Control Sample 







B Std. Error Beta   
Level of Contact -0.10 0.04 -0.26 .006 0.05 
Female 1.18 0.27 0.40 .001 0.15 
Interaction -0.08 0.07 -0.09 .316 0.01 
Total     0.21 
Note: Interaction is defined as Level of Contact x Female. 
Dependent Variable: Pre-Negative Emotions 






Appendix O Table 10 
Hypothesis 3c-2: Path Analysis Model Examining the Moderating Effects of Female on 
the Level of Contact and Negative Emotions Regarding Recreational Marijuana Users 
After Receiving Video Clip. 
Control Sample 







B Std. Error Beta   
Level of Contact -0.11 0.04 -0.28 .004 0.05 
Female 1.11 0.29 0.36 .001 0.13 
Interaction -0.04 0.08 -0.05 .601 0.00 
Total     0.18 
Note: Interaction is defined as Level of Contact x Female. 
Dependent Variable: Post-Negative Emotions 
* p <0.05, two-tailed test ** p <0.001, two-tailed test 
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Appendix O Table 11  
Hypothesis 3c-3: Path Analysis Model Examining the Moderating Effects of Female on 
the Level of Contact and Negative Emotions Regarding Recreational Marijuana Users 
Before Receiving Module. 
Psychoeducational 







B Std. Error Beta   
Level of Contact -0.21 0.04 -0.53 .001 0.26 
Female 0.28 0.27 0.09 .299 0.01 
Interaction -0.11 0.07 -0.14 .106 0.02 
Total     0.29 
Note: Interaction is defined as Level of Contact x Female. 
Dependent Variable: Pre-Negative Emotions 






Appendix O Table 12  
Hypothesis 3c-4: Path Analysis Model Examining the Moderating Effects of Female on 
the Level of Contact and Negative Emotions Regarding Recreational Marijuana Users 
After Receiving Module. 
Psychoeducational 







B Std. Error Beta   
Level of Contact -0.19 0.03 -0.49 .001 0.24 
Female 0.29 0.27 0.09 .288 0.01 
Interaction -0.09 0.07 -0.11 .210 0.01 
Total     0.26 
Note: Interaction is defined as Level of Contact x Female. 
Dependent Variable: Post-Negative Emotions 
* p <0.05, two-tailed test ** p <0.001, two-tailed test 
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Appendix O Table 13  
Hypothesis 3d-1: Path Analysis Model Examining the Moderating Effects of Female on 
the Level of Familiarity and Preferred Social Distance Before Receiving Video Clip. 
Control Sample 







B Std. Error Beta   
Level of Familiarity -0.22 0.03 -0.57 .001 0.32 
Female 0.41 0.13 0.26 .002 0.06 
Interaction -0.10 0.06 -0.13 .112 0.02 
Total     0.40 
Note: Interaction is defined as Level of Familiarity x Female. 
Dependent Variable: Pre-Preferred Social Distance 








Appendix O Table 14  
Hypothesis 3d-3: Path Analysis Model Examining the Moderating Effects of Female on 
the Level of Familiarity and Preferred Social Distance Before Receiving Module. 
Psychoeducational 







B Std. Error Beta   
Level of Familiarity -0.18 0.03 -0.57 .001 0.33 
Female 0.09 0.14 0.05 .519 0.01 
Interaction -0.03 0.06 -0.05 .549 0.00 
Total     0.34 
Note: Interaction is defined as Level of Familiarity x Female. 
Dependent Variable: Pre-Preferred Social Distance 




Appendix O Table 15 
Hypothesis 3d-4: Path Analysis Model Examining the Moderating Effects of Female on 
the Level of Familiarity and Preferred Social Distance After Receiving Module. 
Psychoeducational 







B Std. Error Beta   
Level of Familiarity -0.19 0.03 -0.59 .001 0.37 
Female 0.16 0.13 0.10 .229 0.01 
Interaction -0.03 0.06 -0.05 .556 0.00 
Total     0.38 
Note: Interaction is defined as Level of Familiarity x Female. 
Dependent Variable: Post-Preferred Social Distance 







Appendix O Table 16  
Hypothesis 3e-1: Path Analysis Model Examining the Moderating Effects of Female on 
the Level of Familiarity and Perceived Dangerousness Before Receiving Video Clip. 
Control Sample 







B Std. Error Beta   
Level of Familiarity 0.24 0.05 0.45 .001 0.20 
Female -0.47 0.19 -0.22 .019 0.04 
Interaction 0.14 0.10 0.13 .163 0.02 
Total     0.26 
Note: Interaction is defined as Level of Familiarity x Female. 
Dependent Variable: Pre-Perceived Dangerousness 









Appendix O Table 18  
Hypothesis 3e-3: Path Analysis Model Examining the Moderating Effects of Female on the Level 
of Familiarity and Perceived Dangerousness Before Receiving Module. 
Psychoeducational 







B Std. Error Beta   
Level of Familiarity -0.20 0.04 -0.47 .001 0.25 
Female 0.34 0.19 0.16 .079 0.03 
Interaction 0.03 0.08 0.03 .708 0.00 
Total     0.28 
Note: Interaction is defined as Level of Familiarity x Female. 
Dependent Variable: Pre-Perceived Dangerousness 
* p <0.05, two-tailed test ** p <0.001, two-tailed test 
Appendix O Table 17  
Hypothesis 3e-2: Path Analysis Model Examining the Moderating Effects of Female on 
the Level of Familiarity and Perceived Dangerousness After Receiving Video Clip. 
Control Sample 







B Std. Error Beta   
Level of Familiarity 0.23 0.05 0.44 .001 0.19 
Female -0.38 0.20 -0.18 .058 0.03 
Interaction 0.08 0.10 0.08 .393 0.01 
Total     0.23 
Note: Interaction is defined as Level of Familiarity x Female. 
Dependent Variable: Post-Perceived Dangerousness 








Appendix O Table 20  
Hypothesis 3f-1: Path Analysis Model Examining the Moderating Effects of Female on 
the Level of Familiarity and Negative Emotions Regarding Recreational Marijuana 
Users Before Receiving Video Clip. 
Control Sample 







B Std. Error Beta   
Level of Familiarity -0.40 0.06 -0.54 .001 0.30 
Female 0.90 0.24 0.31 .001 0.09 
Interaction -0.18 0.12 -0.13 .133 0.01 
Total     0.40 
Note: Interaction is defined as Level of Familiarity x Female. 
Dependent Variable: Pre-Negative Emotions 
* p <0.05, two-tailed test ** p <0.001, two-tailed test 
Appendix O Table 19  
Hypothesis 3e-4: Path Analysis Model Examining the Moderating Effects of Female on 
the Level of Familiarity and Perceived Dangerousness After Receiving Module. 
Psychoeducational 







B Std. Error Beta   
Level of Familiarity -0.21 0.04 -0.44 .001 0.22 
Female 0.43 0.22 0.18 .052 0.03 
Interaction 0.01 0.09 0.00 .960 0.00 
Total     0.25 
Note: Interaction is defined as Level of Familiarity x Female. 
Dependent Variable: Post-Perceived Dangerousness 








Appendix O Table 22  
Hypothesis 3f-3: Path Analysis Model Examining the Moderating Effects of Female on 
the Level of Familiarity and Negative Emotions Regarding Recreational Marijuana 
Users Before Receiving Module. 
Psychoeducational 







B Std. Error Beta   
Level of Familiarity -0.30 0.06 -0.47 .001 0.23 
Female 0.17 0.29 0.05 .568 0.00 
Interaction -0.07 0.12 -0.05 .570 0.00 
Total     0.23 
Note: Interaction is defined as Level of Familiarity x Female. 
Dependent Variable: Pre-Negative Emotions 
* p <0.05, two-tailed test ** p <0.001, two-tailed test 
Appendix O Table 21  
Hypothesis 3f-2: Path Analysis Model Examining the Moderating Effects of Female on 
the Level of Familiarity and Negative Emotions Regarding Recreational Marijuana 
Users After Receiving Video Clip. 
Control Sample 







B Std. Error Beta   
Level of Familiarity -0.41 0.07 -0.54 .001 0.29 
Female 0.82 0.25 0.27 .002 0.07 
Interaction -0.18 0.13 -0.12 .158 0.01 
Total     0.37 
Note: Interaction is defined as Level of Familiarity x Female. 
Dependent Variable: Post-Negative Emotions 







Appendix O Table 24  
Hypothesis 3g-1: Path Analysis Model Examining the Moderating Effects of Ever 
Personally Using Marijuana on the Level of Contact and Preferred Social Distance 
Before Receiving Video Clip. 
Control Sample 







B Std. Error Beta   
Level of Contact -0.04 0.02 -0.21 .014 0.09 
Ever Used -0.89 0.14 -0.55 .001 0.27 
Interaction 0.03 0.04 0.07 .442 0.01 
Total     0.37 
Note: Interaction is defined as Level of Contact x Ever Used. 
Dependent Variable: Pre-Preferred Social Distance 
* p <0.05, two-tailed test ** p <0.001, two-tailed test 
 
Appendix O Table 23 
Hypothesis 3f-4: Path Analysis Model Examining the Moderating Effects of Female on 
the Level of Familiarity and Negative Emotions Regarding Recreational Marijuana 
Users After Receiving Module. 
Psychoeducational 







B Std. Error Beta   
Level of Familiarity -0.29 0.06 -0.46 .001 0.22 
Female 0.18 0.28 0.06 .534 0.00 
Interaction -0.08 0.12 -0.06 .499 0.01 
Total     0.23 
Note: Interaction is defined as Level of Familiarity x Female. 
Dependent Variable: Post-Negative Emotions 
* p <0.05, two-tailed test ** p <0.001, two-tailed test 
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Appendix O Table 25  
Hypothesis 3g-2: Path Analysis Model Examining the Moderating Effects of Ever 
Personally Using Marijuana on the Level of Contact and Preferred Social Distance After 
Receiving Video Clip. 
Control Sample 







B Std. Error Beta   
Level of Contact -0.04 0.02 -0.22 .011 0.09 
Ever Used -0.89 0.14 -0.55 .001 0.28 
Interaction 0.02 0.04 0.05 .552 0.00 
Total     0.37 
Note: Interaction is defined as Level of Contact x Ever Used. 
Dependent Variable: Post-Preferred Social Distance 






Appendix O Table 26  
Hypothesis 3g-3: Path Analysis Model Examining the Moderating Effects of Ever 
Personally Using Marijuana on the Level of Contact and Preferred Social Distance 
Before Receiving Module. 
Psychoeducational 







B Std. Error Beta   
Level of Contact -0.09 0.02 -0.46 .001 0.32 
Ever Used -0.47 0.13 -0.30 .001 0.08 
Interaction 0.00 0.03 0.01 .896 0.00 
Total     0.40 
Note: Interaction is defined as Level of Contact x Ever Used. 
Dependent Variable: Pre-Preferred Social Distance 







Appendix O Table 28  
Hypothesis 3h-1: Path Analysis Model Examining the Moderating Effects of Ever 
Personally Using Marijuana on the Level of Contact and Perceived Dangerousness 
Before Receiving Video Clip. 
Control Sample 







B Std. Error Beta   
Level of Contact -0.00 0.03 -0.00 .977 0.01 
Ever Used 1.16 0.21 0.52 .001 0.22 
Interaction -0.11 0.06 -0.17 .065 0.03 
Total     0.26 
Note: Interaction is defined as Level of Contact x Ever Used. 
Dependent Variable: Pre-Perceived Dangerousness 
* p <0.05, two-tailed test ** p <0.001, two-tailed test 
Appendix O Table 27  
Hypothesis 3g-4: Path Analysis Model Examining the Moderating Effects of Ever 
Personally Using Marijuana on the Level of Contact and Preferred Social Distance After 
Receiving Module. 
Psychoeducational 







B Std. Error Beta   
Level of Contact -0.10 0.02 -0.50 .001 0.36 
Ever Used -0.45 0.13 -0.29 .001 0.07 
Interaction 0.01 0.03 0.03 .713 0.00 
Total     0.43 
Note: Interaction is defined as Level of Contact x Ever Used. 
Dependent Variable: Post-Preferred Social Distance 







Appendix O Table 30  
Hypothesis 3h-3: Path Analysis Model Examining the Moderating Effects of Ever 
Personally Using Marijuana on the Level of Contact and Perceived Dangerousness 
Before Receiving Module. 
Psychoeducational 







B Std. Error Beta   
Level of Contact -0.10 0.02 -0.35 .001 0.21 
Ever Used -0.71 0.18 -0.34 .001 0.10 
Interaction 0.07 0.05 0.11 .186 0.01 
Total     0.32 
Note: Interaction is defined as Level of Contact x Ever Used. 
Dependent Variable: Pre-Perceived Dangerousness 
* p <0.05, two-tailed test ** p <0.001, two-tailed test 
Appendix O Table 29  
Hypothesis 3h-2: Path Analysis Model Examining the Moderating Effects of Ever 
Personally Using Marijuana on the Level of Contact and Perceived Dangerousness After 
Receiving Video Clip. 
Control Sample 







B Std. Error Beta   
Level of Contact 0.02 0.03 0.05 .564 0.02 
Ever Used 1.05 0.21 0.47 .001 0.19 
Interaction -0.07 0.06 -0.11 .275 0.01 
Total     0.22 
Note: Interaction is defined as Level of Contact x Ever Used. 
Dependent Variable: Post-Perceived Dangerousness 







Appendix O Table 32  
Hypothesis 3i-1: Path Analysis Model Examining the Moderating Effects of Ever 
Personally Using Marijuana on the Level of Contact and Negative Emotions Regarding 
Recreational Marijuana Users Before Receiving Video Clip. 
Control Sample 







B Std. Error Beta   
Level of Contact -0.05 0.03 -0.13 .151 0.05 
Ever Used -1.71 0.27 -0.56 .001 0.27 
Interaction 0.10 0.08 0.12 .194 0.01 
Total     0.33 
Note: Interaction is defined as Level of Contact x Ever Used. 
Dependent Variable: Pre-Negative Emotions 
* p <0.05, two-tailed test ** p <0.001, two-tailed test 
Appendix O Table 31  
Hypothesis 3h-4: Path Analysis Model Examining the Moderating Effects of Ever 
Personally Using Marijuana on the Level of Contact and Perceived Dangerousness After 
Receiving Module. 
Psychoeducational 







B Std. Error Beta   
Level of Contact -0.10 0.03 -0.33 .001 0.18 
Ever Used -0.67 0.22 -0.29 .002 0.07 
Interaction 0.07 0.06 0.10 .257 0.01 
Total     0.26 
Note: Interaction is defined as Level of Contact x Ever Used. 
Dependent Variable: Post-Perceived Dangerousness 







Appendix O Table 34  
Hypothesis 3i-3: Path Analysis Model Examining the Moderating Effects of Ever 
Personally Using Marijuana on the Level of Contact and Negative Emotions Regarding 
Recreational Marijuana Users Before Receiving Module. 
Psychoeducational 







B Std. Error Beta   
Level of Contact -0.17 0.04 -0.42 .001 0.27 
Ever Used -0.91 0.27 -0.30 .001 0.07 
Interaction 0.09 0.07 0.10 .224 0.01 
Total     0.35 
Note: Interaction is defined as Level of Contact x Ever Used. 
Dependent Variable: Pre-Negative Emotions 
* p <0.05, two-tailed test ** p <0.001, two-tailed test 
 
Appendix O Table 33  
Hypothesis 3i-2: Path Analysis Model Examining the Moderating Effects of Ever 
Personally Using Marijuana on the Level of Contact and Negative Emotions Regarding 
Recreational Marijuana Users After Receiving Video Clip. 
Control Sample 







B Std. Error Beta   
Level of Contact -0.06 0.04 -0.15 .097 0.05 
Ever Used -1.63 0.29 -0.51 .001 0.23 
Interaction 0.09 0.08 0.10 .266 0.01 
Total     0.29 
Note: Interaction is defined as Level of Contact x Ever Used. 
Dependent Variable: Post-Negative Emotions 
* p <0.05, two-tailed test ** p <0.001, two-tailed test 
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Appendix O Table 35  
Hypothesis 3i-4: Path Analysis Model Examining the Moderating Effects of Ever 
Personally Using Marijuana on the Level of Contact and Negative Emotions Regarding 
Recreational Marijuana Users After Receiving Module. 
Psychoeducational 







B Std. Error Beta   
Level of Contact -0.15 0.03 -0.39 .001 0.24 
Ever Used -0.93 0.26 -0.31 .001 0.08 
Interaction 0.10 0.07 0.12 .153 0.01 
Total     0.33 
Note: Interaction is defined as Level of Contact x Ever Used. 
Dependent Variable: Post-Negative Emotions 





Appendix O Table 36  
Hypothesis 3j-1: Path Analysis Model Examining the Moderating Effects of Ever 
Personally Using Marijuana on the Level of Familiarity and Preferred Social Distance 
Before Receiving Video Clip. 
Control Sample 







B Std. Error Beta   
Level of Familiarity -0.14 0.04 -0.37 .001 0.32 
Ever Used 0.54 0.17 0.34 .002 0.08 
Interaction 0.02 0.08 0.03 .772 0.00 
Total     0.40 
Note: Interaction is defined as Level of Familiarity x Ever Used. 
Dependent Variable: Pre-Preferred Social Distance 




Appendix O Table 37  
Hypothesis 3j-2: Path Analysis Model Examining the Moderating Effects of Ever 
Personally Using Marijuana on the Level of Familiarity and Preferred Social Distance 
After Receiving Video Clip. 
Control Sample 







B Std. Error Beta   
Level of Familiarity -0.13 0.04 -0.35 .001 0.30 
Ever Used 0.60 0.16 0.38 .001 0.11 
Interaction 0.01 0.08 0.02 .869 0.00 
Total     0.41 
Note: Interaction is defined as Level of Familiarity x Ever Used. 
Dependent Variable: Post-Preferred Social Distance 





Appendix O Table 38  
Hypothesis 3j-3: Path Analysis Model Examining the Moderating Effects of Ever 
Personally Using Marijuana on the Level of Familiarity and Preferred Social Distance 
Before Receiving Module. 
Psychoeducational 







B Std. Error Beta   
Level of Familiarity -1.83 0.43 -0.52 .001 0.33 
Ever Used -0.14 0.20 -0.09 .485 0.01 
Interaction 0.42 0.89 0.04 .639 0.00 
Total     0.34 
Note: Interaction is defined as Level of Familiarity x Ever Used. 
Dependent Variable: Pre-Preferred Social Distance 




Appendix O Table 39  
Hypothesis 3j-4: Path Analysis Model Examining the Moderating Effects of Ever 
Personally Using Marijuana on the Level of Familiarity and Preferred Social Distance 
After Receiving Module. 
Psychoeducational 







B Std. Error Beta   
Level of Familiarity -2.10 0.43 -0.59 .001 0.37 
Ever Used -0.04 0.20 -0.03 .845 0.00 
Interaction -0.10 0.89 -0.01 .915 0.00 
Total     0.37 
Note: Interaction is defined as Level of Familiarity x Ever Used. 
Dependent Variable: Post-Preferred Social Distance 





Appendix O Table 40  
Hypothesis 3k-1: Path Analysis Model Examining the Moderating Effects of Ever 
Personally Using Marijuana on the Level of Familiarity and Perceived Dangerousness 
Before Receiving Video Clip. 
Control Sample 







B Std. Error Beta   
Level of Familiarity 0.13 0.06 0.25 .021 0.20 
Ever Used -0.80 0.25 -0.37 .002 0.09 
Interaction 0.03 0.12 0.03 .789 0.00 
Total     0.29 
Note: Interaction is defined as Level of Familiarity x Ever Used. 
Dependent Variable: Pre-Perceived Dangerousness 




Appendix O Table 41  
Hypothesis 3k-2: Path Analysis Model Examining the Moderating Effects of Ever 
Personally Using Marijuana on the Level of Familiarity and Perceived Dangerousness 
After Receiving Video Clip. 
Control Sample 







B Std. Error Beta   
Level of Familiarity 0.14 0.06 0.26 .015 0.19 
Ever Used -0.73 0.25 -0.34 .004 0.09 
Interaction -0.01 0.12 -0.01 .909 0.00 
Total     0.28 
Note: Interaction is defined as Level of Familiarity x Ever Used. 
Dependent Variable: Post-Perceived Dangerousness 





Appendix O Table 42  
Hypothesis 3k-3: Path Analysis Model Examining the Moderating Effects of Ever 
Personally Using Marijuana on the Level of Familiarity and Perceived Dangerousness 
Before Receiving Module. 
Psychoeducational 







B Std. Error Beta   
Level of Familiarity -1.69 0.60 -0.36 .006 0.25 
Ever Used -0.47 0.28 -0.23 .095 0.02 
Interaction 1.64 1.25 0.12 .192 0.01 
Total     0.28 
Note: Interaction is defined as Level of Familiarity x Ever Used. 
Dependent Variable: Pre-Perceived Dangerousness 




Appendix O Table 43  
Hypothesis 3k-4: Path Analysis Model Examining the Moderating Effects of Ever 
Personally Using Marijuana on the Level of Familiarity and Perceived Dangerousness 
After Receiving Module. 
Psychoeducational 







B Std. Error Beta   
Level of Familiarity -2.08 0.69 -0.39 .003 0.22 
Ever Used -0.32 0.32 -0.14 .319 0.01 
Interaction 1.62 1.44 0.11 .263 0.01 
Total     0.24 
Note: Interaction is defined as Level of Familiarity x Ever Used. 
Dependent Variable: Post-Perceived Dangerousness 





Appendix O Table 44 
Hypothesis 3l-1: Path Analysis Model Examining the Moderating Effects of Ever 
Personally Using Marijuana on the Level of Familiarity and Negative Emotions 
Regarding Recreational Marijuana Users Before Receiving Video Clip. 
Control Sample 







B Std. Error Beta   
Level of Familiarity -0.25 0.07 -0.34 .001 0.30 
Ever Used 1.05 0.31 0.35 .001 0.11 
Interaction 0.12 0.15 0.08 .401 0.00 
Total     0.41 
Note: Interaction is defined as Level of Familiarity x Ever Used. 
Dependent Variable: Pre-Negative Emotions 




Appendix O Table 45  
Hypothesis 3l-2: Path Analysis Model Examining the Moderating Effects of Ever 
Personally Using Marijuana on the Level of Familiarity and Negative Emotions 
Regarding Recreational Marijuana Users After Receiving Video Clip. 
Control Sample 







B Std. Error Beta   
Level of Familiarity -0.27 0.07 -0.35 .001 0.29 
Ever Used 0.97 0.32 0.31 .004 0.09 
Interaction 0.14 0.16 0.09 .356 0.01 
Total     0.39 
Note: Interaction is defined as Level of Familiarity x Ever Used. 
Dependent Variable: Post-Negative Emotions 






Appendix O Table 46  
Hypothesis 3l-3: Path Analysis Model Examining the Moderating Effects of Ever 
Personally Using Marijuana on the Level of Familiarity and Negative Emotions 
Regarding Recreational Marijuana Users Before Receiving Module. 
Psychoeducational 







B Std. Error Beta   
Level of Familiarity -2.36 0.91 -0.34 .011 0.23 
Ever Used -0.64 0.42 -0.21 .131 0.01 
Interaction 1.64 1.89 0.08 .387 0.01 
Total     0.25 
Note: Interaction is defined as Level of Familiarity x Ever Used. 
Dependent Variable: Pre-Negative Emotions 








Appendix O Table 48  
Hypothesis 3m-1: Path Analysis Model Examining the Moderating Effects of Age on the 
Level of Contact and Preferred Social Distance Before Receiving Video Clip. 
Control Sample 







B Std. Error Beta   
Level of Contact -0.06 0.02 -0.31 .001 0.09 
Age -0.20 0.05 -0.42 .001 0.18 
Interaction 0.00 0.02 0.01 .911 0.00 
Total     0.27 
Note: Interaction is defined as Level of Contact x Age. 
Dependent Variable: Pre-Preferred Social Distance 
* p <0.05, two-tailed test ** p <0.001, two-tailed test 
Appendix O Table 47  
Hypothesis 3l-4: Path Analysis Model Examining the Moderating Effects of Ever 
Personally Using Marijuana on the Level of Familiarity and Negative Emotions 
Regarding Recreational Marijuana Users After Receiving Module. 
Psychoeducational 







B Std. Error Beta   
Level of Familiarity -2.28 0.89 -0.34 .012 0.22 
Ever Used -0.59 0.41 -0.20 .154 0.02 
Interaction 0.89 1.84 0.05 .628 0.00 
Total     0.24 
Note: Interaction is defined as Level of Familiarity x Ever Used. 
Dependent Variable: Post-Negative Emotions 









Appendix O Table 50  
Hypothesis 3m-3: Path Analysis Model Examining the Moderating Effects of Age on the 
Level of Contact and Preferred Social Distance Before Receiving Module. 
Psychoeducational 







B Std. Error Beta   
Level of Contact -0.12 0.02 -0.57 .001 0.31 
Age 0.08 0.07 0.09 .284 0.01 
Interaction 0.00 0.02 0.02 .832 0.00 
Total     0.32 
Note: Interaction is defined as Level of Contact x Age. 
Dependent Variable: Pre-Preferred Social Distance 
* p <0.05, two-tailed test ** p <0.001, two-tailed test 
Appendix O Table 49  
Hypothesis 3m-2: Path Analysis Model Examining the Moderating Effects of Age on the 
Level of Contact and Preferred Social Distance After Receiving Video Clip. 
Control Sample 







B Std. Error Beta   
Level of Contact -0.06 0.02 -0.31 .001 0.09 
Age -0.21 0.05 -0.44 .001 0.20 
Interaction 0.00 0.02 0.00 .975 0.00 
Total     0.29 
Note: Interaction is defined as Level of Contact x Age. 
Dependent Variable: Post-Preferred Social Distance 









Appendix O Table 52  
Hypothesis 3n-1: Path Analysis Model Examining the Moderating Effects of Age on the 
Level of Contact and Perceived Dangerousness Before Receiving Video Clip. 
Control Sample 







B Std. Error Beta   
Level of Contact 0.03 0.03 0.10 .304 0.01 
Age 0.26 0.07 0.39 .001 0.14 
Interaction 0.01 0.03 0.03 .790 0.00 
Total     0.15 
Note: Interaction is defined as Level of Contact x Age. 
Dependent Variable: Pre-Perceived Dangerousness 
* p <0.05, two-tailed test ** p <0.001, two-tailed test 
Appendix O Table 51  
Hypothesis 3m-4: Path Analysis Model Examining the Moderating Effects of Age on the 
Level of Contact and Preferred Social Distance After Receiving Module. 
Psychoeducational 







B Std. Error Beta   
Level of Contact -0.13 0.02 -0.61 .001 0.36 
Age 0.04 0.07 0.05 .539 0.00 
Interaction -0.01 0.02 -0.06 .429 0.01 
Total     0.37 
Note: Interaction is defined as Level of Contact x Age. 
Dependent Variable: Post-Preferred Social Distance 









Appendix O Table 54  
Hypothesis 3n-3: Path Analysis Model Examining the Moderating Effects of Age on the 
Level of Contact and Perceived Dangerousness Before Receiving Module. 
Psychoeducational 







B Std. Error Beta   
Level of Contact -0.12 0.02 -0.45 .001 0.21 
Age -0.04 0.10 -0.03 .733 0.00 
Interaction 0.01 0.03 0.02 .805 0.00 
Total     0.21 
Note: Interaction is defined as Level of Contact x Age. 
Dependent Variable: Pre-Perceived Dangerousness 
* p <0.05, two-tailed test ** p <0.001, two-tailed test 
Appendix O Table 53  
Hypothesis 3n-2: Path Analysis Model Examining the Moderating Effects of Age on the 
Level of Contact and Perceived Dangerousness After Receiving Video Clip. 
Control Sample 







B Std. Error Beta   
Level of Contact 0.04 0.03 0.14 .156 0.02 
Age 0.23 0.07 0.36 .001 0.13 
Interaction -0.01 0.03 -0.03 .806 0.00 
Total     0.15 
Note: Interaction is defined as Level of Contact x Age. 
Dependent Variable: Post-Perceived Dangerousness 








Appendix O Table 56  
Hypothesis 3o-1: Path Analysis Model Examining the Moderating Effects of Age on the 
Level of Contact and Negative Emotions Regarding Recreational Marijuana Users 
Before Receiving Video Clip. 
Control Sample 







B Std. Error Beta   
Level of Contact -0.09 0.03 -0.23 .011 0.05 
Age -0.45 0.09 -0.49 .001 0.22 
Interaction -0.01 0.03 -0.02 .824 0.00 
Total     0.27 
Note: Interaction is defined as Level of Contact x Age. 
Dependent Variable: Pre-Negative Emotions 
* p <0.05, two-tailed test ** p <0.001, two-tailed test 
Appendix O Table 55 
Hypothesis 3n-4: Path Analysis Model Examining the Moderating Effects of Age on the 
Level of Contact and Perceived Dangerousness After Receiving Module. 
Psychoeducational 







B Std. Error Beta   
Level of Contact -0.13 0.03 -0.42 .001 0.18 
Age -0.01 0.12 -0.01 .912 0.00 
Interaction -0.01 0.03 -0.03 .732 0.00 
Total     0.18 
Note: Interaction is defined as Level of Contact x Age. 
Dependent Variable: Post-Perceived Dangerousness 







Appendix O Table 58  
Hypothesis 3o-3: Path Analysis Model Examining the Moderating Effects of Age on the 
Level of Contact and Negative Emotions Regarding Recreational Marijuana Users 
Before Receiving Module. 
Psychoeducational 







B Std. Error Beta   
Level of Contact -0.21 0.04 -0.52 .001 0.27 
Age 0.05 0.15 0.03 .753 0.00 
Interaction 0.02 0.04 0.04 .641 0.00 
Total     0.27 
Note: Interaction is defined as Level of Contact x Age. 
Dependent Variable: Pre-Negative Emotions 
* p <0.05, two-tailed test ** p <0.001, two-tailed test 
 
Appendix O Table 57  
Hypothesis 3o-2: Path Analysis Model Examining the Moderating Effects of Age on the 
Level of Contact and Negative Emotions Regarding Recreational Marijuana Users After 
Receiving Video Clip. 
Control Sample 







B Std. Error Beta   
Level of Contact -0.10 0.04 -0.25 .007 0.05 
Age -0.45 0.09 -0.47 .001 0.22 
Interaction -0.00 0.03 -0.01 .936 0.00 
Total     0.27 
Note: Interaction is defined as Level of Contact x Age. 
Dependent Variable: Post-Negative Emotions 
* p <0.05, two-tailed test ** p <0.001, two-tailed test 
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Appendix O Table 59  
Hypothesis 3o-4: Path Analysis Model Examining the Moderating Effects of Age on the 
Level of Contact and Negative Emotions Regarding Recreational Marijuana Users After 
Receiving Module. 
Psychoeducational 







B Std. Error Beta   
Level of Contact -0.19 0.03 -0.49 .001 0.24 
Age 0.07 0.15 0.05 .612 0.00 
Interaction 0.00 0.04 0.00 .995 0.00 
Total     0.24 
Note: Interaction is defined as Level of Contact x Age. 
Dependent Variable: Post-Negative Emotions 






Appendix O Table 60  
Hypothesis 3p-3: Path Analysis Model Examining the Moderating Effects of Age on the 
Level of Familiarity and Preferred Social Distance Before Receiving Module. 
Psychoeducational 







B Std. Error Beta   
Level of Familiarity -2.05 0.29 -0.58 .001 0.33 
Age 0.09 0.07 0.10 .230 0.02 
Interaction 0.56 0.32 0.14 .083 0.02 
Total     0.37 
Note: Interaction is defined as Level of Familiarity x Age. 
Dependent Variable: Pre-Preferred Social Distance 









Appendix O Table 62  
Hypothesis 3q-1: Path Analysis Model Examining the Moderating Effects of Age on the 
Level of Familiarity and Perceived Dangerousness Before Receiving Video Clip. 
Control Sample 







B Std. Error Beta   
Level of Familiarity 2.22 0.54 0.38 .001 0.20 
Age 0.21 0.07 0.32 .005 0.07 
Interaction -0.27 0.42 -0.07 .512 0.00 
Total     0.27 
Note: Interaction is defined as Level of Familiarity x Age. 
Dependent Variable: Pre-Perceived Dangerousness 
* p <0.05, two-tailed test ** p <0.001, two-tailed test 
Appendix O Table 61  
Hypothesis 3p-4: Path Analysis Model Examining the Moderating Effects of Age on the 
Level of Familiarity and Preferred Social Distance After Receiving Module. 
Psychoeducational 







B Std. Error Beta   
Level of Familiarity -2.18 0.29 -0.61 .001 0.36 
Age 0.05 0.07 0.06 .481 0.01 
Interaction 0.28 0.32 0.07 .379 0.01 
Total     0.38 
Note: Interaction is defined as Level of Familiarity x Age. 
Dependent Variable: Post-Preferred Social Distance 









Appendix O Table 64  
Hypothesis 3q-3: Path Analysis Model Examining the Moderating Effects of Age on the 
Level of Familiarity and Perceived Dangerousness Before Receiving Module. 
Psychoeducational 







B Std. Error Beta   
Level of Familiarity -2.35 0.42 -0.50 .001 0.25 
Age -0.01 0.10 -0.01 .952 0.00 
Interaction 0.21 0.46 0.04 .659 0.00 
Total     0.25 
Note: Interaction is defined as Level of Familiarity x Age. 
Dependent Variable: Pre-Perceived Dangerousness 
* p <0.05, two-tailed test ** p <0.001, two-tailed test 
Appendix O Table 63  
Hypothesis 3q-2: Path Analysis Model Examining the Moderating Effects of Age on the 
Level of Familiarity and Perceived Dangerousness After Receiving Video Clip. 
Control Sample 







B Std. Error Beta   
Level of Familiarity 2.19 0.53 0.38 .001 0.19 
Age 0.22 0.07 0.34 .003 0.07 
Interaction -0.43 0.41 -0.12 .294 0.01 
Total     0.27 
Note: Interaction is defined as Level of Familiarity x Age. 
Dependent Variable: Post-Perceived Dangerousness 








Appendix O Table 66  
Hypothesis 3r-1: Path Analysis Model Examining the Moderating Effects of Age on the 
Level of Familiarity and Negative Emotions Regarding Recreational Marijuana Users 
Before Receiving Video Clip. 
Control Sample 







B Std. Error Beta   
Level of Familiarity -3.77 0.65 -0.47 .001 0.30 
Age -0.39 0.09 -0.43 .001 0.12 
Interaction 0.64 0.50 0.12 .204 0.01 
Total     0.43 
Note: Interaction is defined as Level of Familiarity x Age. 
Dependent Variable: Pre-Negative Emotions 
* p <0.05, two-tailed test ** p <0.001, two-tailed test 
Appendix O Table 65  
Hypothesis 3q-4: Path Analysis Model Examining the Moderating Effects of Age on the 
Level of Familiarity and Perceived Dangerousness After Receiving Module. 
Psychoeducational 







B Std. Error Beta   
Level of Familiarity -2.51 0.47 -0.47 .001 0.22 
Age 0.02 0.12 0.01 .887 0.00 
Interaction 0.08 0.53 0.01 .888 0.00 
Total     0.22 
Note: Interaction is defined as Level of Familiarity x Age. 
Dependent Variable: Post-Perceived Dangerousness 







Appendix O Table 68  
Hypothesis 3r-3: Path Analysis Model Examining the Moderating Effects of Age on the 
Level of Familiarity and Negative Emotions Regarding Recreational Marijuana Users 
Before Receiving Module. 
Psychoeducational 







B Std. Error Beta   
Level of Familiarity -3.34 0.62 -0.48 .001 0.23 
Age 0.07 0.15 0.04 .641 0.00 
Interaction 0.48 0.70 0.06 .496 0.00 
Total     0.23 
Note: Interaction is defined as Level of Familiarity x Age. 
Dependent Variable: Pre-Negative Emotions 
* p <0.05, two-tailed test ** p <0.001, two-tailed test 
 
Appendix O Table 67  
Hypothesis 3r-2: Path Analysis Model Examining the Moderating Effects of Age on the 
Level of Familiarity and Negative Emotions Regarding Recreational Marijuana Users 
After Receiving Video Clip. 
Control Sample 







B Std. Error Beta   
Level of Familiarity -3.88 0.68 -0.47 .001 0.29 
Age -0.41 0.09 -0.43 .001 0.12 
Interaction 0.78 0.53 0.15 .141 0.01 
Total     0.42 
Note: Interaction is defined as Level of Familiarity x Age. 
Dependent Variable: Post-Negative Emotions 
* p <0.05, two-tailed test ** p <0.001, two-tailed test 
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Appendix O Table 69  
Hypothesis 3r-4: Path Analysis Model Examining the Moderating Effects of Age on the 
Level of Familiarity and Negative Emotions Regarding Recreational Marijuana Users 
After Receiving Module. 
Psychoeducational 







B Std. Error Beta   
Level of Familiarity -3.24 0.60 -0.48 .001 0.22 
Age 0.10 0.15 0.06 .511 0.01 
Interaction 0.39 0.68 0.05 .565 0.00 
Total     0.23 
Note: Interaction is defined as Level of Familiarity x Age. 
Dependent Variable: Post-Negative Emotions 
* p <0.05, two-tailed test ** p <0.001, two-tailed test 
 
 
 
 
